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Abstract 
 
The hypothalamo-pituitary-adrenal (HPA) axis is the main regulator of stress in mammals, and 
prolongation of the stress response can lead to manifestation of metabolic and psychiatric 
disorders.  Leptin is an adipokine known to act at the hypothalamus to regulate body fat stores, 
appetite and energy expenditure, but the role of leptin on the HPA response to stress is still not 
well understood.  Psychological stress, specifically loneliness in humans - referred to as social 
isolation (SI) in social mammals - can also alter HPA functioning.  The work described in this 
thesis investigates the effects of leptin and SI on the HPA response to acute stress.   
 
My studies suggest that leptin does not influence basal HPA activity, or influence the HPA 
response to acute endotoxin challenge in rats.  They also show that SI does not affect basal 
HPA activity, but that short term chronic SI does cause hyperactivity of the HPA in response to 
acute restraint stress, and that the stress axis is hyper-sensitised at the level of the 
hypothalamus and the adrenal gland after this period of SI.  My work suggests that this HPA 
hyperactivity may be the result of an overactive CRH feed-forward mechanism.  I have also 
shown that short term intermittent SI and long term chronic SI both cause hypoactivity of the 
HPA axis response to acute restraint stress, with the former regulated by an unknown 
mechanism and the latter possibly regulated by an overactive glucocorticoid feedback 
mechanism. 
 
In summary, these studies have highlighted the complex differential activation of the HPA axis in 
response to different types of stressors; both immunological and psychological.  I have also 
demonstrated the different effects of novel SI paradigms on HPA response to acute stress, and 
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how such psychological stress can impair the functioning of a key system in the body that may 
be involved in metabolic and psychiatric disease.  
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1.1 Stress 
 
Living organisms maintain a dynamic equilibrium with their environment at the behavioural, 
physiological, cellular and molecular level.  Stress is the body’s response to an acute disruption 
of this equilibrium, and survival requires the organism to adapt accordingly, resulting in a 
controlled response to the perceived stressor (O'Connor et al., 2000).  The 
hypothalamo‐pituitary‐adrenal (HPA) axis is the main regulator of stress in mammals.  While the 
HPA axis has a well-characterized circadian pattern, physical and emotional stressors can alter 
this pattern and disrupt normal neuroendocrine function.  The adaptive stress response results 
in a number of behavioural changes that allow the body to focus on the threat.  At the 
physiological level, central and peripheral changes evoke the redirection of energy to sites of 
stress, muscles and the central nervous system (CNS).  Brain function and attention is 
enhanced, cardiac output and respiration are accelerated, and blood pressure is elevated 
(Kyrou and Tsigos, 2009).  However, prolongation of the stress response results in impairment 
of key physiological functions, such as metabolism, growth, reproduction, immune-competence 
and behaviour (McEwen, 1998).  The effects of chronic stress on the body’s metabolism 
(Chrousos, 2009) are linked to manifestation of the metabolic syndrome commonly associated 
with obesity.  Metabolic syndrome is a complex disorder comprising abdominal obesity, 
dyslipidemia, hyperglycaemia, and hypertension that is associated with an increased risk of type 
2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and atherosclerosis (Holvoet, 2008, 
Laaksonen et al., 2002, Lakka et al., 2002).  An exaggerated stress response is also strongly 
associated with psychiatric disorders, including melancholic depression (O'Connor et al., 2000), 
anorexia nervosa (Kaye et al., 1987), panic disorder (Gold et al., 1988) and schizophrenia and 
anxiety disorders (Weiss et al., 2004).    
  
25 
 
1.1.1 Anatomy & physiology of the hypothalamo-pituitary-adrenocortical (HPA) 
axis  
The HPA axis is comprised of the hypothalamus, and the pituitary and adrenal glands; it is a 
major neuroendocrine system that regulates the stress response.    
1.1.1.2 The hypothalamus 
The hypothalamus is a double diencephalic structure in the brain, located just below the 
thalamus and above the brainstem.  The adult human hypothalamus has a volume of 
approximately 104 cm3 (Lemaire et al., 2013).  It regulates many metabolic processes, including 
hunger, thirst, body temperature, sleep, circadian cycles and emotional behaviour (Mayer et al., 
1952, Rodbard, 1948, Davison and Demuth, 1946).  In accord with these many and varied 
functions, the hypothalamus is connected to a vast number of inputs and outputs, making it 
responsive to light and olfactory stimuli, steroids, neural transmission from regions such as the 
heart, stomach and reproductive tract, stressful stimuli and invading microorganisms (Busnardo 
et al., 2012, Faber and Gebhardt, 1933, Wren et al., 2000, Davison and Demuth, 1946, 
Osterlund and Spencer, 2011).  Peripheral signals can be relayed to the hypothalamus via the 
brainstem, vagus nerve and directly from the circulation. Hormones and nutrients in the blood 
can access the hypothalamus via specific transport mechanisms and via the incomplete blood-
brain barrier (BBB) at the hypothalamic median eminence (ME) which allows specific circulating 
factors direct access to the CNS (Gross, 1992).  The hypothalamus is comprised of distinct 
nuclei that release different hormones and respond to different neuropeptides, each with a 
specific function and target as illustrated in Tables 1.1-1.2 and Figure 1.1.  Most hypothalamic-
releasing hormones are targeted to the pituitary gland via the hypophyseal portal system 
(Besser and Mortimer, 1974).  The magnocellular cells of two of these nuclei, the hypothalamic 
paraventricular (PVN) and supraoptic (SON) nuclei comprise the posterior pituitary while the 
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parvocellular neurons of the PVN release corticotrophin-releasing hormone (CRH) into the 
hypophyseal portal system to act on the anterior pituitary.    
 
 
 
 
 
 
 
 
 
 
27 
 
 
 
FIGURE 1.1 Schematic three dimensional view of the rat hypothalamus; dorsal and 
caudal view of the right hemisphere.  Abbreviations: AHA, anterior hypothalamic area; ARC, 
arcuate nucleus; AV3V, anteroventral area of third ventricle; CI, capsula interna; DP, dorsal 
parvocellular subnucleus of PVN; DMN, dorsomedial nucleus; LHA, lateral hypothalamic area; 
LM, lateral magnocellular subnucleus of PVN; LPOA, lateral preoptic area; ME, median 
eminence; MP, medial parvocellular PVN; MPO, medial preoptic area; OT, optic tract; SCh, 
suprachiasmatic nucleus; SON, supraoptic nucleus; ST, subthalamic nucleus; VMN, 
ventromedial nucleus; VP, ventral parvocellular subnucleus of PVN. Adapted from (Berthoud, 
2002). 
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TABLE 1.1 Nuclei of the hypothalamus, their secretions and hypothesized roles.  Abbreviations: CRH, corticotrophin-releasing 
hormone; GABA, gamma-aminobutyric acid; GHRH, growth-hormone-releasing hormone; GnRH, gonadotropin-releasing hormone; 
REM, rapid eye movement; TRH, thyrotropin-releasing  hormone.  
 
Hypothalamic Nucleus  Abbreviation  Function  
Median preoptic nucleus  MnPO  Secretes noradrenaline, regulates thirst (Miyakubo et al., 2003).  
Medial preoptic nucleus  MPON  Secretes GnRH, controls copulation in males (Sinchak and Micevych, 2003).  
Ventrolateral preoptic 
nucleus  
VLPO  Secretes inhibitory neurotransmitters such as galanin and GABA, mediates non-REM sleep onset 
(Luppi, 2010).  
Supraoptic nucleus  SO  Secretes oxytocin and vasopressin (Trudel and Bourque, 2012).  
Suprachiasmatic nucleus  SCh Secretes vasopressin, controls circadian rhythms (Giolli et al., 2006).  
Paraventricular nucleus  PVN  Secretes CRH, GHRH, GnRH, TRH, oxytocin, vasopressin, somatostatin and dopamine, controls 
feeding and the stress response (Pego et al., 2010).  
Dorsomedial hypothalamic 
nucleus  
DMN  Regulates feeding, drinking, body-weight and circadian activity (Chou et al., 2003).  
Median Eminence  ME  Part of the hypothalamus from which regulatory hormones are secreted (Levine et al., 2011).  
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TABLE 1.1 Continued 
 
Hypothalamic Nucleus  Abbreviation  Function  
Ventromedial nucleus  VMN  Neuroendocrine control: regulates satiety, fear, thermoregulation, and sexual activity (Kurrasch et al., 
2007).  
Arcuate Nucleus  ARC  Secretes GHRH and dopamine, regulates feeding and stress (Arora and Anubhuti, 2006).  
Anterior hypothalamic 
nucleus  
AH  Involved in thermoregulation, regulates panting and sweating, and inhibits thyrotropin (Onoe et al., 
1992).  
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TABLE 1.2 Hypothalamic-releasing hormones, their site of production and their effects.  Abbreviations: ACTH, 
adrenocorticotropic hormone; ARC, arcuate nucleus; FSH, follicle-stimulating hormone; GH, growth hormone; LH, luteinizing 
hormone; MPON, medial preoptic nucleus; PVN, paraventricular nucleus; SON, supraoptic nucleus, TSH, thyroid-stimulating  
hormone.  Adapted from (Schally et al., 1973).    
 
Hormone Abbreviation Site of production Effect 
Thyrotropin-releasing 
hormone 
TRH Parvocellular neurons of 
the PVN 
Stimulates TSH and prolactin release from the anterior pituitary. 
Dopamine DA ARC Inhibits prolactin release from the anterior pituitary. 
Growth hormone-releasing 
hormone 
GHRH ARC Stimulates GH release from the anterior pituitary. 
Somatostatin SS Periventricular nucleus Inhibits GH release from the anterior pituitary, inhibits TSH 
release from the anterior pituitary. 
Gonadotropin-releasing 
hormone 
GnRH MPON Stimulates FSH release from the anterior pituitary. 
Stimulates LH release from the anterior pituitary. 
Corticotropin-releasing 
hormone 
CRH Parvocellular neurons of 
the PVN 
Stimulates ACTH release from the anterior pituitary. 
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TABLE 1.2 Continued 
 
Hormone Abbreviation Site of production Effect 
Oxytocin  Magnocellular neurosecretory neurons of 
the SON and PVN 
Controls uterine contraction 
and lactation. 
Vasopressin AVP Magnocellular neurosecretory neurons of 
the SON and PVN 
Regulates water retention by increasing absorption in the 
collecting ducts of the kidney nephron. 
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The hypothalamus is home to the primary mediators of the stress system; CRH and arginine 
vasopressin (AVP).  Both hypothalamic hormones are secreted in a synchronized fashion, with 
higher secretory pulses in the early morning that are reduced in magnitude moving into the dark 
phase in humans (Veldhuis et al., 1990).  CRH is a 41 amino acid neuropeptide originally 
isolated from the ovine hypothalamus (Seasholtz et al., 1991).   
 
CRH was first determined to be involved in the stress response when, in the 1980’s, 
researchers found that intracerebroventricular (ICV) administration of CRH to rats reproduced 
the stress response, by specifically stimulating adrenocorticotropic hormone (ACTH) and β-
endorphin from the pituitary gland (Vale et al., 1981).  During an acute stress response, 
cytokines and inflammatory mediators stimulate CRH and AVP release from the parvocellular 
neurons of the PVN into the hypophyseal portal system, as illustrated in Figure 1.2.  The 
hypophyseal portal system is a set of blood vessels that link the hypothalamus to the anterior 
pituitary, allowing cross-talk between the two structures.  Once in the portal system, both CRH 
and AVP regulate ACTH secretion from the anterior pituitary gland (Vale et al., 1981, Lamberts 
et al., 1984).  CRH is a powerful stimulator of ACTH release from the pituitary.  Whilst AVP has 
little effect on its own on basal ACTH release, it acts synergistically with CRH to stimulate ACTH 
release (Lamberts et al., 1984).  During a stress response, additional AVP is thought to be 
released from the magnocellular cells of the PVN, resulting in a higher CRH-AVP stimulatory 
effect on pituitary ACTH release (Holmes et al., 1986).  CRH and AVP are stimulated by 
serotonergic and cholinergic signalling systems of the brain, and are inhibited by the gamma-
aminobutyric acid (GABA) system, glucocorticoids, ACTH and CRH itself (Chrousos, 1995).             
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FIGURE 1.2 Schematic diagram of the HPA axis stress cascade and negative feedback 
mechanism. Abbreviations: CRH, corticotrophin-releasing hormone; ACTH, adrenocorticotropic 
hormone.  Adapted from (Stangor, 2011).  
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The hypothalamus also has an important role in appetite regulation.  Early experiments 
involving lesions of the specific regions of the hypothalamus suggested that the lateral 
hypothalamic area (LHA) controlled hunger and that the ventromedial nucleus (VMN) controlled 
satiety (Mayer and Thomas, 1967).  It is now known that many other hypothalamic nuclei are 
involved in appetite regulation (Arora and Anubhuti, 2006, Bouret, 2010).  The hypothalamic 
arcuate nucleus (ARC) sits adjacent to the ME and has neuronal projections into the ME.  It 
contains two neuronal populations with opposing effects on food intake.  Neurons which express 
neuropeptide Y (NPY) and agouti related peptide (AgRP) stimulate food intake (Clark et al., 
1984, Rossi et al., 1998), whilst neurons expressing pro-opiomelanocortin (POMC) and cocaine 
and amphetamine regulated transcript (CART) inhibit food intake (Kristensen et al., 1998, 
Aponte et al., 2011).  Whilst both neuronal populations project to the PVN, the ARC also 
projects to the hypothalamic dorsomedial nucleus (DMN), LHA and VMN (Suzuki et al., 2010).  
POMC neurons release α-melanocyte-stimulating hormone (α-MSH) which binds to 
melanocortin-4 receptors (MC4R) in regions including the PVN to inhibit feeding (Schwartz et 
al., 2000).  The hyperphagia and obesity observed in MC4R knock-out mice suggests that the 
melanocortin system plays an important physiological role in the regulation of food intake and 
body weight (Huszar et al., 1997).  The PVN also contains neurons that express thyrotropin-
releasing hormone (TRH), the secretagogue of thyroid-stimulating hormone (TSH) from the 
anterior pituitary.  Both hormones regulate growth and thyroid function.  TRH and the stress 
hormone CRH may have an anorexigenic role in appetite regulation (Valassi et al., 2008, Vettor 
et al., 2002), with central injection of TRH in rats promoting a negative energy balance (al-Arabi 
and Andrews, 2003) and central administration of CRH reducing body weight in rats (Vettor et 
al., 2002). 
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1.1.1.2 Pituitary gland  
The pituitary gland is a small endocrine gland of the brain, and in adult humans has a height of 
approximately 8 mm (Yousem and Grossman, 2010).  It sits at the base of the brain and is 
connected to the hypothalamus by the pituitary stalk and the pars tuberalis.  The pituitary gland 
is split into two main sections; the posterior and anterior lobes.  The posterior lobe is directly 
connected to the hypothalamus. The hypothalamic magnocellular neurosecretory nerve 
terminals reside in the posterior pituitary, where oxytocin and AVP are secreted.  The anterior 
pituitary is regulated by hypothalamic hormones via the hypothalamo-hypophyseal portal 
system.  The anterior pituitary synthesizes and secretes growth hormone (GH), TSH, prolactin 
(PRL), luteinizing hormone (LH), follicle-stimulating hormone (FSH), ACTH, β-endorphin and 
small amounts of α-MSH.  The synthesis and secretion of these hormones are regulated by the 
hypothalamus (Gibo et al., 1993, Knepel et al., 1984).  In response to a stressful stimulus, 
hypothalamic CRH and AVP are not only secreted from parvocellular PVN neurons, but are also 
released from a ME store and travel in the hypophyseal portal circulation to act directly on 
corticotroph cells of the anterior pituitary to stimulate the release of ACTH (Lamberts et al., 
1984), a 39 amino acid peptide hormone.   
 
 
ACTH is a product of POMC, which undergoes a series of post-translational modifications 
involving proteolytic cleavage by endopeptidases (see Figure 1.3).  These enzymes break down 
POMC into various polypeptide fragments including ACTH, α-MSH and β-endorphin (Bertagna, 
1994).  Release of ACTH is regulated by glucocorticoids which inhibit CRH secretion, and in 
turn decrease secretion of ACTH.  Glucocorticoids can act directly on the pituitary gland to 
regulate the rate at which the POMC gene is transcribed, as well as the rate at which the POMC 
peptide is synthesized (de Kloet et al., 2008b).  The principal effects of ACTH are to stimulate 
production and release of corticosteroids from the adrenal gland by binding to the cell surface 
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receptor, melanocortin-2 receptor (MC2R).  Abnormal functioning of the pituitary gland can lead 
to diseases including hypopituitarism, a form of pituitary hypo-function (Mitchell and Pearce, 
2012), or Cushing’s disease, a form of adrenal hypercorticism secondary to pituitary hyper-
function (Luton et al., 1983).   
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FIGURE 1.3 Schematic diagram of the POMC precursor molecule and its 
endoproteolytically cleaved peptide products.  Abbreviations: POMC, pro-opiomelanocortin; 
JP, joining peptide; ACTH, adrenocorticotropic hormone; β-LPH, β-lipotropin; CLIP, 
corticotropin-like-intermediate lobe peptide; da-α-MSH, desacetyl α-MSH; PC1/3 and PC2, 
prohormone convertases 1/3 and 2; CPE, carboxypeptidase E; N-AT, N-acetyltransferase; 
PAM, peptidyl α-amidating monooxygenase; PRCP, prolylcarboxypeptidase.  Adapted from 
(Wardlaw, 2011). 
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1.1.1.3 Adrenal gland  
In mammals, the adrenal glands are a pair of endocrine glands located immediately anterior to 
the kidneys.  Each gland measures approximately 13 mm in height and 76 mm in length.  In 
humans, the right adrenal gland is triangular shaped, while the left adrenal gland is semi-lunar 
shaped. Each adrenal gland has two distinct structures, the outer adrenal cortex and the inner 
medulla. The adrenal cortex is directly controlled by hormones released from the pituitary gland 
and primarily produces the glucocorticoids cortisol in humans, or corticosterone in rodents, 
aldosterone and androgens.  The adrenal cortex can be further split into three main zones; 1) 
the zona glomerulosa which is the outer most layer and is the major site of production of 
mineralocorticoids, mainly aldosterone, 2) the zona fasciculata which is responsible for 
producing glucocorticoids such as 11-deoxycorticosterone and cortisol and which secretes low 
levels of cortisol throughout the day but also produces bursts of cortisol in response to ACTH, 
and 3) the zona reticularis, the inner most layer of the adrenal cortex which produces 
androgens, principally dehydroepiandrosterone (DHEA) and androstenedione (Kemppainen and 
Behrend, 1997).   
 
The second major sub section of the adrenal gland, the medulla, predominantly produces 
adrenaline and noradrenaline from its chromaffin cells (Kemppainen and Behrend, 1997).  
These are the main hormones essential for the acute stress response ‘fight-or-flight’ reaction.  
The adrenal medulla receives input from the sympathetic nervous system (SNS) which is the 
major system controlling the medulla, but cortisol from the cortex can also indirectly promote 
adrenaline synthesis in the medulla (de Kloet et al., 2008b).  High levels of cortisol can 
upregulate phenylethanolamine N-methyltransferase (PNMT), an enzyme that converts 
noradrenaline to adrenaline, thereby increasing adrenaline synthesis and secretion (Wan and 
Livett, 1989).  
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The steroidogenic acute regulatory protein (StAR) plays an extremely important role in 
steroidogenesis.  StAR, primarily produced in steroid-secreting cells, is a transport protein that 
mediates the first enzymatic reaction in all steroid synthesis; it regulates cholesterol transfer 
from the outer mitochondrial membrane to the inner mitochondrial membrane, where cholesterol 
can be cleaved to pregnenolone (Stocco, 2000) (see Figure 1.5).   
 
During a stress response, ACTH from the pituitary gland stimulates secretion of glucocorticoids 
from the zona fasciculata cells of the adrenal cortex (Chrousos, 2009) (see Figure 1.2).  At the 
intracellular level, ACTH binds to its transmembrane G-protein coupled receptor, MC2R and 
stimulates production of cyclic adenosine monophosphate (cAMP), which activates protein 
kinase A (PKA), leading to the phosphorylation of the cAMP-responsive element-binding protein 
(CREB).  The activation of the transcription factor CREB, results in transcriptional activation of 
steroidogenic enzymes.  MC2R can also interact with the mitogen-activated protein kinases 
(MAPK), extracellular-signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38, 
also leading to the activation of CREB and other transcription factors like activator protein 1 (AP 
1) (see Figure 1.4).   
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FIGURE 1.4 The ACTH-activated MC2R intracellular signalling pathway.  ACTH binds 
MC2R and stimulates production of cAMP.  cAMP activates PKA, leading to the phosphorylation 
of CREB.  MC2R also activates the MAPK’s ERK, JKN and p38, also leading to the activation of 
CREB and other transcription factors, like activator protein 1 (AP 1).  This results in 
transcriptional activation of steroidogenic enzymes.  Abbreviations: cAMP, cyclic adenosine 
monophosphate; ERK, extracellular-signal-regulated kinase; JNK, c-Jun N-terminal kinase; 
PKA, protein kinase A; TFs, transcription factors; CREB-P, phosphorylated cAMP-responsive 
element-binding protein (Lasaga et al., 2008). 
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All steroids are biosynthesized from cholesterol, with most of the cholesterol precursor being 
provided by circulating plasma lipoproteins (Biason-Lauber, 1998).  Glucocorticoids are one of 
three classes of steroid hormones; the other two being mineralocorticoids and sex hormones 
which are important for salt-water balance and reproduction, respectively.  As illustrated in 
Figure 1.5, cholesterol is converted into 17OH-pregnenolone by the actions of 17-α 
hydroxylase, which is converted to 17OH-progesterone by the actions of 3β-hydroxysteroid 
dehydrogenase (3β-HSD), followed by its conversion into 11-deoxycortisol by 21-hydroxylase 
and then finally into cortisol by the actions of 11β hydroxylase. 
 
 
These glucocorticoids are released into the systemic circulation by diffusion across a 
concentration gradient across the plasma membrane of zona fasciculata cells.  Whilst 
glucocorticoids are released into the systemic circulation in a pulsatile manner according to a 
distinct circadian pattern, glucocorticoids released in response to stress superimpose upon this 
existing circadian pattern (Buckingham, 2006) and subsequently activate various physiological 
processes in the body to assist the organism to cope with stress.  
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FIGURE 1.5 Enzymatic pathways for conversion of cholesterol to steroids. Red outlined text highlights the pathway for 
conversion of cholesterol to cortisol.  Italics denote enzymes.  Adapted from (Deaton et al., 1999, Biason-Lauber, 1998).   
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1.1.1.4 Mechanism of glucocorticoid action 
Glucocorticoid- Glucocorticoid Receptor Binding  
Glucocorticoid action is principally mediated via interaction with its intracellular glucocorticoid 
receptor (GR).  The GR is formed of three functionally separate domains; the C-terminal, the 
central domain and the N-terminal.  The C-terminal is the region responsible for binding the 
glucocorticoid ligand.  When unbound to its ligand, the C-terminal of the GR is bound to two 
heat-shock proteins (HSP) that act as chaperones to prevent the unoccupied GR localizing 
to the cell nucleus.  When the glucocorticoid-GR complex is formed, dissociation of the 
HSP’s from GR occurs, as illustrated in Figure 1.6.  The central domain of the GR contains 
two zinc finger-like projections that interact with DNA; with each finger comprised of a single 
zinc molecule bound to four cysteine residues.  Finally the N-terminal of the GR contains 
specific amino acid sequences that are involved in activating or inhibiting gene transcription 
(Schoenmakers et al., 2000, Beato, 1989). 
 
There are three ways through which glucocorticoids exerts their effect.  The first is 
transactivation whereby glucocorticoids bind to GR’s to form a glucocorticoid–GR complex.  
The activated complex, now dissociated from its chaperone HSP’s, moves to the cell 
nucleus where it binds homodimerically to DNA sequences called glucocorticoid-responsive 
elements (GRE). This allows the recruitment of repressor or activator proteins that inhibit or 
facilitate the transcription of specific genes (Hebbar and Archer, 2003), for example 
increasing the transcription of genes encoding anti-inflammatory proteins such as lipocortin-
1 and interleukin-10 (IL-10) (Barnes, 1998), while also repressing the pro-inflammatory 
POMC gene (Drouin et al., 1998).  The second way glucocorticoids exert their effects is 
through interaction of the glucocorticoid–GR complex with transcription factors, such as 
nuclear factor kB (NF-kB) (McKay and Cidlowski, 1999).  This second mode of glucocorticoid 
action occurs at lower levels of cortisol than are required for the first mechanism of cortisol 
action.  Finally, the third mechanism involves non-genomic pathways such as glucocorticoid 
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signaling through membrane-associated receptors.  Studies using GR antagonists and GR-
knockout mice have demonstrated the involvement of this receptor in non-genomic 
corticosteroid signaling in neurons of the brain (Karst et al., 2010), and many other studies 
support their membrane localization (reviewed in (Groeneweg et al., 2012).  The fact that 
intracellularly administered corticosterone does not produce non-genomic effects, and 
membrane impermeable corticosterone conjugates can induce the same rapid effects as 
free corticosterone; suggests these receptors are situated outside of the plasma membrane 
(Groeneweg et al., 2012).  Furthermore, electron microscopy studies reveal GR association 
with neuronal plasma membranes and neuronal postsynaptic membranes (Johnson et al., 
2005).  In addition, some GR’s reside at the plasma membrane in lymphocytes (Bartholome 
et al., 2004).       
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FIGURE 1.6 Diagrammatic representation of glucocorticoid-GR binding and its 
intracellular effects.  Cortisol binds to the GR/HSP complex in the cytoplasm.  This leads to 
HSP dissociation and nuclear translocation of the glucocorticoid‐GR complex.  Once in the 
nucleus, the glucocorticoid‐GR complex binds to glucocorticoid-responsive elements (GRE) 
and activates target genes.  Abbreviations: GR, glucocorticoid receptor; HSP, heat shock 
protein; NF-kB, nuclear factor kB; IkB, NF-kB inhibitor; IL-1β, interleukin-1 β; TNF, tumour 
necrosis factor.  Taken from (O'Connor et al., 2000).  
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Physiological effects of Glucocorticoids 
The physiological functions of glucocorticoids are varied, including cardiovascular, 
metabolic, immunologic, and homeostatic regulation.  For example, glucocorticoids have a 
major effect on glucose homeostasis whereby circulating cortisol levels rise during periods of 
hunger in an effort to maintain normal blood glucose concentrations via gluconeogenesis 
and glycogenolysis (Wajchenberg et al., 1984).  Their effects on metabolism include 
promoting the breakdown of carbohydrate and protein and exerting complex effects on lipid 
deposition and breakdown (McKay and Cidlowski, 2003).  They also play a role in the 
development and homeostasis of T lymphocytes, directly controlling the size of both 
thymocytes and T-cell numbers (Pazirandeh et al., 2002).  Glucocorticoids also have 
permissive effects on vascular tone, such as raising blood pressure by altering the sensitivity 
of tissues to catecholamines, and they also exert aldosterone-like actions that regulate 
electrolyte and water balance (Fan et al., 1975).  Glucocorticoids exert complex, and 
sometimes damaging effects on bone (Kim, 2010) and can have both positive and negative 
effects on cell growth (Baxter, 1978).  Within the CNS, glucocorticoids target neurons and 
glial cells to support organizational activities in the brain during development, and neuronal 
plasticity in adulthood (Nichols et al., 2005, de Kloet et al., 2008a).  The other central effects 
of glucocorticoids include changes in mood/behaviour, regulation of food intake, control of 
body temperature and neuroendocrine function (Pearson Murphy, 2002).  
 
But the most important role of glucocorticoids is most certainly their regulation of the 
immunologic response to stress.  As the end product of the HPA axis, glucocorticoids 
terminate activation of the stress axis (primarily via a negative feedback mechanism) and 
regulate the processing, storage and retrieval of stressful experiences (Oitzl et al., 2001, 
Sapolsky et al., 2000).  In rats local infusion of dexamethasone, a synthetic glucocorticoid, 
into the PVN rapidly inhibits restraint-induced ACTH and corticosterone release (Evanson et 
al., 2010), while 50 µg/kg intraperitoneal (i.p) injected dexamethasone suppresses the 
corticosterone response to restraint stress by 80% and completely blocks the otherwise 
47 
 
stimulatory effects of 3 µg/kg i.p injected CRH on corticosterone secretion (Cole et al., 
2000).     
  
During a stress response, leukocytes localize at sites of inflammation and activate a cascade 
of secretory products.  To terminate the stress response glucocorticoids inhibit this 
localisation of leukocytes to inflammatory sites and impede their function, as well as 
interfering with the function of many other immune cells. The effects of glucocorticoids on 
endothelial cells are also of profound importance as these cells are the barrier between 
blood and tissue, and affect hemostasis, vascular permeability and excretion of leukocytes 
into inflammatory sites (Sternberg and Wilder, 1993). Glucocorticoids inhibit vascular 
permeability and regulate the expression of adhesion molecules critical to leukocyte 
localization (Shimizu et al., 1992, Cronstein et al., 1992).  In humans, one dose of 
glucocorticoids can markedly reduce T-lymphocyte levels by redistributing circulating 
lymphocytes to other areas such as bone marrow (Fauci and Dale, 1974, Fauci et al., 1976); 
though this effect could be due to changes in the expression of adhesion molecules as 
described above.  Glucocorticoids also antagonize macrophage differentiation (Baybutt and 
Holsboer, 1990) and therefore indirectly block the release of pro-inflammatory cytokines 
such as interleukin 1 and 6 (IL-1 and IL-6) and tumour necrosis factor (TNF) (Joyce et al., 
1997, Calandra and Bucala, 1997).  They inhibit neutrophil adhesion to endothelial cells and 
at pharmacologic doses impair important neutrophil functions (Sternberg et al., 1992a).  
Furthermore, glucocorticoids lower circulating eosinophil and basophil levels, and reduce 
eosinophil and mast cell accumulation at sites of allergic reactions (Sternberg and Wilder, 
1993).   
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1.1.1.4 Other endocrine interactions 
Activation of the stress axis also affects growth, reproductive function and the thyroid axis.  
During an acute stress in humans, glucocorticoids stimulate GH secretion (Casanueva et al., 
1990), but during chronic stress GH secretion is attenuated (Raza et al., 1998) and the 
effects of GH at target tissues are blocked by glucocorticoids (Unterman and Phillips, 1985).  
This effect of stress on the growth axis may account for the delay in growth seen in children 
that undergo emotional deprivation, as well as the lack of growth associated with chronic 
diseases.  It is important to note that the effects of acute stress on GH release in rats are 
oppositional to those seen in humans (Jurcovicova et al., 1984).  The stress axis also 
interacts with the reproductive axis.  Many female patients presenting with HPA axis 
hyperactivity related diseases also experience abnormal menstrual cycles and have 
impaired reproductive function (Chrousos et al., 1998).  This may be because stress 
mediators such as CRH and glucocorticoids inhibit gonadotropin-releasing hormone (GnRH) 
release from the hypothalamus, and gonadotropin release from the pituitary gland (Rabin et 
al., 1988).  The thyroid axis is also affected by activation of the stress axis.  Somatostatin is 
an inhibitory neuroendocrine hormone produced in the periventricular nucleus of the 
hypothalamus.  It inhibits the release of GH and TSH from the pituitary gland (Spoudeas et 
al., 1992) and also inhibits the release of gastrointestinal hormones (Corleto, 2010).  CRH-
stimulated increases in somatostatin and inflammatory IL-6, a pro-inflammatory cytokine, 
both inhibit TSH production and secretion (Papanicolaou et al., 1998).  In patients with 
chronic stress system activation, dysregulation of the thyroid axis results in euthyroid ‘sick’ 
syndrome whereby thyrotropic feedback control is impaired (Benker et al., 1990).   
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1.1.2 Regulation of glucocorticoid secretion  
Controlled by the hypothalamic suprachiasmatic nucleus (SCh) in mammals (Maywood et 
al., 2007), circulating glucocorticoids follow a circadian (24 hour) pattern consisting of a 
succession of pulses of varying amplitude but fixed frequency, of approximately one pulse 
per hour (ultradian) (Lightman and Conway-Campbell, 2010).  Basal levels of glucocorticoids 
vary throughout the day and peak just before the active phase of the mammal’s 24 hour 
cycle, i.e. in the early morning for humans and in the early evening for nocturnal animals 
(Cheifetz, 1971) (Van Cauter, 1990).  It is thought that this peak in circulating glucocorticoids 
prepares the organism for the increase in likelihood of experiencing stress throughout their 
active phase, such as stress from conflict with other organisms or stress from searching for 
food (Romero, 2002) (Sapolsky et al., 2000).  Therefore the strength of the stress response 
to different types of stress is variable throughout the day.  For example, psychological 
stressors lead to a higher stress response during the resting phase (Kalsbeek et al., 2003), 
whilst the response to a hypoglycaemic shock leads to a higher stress response at the 
beginning of the active phase (Gorton et al., 2007). 
 
As mentioned above, the circadian pattern of glucocorticoid release reflects ultradian pulses 
of hormone release (Conway-Campbell et al., 2012), with these hourly pulses leading to 
hormone level changes not only in circulation but also in target tissues such as the brain 
(Droste et al., 2008).  The phases of the ultradian pulse are also important in determining the 
severity of the stress response.  Rats are more responsive to noise stress during the rise of 
the ultradian rhythm whilst their stress response to the same stressor is inhibited during the 
falling phase of the ultradian rhythm (Windle et al., 1998).  It has also been shown that equal 
spacing of the ultradian pulses is important in maintaining a normal stress response.  
Chronic stress increases ultradian frequency and decreases responsiveness to an acute 
stimulus (Windle et al., 2001), with this reduction in responsiveness thought to be a 
50 
 
conditioning of the stress response to the increased probability of the organism experiencing 
stress due to increases in the number of ‘falling phases’ within the ultradian rhythm.  
 
Once in circulation, most cortisol is bound to corticosteroid-binding globulins (CBG) in the 
blood, leaving only approximately 7% cortisol free and therefore biologically active 
(Westphal, 1971, Kemppainen et al., 1991, Meyer and Rothuizen, 1993).  It is thought that 
this binding of cortisol to CBG’s can act as a defence against the possible adverse effects of 
elevated cortisol levels and can in fact control the accessibility of free cortisol to target 
tissues and even adjust the rate of cortisol clearance (Breuner and Orchinik, 2002, Siiteri et 
al., 1982).  Only free cortisol is able to enter cells to activate intracellular/membrane 
receptors and therefore is the only form of cortisol that can be metabolized in the liver 
(Breuner and Orchinik, 2002).  Bound cortisol becomes free by cellular uptake of CBG’s.  
First the cortisol-CBG complex binds to a membrane CBG receptor (CBGR) which transports 
the complex across the cell membrane.  CBG is then cleaved, leaving free unbound cortisol 
to activate intracellular receptors (Singer et al., 1988, Hryb et al., 1986).  Thus CBG-binding 
can regulate local cortisol levels at specific tissue sites and at the cellular level.  There is 
also evidence of cellular synthesis of CBG which is thought to limit free cortisol availability to 
intracellular receptors and therefore inhibit cortisol action within specific tissues (Berdusco et 
al., 1995).  Stressful experiences can reduce CBG capacity and therefore increase the 
availability of local free cortisol to all tissues.  For example restraint stress can decrease 
CBG capacity and cause a prolonged period of elevated free cortisol when total cortisol 
levels are no longer elevated (Fleshner et al., 1995).   
 
Another major regulator of local glucocorticoid action is 11β-hydroxysteroid dehydrogenase 
(11β-HSD) (Anagnostis et al., 2009).  The 11β-HSD1 isoform is an enzyme that utilizes the 
reducing agent nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) to 
hydrogenate inactive cortisol, called cortisone, to its active form. 11β-HSD1 is expressed in 
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many tissues such as the liver, adipose tissue, fibroblasts, immune cells and the CNS 
(Cooper and Stewart, 2009).  It facilitates glucocorticoid action in target tissue via GR and 
increased expression of this enzyme has been found in the adipose tissue of obese subjects 
(Tomlinson et al., 2004).  Conversely, the 11β-HSD2 isoform employs the coenzyme 
nicotinamide adenine dinucleotide (NAD+) to convert active cortisol to cortisone (Yang and 
Zhang, 2004).  11β-HSD2 is mainly expressed in mineralocorticoid target tissues (Cooper 
and Stewart, 2009) and rapidly inactivates glucocorticoids to protect the mineralocorticoid 
receptor (MR) from excess stimulation by cortisol (Cooper and Stewart, 2009). 
 
1.1.2.1 The glucocorticoid feedback mechanism 
The HPA axis is regulated in part by a negative feedback effect exerted by glucocorticoids 
(illustrated in Figure 1.2) at the level of the hypothalamus (Jones et al., 1977), upstream 
limbic structures such as the hippocampus (Sapolsky et al., 1984), the prefrontal cortex (Hill 
et al., 2011), and the pituitary gland (Russell et al., 2010).  These feedback effects can be 
fast, mediated by non-genomic mechanisms and occurring as quickly as a few seconds to a 
few minutes, or slow, involving binding to the GR and changes in gene transcription which 
can take from 30-60 minutes.  To exert a fast feedback effect, glucocorticoids bind to 
membrane G-protein-coupled-GR’s (GpcGR) (Orchinik et al., 1991) on the extracellular 
surface of CRH-releasing neurons in the PVN.  This stimulates endocannabinoid synthesis 
in post-synaptic neurons, which act on endocannabinoid receptors (CB1) that are localized 
to glutamatergic terminals impinging on pre-synaptic CRH neurosecretory neurons.  
Activation of CB1 results in inhibition of pre-synaptic glutamate release, which ultimately 
reduces the neural activity of parvocellular CRH neurons (Di et al., 2003, Hill and Tasker, 
2012).  The delayed genomic effects of glucocorticoids are mediated via nuclear GR’s 
(Joels, 1997) and promote recovery and adaptation of the organism to the stress, resulting in 
normalization of plasma glucocorticoid levels several hours after stress exposure.  They 
include activation of nuclear GR’s which raises the threshold of long-term potentiation (LTP) 
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of signal transmission between neurons, thus reducing the transfer of excitatory information 
arisen from the stressor (de Kloet et al., 2008c).  This results in down regulation of CRH and 
vasopressin expression in PVN neurons.  Glucocorticoids further dampen the stress 
response by enhancing the inhibitory effects of serotonin (5-HT) and suppressing excitatory 
β-adrenergic actions (de Kloet et al., 2008b).  
 
1.1.2.2 Diseases linked to HPA dysfunction 
HPA dysfunction can lead to, or be the result of, many neuroendocrine diseases.  But one 
common denominator of these diseases is deregulated release of glucocorticoids.  Many 
physical, behavioural and psychiatric disorders are associated with chronic stress i.e. 
chronic HPA activation, including anxiety, depression, hypertension, obesity, T2DM and 
insomnia (see Table 1.3).  The pathogenesis of these disorders is linked to excessive and 
constant secretion of stress hormones that influence multiple homeostatic systems 
(Chrousos and Gold, 1992).  Stress mediators, like IL-6, bring about fatigue, nausea and 
headaches.  Chronic hypercortisolism can result in visceral fat accumulation (Chrousos, 
2000), insulin hyper-secretion, low GH secretion and hypogonadism-related suppression of 
libido and fertility (Chrousos et al., 1998, Chrousos and Gold, 1992). 
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TABLE 1.3 Conditions with altered HPA axis activity. Adapted from (Chrousos, 2009). 
 
Increased activity of the HPA axis  Decreased activity of the HPA axis  
Cushing syndrome  Adrenal insufficiency  
Chronic stress  Seasonal depression  
Melancholic depression  Chronic fatigue syndrome  
Anorexia nervosa Post-traumatic stress disorder in adults  
Obsessive-compulsive disorder  Climacteric depression  
Panic disorder  Hypothyroidism  
Diabetes Mellitus  Rheumatoid arthritis  
Post-traumatic stress disorder in children  Asthma/eczema  
Hyperthyroidism  Following cessation of glucocorticoid therapy 
or Cushing syndrome cure  
Metabolic syndrome  Following chronic stress  
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Hyper-activation of the HPA axis, as seen in the genetically CRH‐hyper‐responsive Fischer 
rat, which consequently has hypercorticosteronemia, can increase the host’s risk of infection 
and vulnerability to developing tumours, whilst simultaneously reducing susceptibility to 
inflammatory and autoimmune disease.  In contrast, the Lewis rat presents HPA hypo-
activation and its resulting hypocortisolism can boost resistance to infection and tumours but 
increase sensitivity to inflammatory and autoimmune disorders and depression (Sternberg et 
al., 1992b, Patchev et al., 1992).  
 
HPA‐axis abnormalities are also seen in patients with rheumatoid arthritis, who have a weak 
circadian cortisol rhythm and low ACTH/cortisol levels, despite increased TNF‐α, interleukin 
1-β (IL‐1β) and IL‐6 levels (Templ et al., 1996).  Rheumatoid arthritis patients often display 
fatigue and depression, consistent with the behavioural responses seen in the HPA 
hypoactive Lewis rat.  This is also the case with chronic fatigue syndrome patients, who 
display symptoms of a dysfunctional HPA axis, with low basal cortisol levels in spite of clear 
ACTH responses to exogenous CRH (Demitrack et al., 1991).   
 
Interestingly, chronic HPA axis hyper-activation can ameliorate the negative effects of 
excess circulating cortisol.  An example of this is the mild immune suppression seen in 
Cushing's disease, in spite of extremely high hypercortisolism.  It is thought that the 
hypothalamic neurotransmitter, substance P, inhibits CRH neuron activity (Larsen et al., 
1993) or that the inflammatory cytokines may be inhibiting the otherwise stimulatory effects 
of CRH and ACTH on the pituitary and adrenal glands (Jaattela et al., 1991), as seen in 
septic shock (Rothwell et al., 1991).   
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1.2 Effects of leptin on HPA physiology 
1.2.1 Leptin 
In 1949 random single mutations of a gene, named ob at the time, were found in a mouse 
colony at the Jackson Laboratory.  These mice, named ob/ob, presented with severe 
obesity, rapidly gaining weight until they were about four times their normal size. They were 
hyperphagic, had mild diabetes and were sterile (Ingalls et al., 1950).  Then in 1965, the 
db/db was discovered; a mutant obese mouse with severe obesity and hyperphagia, but 
that, unlike the ob/ob mouse, presented with severe life-shortening diabetes (Hummel et al., 
1966).  Later it was found that the mutated gene in the ob/ob mouse codes for a 167 amino 
acid protein hormone named leptin (Zhang et al., 1994) and that the mutated gene in the 
db/db mouse codes for the leptin receptor (LepR).  These findings allowed the first 
observations of the effects of leptin deficiency/resistance on energy intake and expenditure.  
Administration of exogenous leptin can reverse the excessive weight gain seen in ob/ob 
mice (Harris et al., 1998).  Although the mouse and human leptin genes are located on 
chromosome 6 and 7 respectively, structurally they closely resemble one another (Sone and 
Osamura, 2001).  Leptin is largely synthesized in the adipocytes of subcutaneous white 
adipose tissue (WAT) and is secreted in proportion to adipocyte triglyceride content (Scherer 
and Buettner, 2011).  Some leptin is also synthesized in visceral WAT, brown adipose tissue 
(BAT), the placenta, ovaries, skeletal muscle, the stomach, mammary epithelial cells, bone 
marrow, the pituitary gland, the liver and the brain (Morash et al., 1999, Hoggard et al., 1997, 
Bado et al., 1998, Wang et al., 1998, Margetic et al., 2002), though out of these BAT is the 
only notable contributor to circulating leptin (Margetic et al., 2002).  
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The LepR is found in numerous peripheral organs, such as the heart, liver, lung, ovaries, 
pituitary gland, pancreas, skeletal muscle, adrenal gland, testis (De Matteis et al., 1998) and 
adipose tissue (Siegrist-Kaiser et al., 1997).  Within the brain, leptin acts on the choroid 
plexus, the ventral tegmental area (VTA), and the hypothalamic ARC, PVN, VMN and DMN 
to signal the extent of the body’s fat stores (Collins et al., 1996).  Leptin binds to six different 
isoforms of the LepR, named LepRa-f (Wang et al., 1996).   
 
Leptin has several well characterized actions, including the regulation of body fat by 
inhibiting food intake, increasing energy expenditure and suppressing lipogenesis, 
modulating T-cell activity and the mammalian ovulatory cycle, promoting angiogenesis and 
surfactant expression in type II pneumocytes, regulating bone metabolism and inflammatory 
responses, and influencing the stress response via the HPA axis (Roubos et al., 2012).  
Leptin has a major role in energy homeostasis, with leptin-deficient or leptin resistant rodents 
and humans displaying features of the metabolic syndrome (Ahima et al., 1998, Halaas et 
al., 1995, Chua et al., 1996). 
 
The satiety inducing effects of leptin are mediated in the brain, at the level of the 
hypothalamus via activation of the only isoform expressed in this region, LepRb.  Leptin 
activates POMC neurons of the ARC which release α-MSH onto downstream target neurons 
in regions including the PVN.  Here α-MSH acts on MC4R and melanocortin-3 receptors 
(MC3R) to inhibit food intake and increase energy expenditure (Morton et al., 2006, Elmquist 
et al., 2005).  At the molecular level, the leptin-LepRb complex activates janus kinase 2 
(JAK2) (Kloek et al., 2002), of the JAK family of tyrosine kinases, which in turn 
phosphorylates intracellular signal transduction and transcription (STAT) proteins that 
stimulate the transcription of target genes to mediate the cellular effects of leptin (Schwartz 
et al., 2000).  Some of leptin’s major effects do not require STAT signals and occur through 
other, STAT-independent, signalling pathways.  One of these is the mitogen-activated 
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protein kinase (MAPK) signal transduction pathway, which can be activated not only by 
LepRb, but also by the short form of LepR, LepRa (Malendowicz et al., 2006, Bjorbaek et al., 
1997).  
 
1.2.2 Leptin Regulation of the Stress axis 
Leptin has a putative role in the regulation of the HPA axis (Maffei et al., 1995).  Leptin 
deficient ob/ob mice have elevated levels of plasma corticosterone and i.p injection of leptin 
to ob/ob mice reduces food intake and body weight (Halaas et al., 1995), but also 
significantly reduces plasma corticosterone levels (Ahima et al., 1998), suggesting that leptin 
exerts an inhibitory influence on HPA function.  Leptin administration has also been shown to 
blunt the stress-induced activation of the HPA axis, with normal fasted mice pre-
administered leptin demonstrating a lower rise in plasma corticosterone levels following 
exposure to restraint stress (Heiman et al., 1997).  It has been suggested that the inhibitory 
effect of leptin on HPA function may be mediated by changes in CRH release from the 
hypothalamus, since leptin does not directly influence basal or CRH-stimulated ACTH 
release from rat pituitary cells in vitro (Heiman et al., 1997).  Leptin has also been shown to 
act directly on the adrenal gland to inhibit cortisol release (Gaillard et al., 2000).   
 
However, there is also evidence that leptin can act to stimulate the HPA axis under specific 
conditions.  ICV administration of leptin has been shown to increase CRH and CRH-receptor 
type 2 (CRH-R2) expression in the PVN, and to stimulate ACTH and corticosterone release 
(Jethwa et al., 2005). Evidence suggests that the stimulatory effects of leptin on HPA axis 
function may be mediated by the hypothalamic neuropeptide Neuromedin U (NMU). Leptin 
stimulates the release of NMU from ex vivo hypothalamic explants, and hypothalamic NMU 
mRNA expression is reduced in conditions of low circulating leptin (Jethwa et al., 2005).  
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Chronic administration of glucocorticoids to rats stimulates leptin gene expression in adipose 
tissue, an effect which is followed by reduced  weight gain and food intake (De Vos et al., 
1995).  In both humans and rats, corticosteroid treatment increases plasma leptin levels 
(Slieker et al., 1996, Larsson and Ahren, 1996).  However, in some cases, chronic activation 
of the HPA axis has been shown to reduce basal plasma leptin levels whilst simultaneously 
elevating plasma corticosterone levels (Lu et al., 2006).   
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1.3 Effects of social isolation (SI) on HPA physiology 
1.3.1 SI and HPA function 
Social isolation (SI) is a stressful experience in all species (Weiss et al., 2004, Arango et al., 
2001) and has been shown in rodents to increase aggression, reactivity and anxiety in 
response to human handling, (Hatch et al., 1965).  In male rats, SI results in elevated basal 
plasma stress hormones, corticosterone and ACTH, compared to group-housed rats, as well 
as a higher stress hormone response to an acoustic stimulation-restraint stress challenge 
compared to their group-housed counterparts (Weiss et al., 2004, Holson et al., 1991).  Thus 
chronic stress in the form of SI leads not only to increased HPA activity but also increased 
HPA sensitivity to subsequent stressors.  It has been suggested that chronic stress leads to 
alterations in the glucocorticoid feedback mechanism, resulting in permanently elevated 
levels of corticosterone under both basal and acute stressful conditions (Ferland and 
Schrader, 2011). 
 
However, other studies have shown that SI causes HPA hypo-reactivity in response to a 
novel stressor, suggesting that desensitization to stressful stimuli occurs after a period of SI 
(Sanchez et al., 1998).  In fact, Serra et al found that long term SI lowers basal plasma 
ACTH levels, increases pituitary sensitivity to CRH and impairs the glucocorticoid negative 
feedback to the hypothalamus in rats (Serra et al., 2005).  In this case, lowered basal ACTH 
levels after SI could be explained by the constant stimulation of the HPA axis diminishing 
readily available stores of ACTH.   
 
These neuroendocrine changes are thought to be a result of alterations of neurotransmitter 
signalling associated with stress.  The serotonergic signalling system is the most widely 
studied transmitter system in the field of social stress.  Many different stressors increase 5-
HT neurotransmission and its actions are mediated by its receptor, 5-HTR.  CRH and AVP 
are both stimulated by the serotonergic system and in patients with melancholic depression, 
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an exaggerated and prolonged activation of the stress axis is thought to be partly a result of 
altered hippocampal serotonin levels (Chrousos, 1995).  These SI-induced neurochemical 
changes can promote anxiolytic/depressive behaviours as seen in male Lewis rat which 
demonstrates reduced locomotion and increased behavioural reactivity in an elevated plus 
maze test, compared to group-housed rats (Berton et al., 1997).  Stress alters both pre- and 
postsynaptic transporters for 5HT, increases 5HT binding in the cortex and has been shown 
to decrease 5HT binding in the hippocampus (Flugge, 1995, McKittrick et al., 1995).  Social 
stress-related HPA dysfunction is also linked with dysregulation of the dopaminergic and 
noradrenergic signalling systems, as commonly seen in rodent models of schizophrenia 
(Sontag et al., 2003).  Furthermore, a dysfunction of GABA receptor (GABA-R) signal 
transduction is involved in the pathophysiology of mental disorders such as depression 
(Romeo et al., 1998).  Social stress activates CRH circuits directly connected to the HPA 
axis and increases pituitary POMC and β-endorphin mRNA levels (Meyerhoff et al., 1988), 
with an increase in pre-synaptic activity corresponding with a down-regulation of the post-
synaptic activity.  On the other hand, social stress inhibits AVP circuits involved in 
aggression and sexual behaviour in rats, but this is thought to be associated with a decrease 
in testosterone in these animals (Albeck et al., 1997).  Behaviours mediated by the 
amygdaloid vasopressinergic circuit include copulation (Smock et al., 1992) and social 
recognition (Bluthe et al., 1990), both of which are changed in socially stressed rats and are 
relevant to altered human behaviours in depressive patients (Yang et al., 2012, Gunderson, 
1963).    
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1.3.2 Diseases linked to SI 
1.3.2.1 Depression 
Depression is a state of labile mood and comprises a mixture of some of the following 
symptoms: hypersomnia/insomnia, agitation, anorexia, weight loss/gain, phobic anxiety, 
somatic complaints, restlessness, fatigue, irritability and feelings of sadness/loss (Bielski and 
Friedel, 1977).  There are many causes of depression including negative life events, side 
effects of a medical treatment such as beta blockers (Luijendijk et al., 2011), having a 
genetic predisposition to depression, or having another medical condition such as diabetes 
(Baskaran et al., 2013).       
 
Abnormalities of the HPA axis are implicated in major depression and many depressed 
patients have high salivary, plasma and urine cortisol levels, as well as enlarged and 
hyperactive pituitary and adrenal glands (Nemeroff and Vale, 2005).  This is thought to be 
related to an impaired glucocorticoid feedback mechanism, supported by studies showing 
that the HPA axis in depressive patients is insensitive to orally administered dexamethasone 
compared to healthy subjects (Pariante, 2006).  Interestingly, successful treatment of 
depression is related to reinstatement of a fully functioning negative feedback loop (Pariante, 
2006).  A susceptibility to depression can be programmed through early life events. 
Separating neonatal rodents from their mothers long term induces permanent HPA axis 
changes resembling those seen in depressed adult individuals (Sanchez et al., 2001).  
Serotonergic signalling dysfunction has also been implicated in the pathogenesis of 
depression (Gardner et al., 2005).  Also important are recent findings that show increased 
plasma IL-6, IL-1β and TNF-α in depressed patients (Raison et al., 2006).  These cytokines 
interact with many of the pathophysiological areas that characterize depression including 
synaptic plasticity, metabolism of neurotransmitters, neuroendocrine function, and behaviour 
(Raison et al., 2006).  The importance of MR in the regulation of HPA activity is also 
significant.  MR has a higher affinity for glucocorticoids than GR (McEwen et al., 1968), with 
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MR mainly present in limbic areas such as the hippocampus and GR widely spread across 
the whole brain (Reul and de Kloet, 1985).  The synergy of MR/GR activation is important in 
mediating the glucocorticoid feedback mechanism and some suggest that major depression 
is accompanied by a change in MR/GR balance (Young et al., 2003).  This has been 
investigated in humans where Young et al found that MR is more functionally active in 
depressed patients than GR, and GR function is in fact impaired in these patients compared 
to controls (Young et al., 2003).  Furthermore, MR inhibits hippocampal serotonin release 
and turnover, while high levels of glucocorticoids can induce GR-stimulated serotonin 
signalling (Joels and de Kloet, 1994).       
 
1.3.2.2 Anxiety 
Anxiety, the feeling of fear and worry, is characterized by somatic, emotional, cognitive, and 
behavioural modifications (Ghadirian, 1981), and is usually accompanied by restlessness, 
fatigue and muscle tension. Although a normal reaction to a stressor, anxiety can become 
overwhelming and manifest as an anxiety disorder.  As in depression, HPA axis hyperactivity 
is found in patients with anxiety disorders such as panic disorder (Abelson et al., 2007) and 
social anxiety disorder (Condren et al., 2002).  It is thought that both glucocorticoid 
insensitivity and CRH over-expression contribute to overall HPA axis hyperactivity (Kunugi et 
al., 2006) in these patients.  Over-activity of the amygdala (Pfleiderer et al., 2007) is also 
associated with the pathogenesis of anxiety disorders.  Many anxiety patients have over-
activation of the amygdala.  The known role of the amygdala in fear and aggression, and as 
one of the main extra-hypothalamic sources of CRH, gives rise to the idea that amygdala-
secreted CRH may drive this over-activation in these patients.   
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1.3.2.3 Schizophrenia 
Schizophrenia is a mental disorder defined by a breakdown of thought processes and poor 
emotional responsiveness (Krystal et al., 2001).  Symptoms include hallucinations, paranoia, 
disorganized speech and thinking, and social dysfunction (Braff and Geyer, 1990).  Whilst 
genetics play an important part in the incidence of schizophrenia, the environment, 
psychological and social processes are also contributory factors (Corcoran et al., 2003) 
(Krystal et al., 2001).  Schizophrenia affects cognition, behaviour and emotion, and patients 
thus commonly present additional conditions such as depression and anxiety (Krystal et al., 
2001).   
 
Stressful life events increase the risk of schizophrenia (Ellenbroek et al., 1998).  
Schizophrenic patients have higher-than-normal plasma noradrenaline and cortisol levels 
(Meltzer, 1987), and generally have a higher stress hormone response to a novel stressor 
(Lammers et al., 1995).  This has been shown in studies in which treatment with 2-deoxy-D-
glucose and dexamethasone induced a higher level of metabolic stress in schizophrenics 
than in controls, as determined by elevated plasma ACTH levels (Elman et al., 1998, Muck-
Seler et al., 1999).  Although 2-deoxy-D-glucose is not a classic stressor, pharmacological 
doses of this glucose analogue block glycolysis and thus prevent neuronal glucose uptake.  
This results in hypoglycemia (Horton et al., 1973) which, although different from 
environmental stress that may be more relevant to the schizophrenic state, still activates 
appropriate stress-related neuroendocrine systems (Breier, 1989).   
 
Others found that the benzodiazepine antagonist iomazenil and the serotonin agonist, m-
chlorophenylpiperazine (m-CPP) act synergistically to increase cortisol levels and produce 
mild psychosis in normal people (D'Souza et al., 2006), but induce a more robust cortisol 
response accompanied by more severe psychotic symptoms when administered to 
schizophrenics, (Lindenmayer et al., 1997).  Reduced numbers of hippocampal GR’s is one 
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potential source of elevated glucocorticoid levels in schizophrenic patients (Corcoran et al., 
2003).  Reduced GR mRNA expression and reduced prefrontal cortex MR mRNA expression 
has been found in the amygdala of schizophrenics (Perlman et al., 2004) (Xing et al., 2004).  
Some schizophrenics have also been found to have decreased GR mRNA levels in the 
frontal cortex, dentate gyrus, and hippocampus (Webster et al., 2002).     
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1.4 Hypotheses and aims  
 
Leptin has several well characterized functions, including regulation of body fat stores, food 
intake, and energy expenditure (Collins et al., 1996, Jethwa et al., 2005, Hamann and 
Matthaei, 1996).  There is evidence to suggest that leptin can also have both stimulatory and 
inhibitory effects on the HPA response to stress (Ahima et al., 1998, Heiman et al., 1997, 
Jethwa et al., 2006).  The alterations in the HPA axis observed in obesity may be mediated 
by leptin as most obese patients have elevated circulating levels of leptin (McGregor et al., 
1996).  The role of leptin in the regulation of HPA activity therefore remains unclear.  This 
project will further investigate the effect of leptin on the HPA axis  
 
SI can alter HPA function in rats and humans (Thornton et al., 2010, Weiss et al., 2004).  In 
rats, SI is sufficiently stressful to lead to aggression and anxiety in response to human 
handling (Hatch et al., 1965, Weiss et al., 2004).  In humans, loneliness can lead to the 
pathogenesis of psychiatric disorders such as schizophrenia and depression (Pariante and 
Lightman, 2008, Kaye et al., 1987, Corcoran et al., 2003).  While some evidence suggests 
that SI causes hyper-activation of the HPA axis in response to a novel stress (Weiss et al., 
2004), possibly caused by the impairment of the glucocorticoid negative feedback loop 
(Serra et al., 2005, Raone et al., 2007), others show that SI causes hypo-activation of the 
HPA axis in response to an acute stress, indicating desensitization to stressful stimuli 
(Sanchez et al., 1998).  This poses the question of whether the three components of the 
HPA axis are more sensitive or less sensitive to stressful stimuli after a period of SI and how 
these changes within the stress axis actually occur.  We therefore aimed to investigate an 
animal model of SI using the Sprague Dawley rat; specifically looking at the effects of SI on 
HPA function within multiple HPA tissues.   
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1.4.1 Hypotheses 
1.4.1.1 Hypothesis 1 
I hypothesize that leptin will modulate the acute HPA response to LPS treatment in rats. 
 
To elucidate the effects of leptin on the HPA axis I will: 
 Investigate the effects of acute leptin administration on basal/acute LPS-stimulated 
HPA axis activity and neuronal activation in hypothalamic, and other stress-related 
brain centres in male rats.     
 
1.4.1.2 Hypothesis 2 
SI can alter the HPA axis response to a novel acute stress in the adult rat, by sensitizing 
and/or desensitizing specific components of the axis. 
 
To test this hypothesis I aim to: 
 Investigate the effects of chronic and intermittent SI on HPA function within multiple 
HPA tissues in adult rats; specifically looking at basal HPA activity, differences in 
HPA axis responsiveness to acute stress and neuronal activation in stress related 
hypothalamic centres. 
 Examine the stress hormone profiles of isolated compared to group-housed rats. 
 Investigate possible changes in the HPA-glucocorticoid feedback mechanism. 
 Investigate possible changes in the expression of stress-related genes in specific 
components of the HPA axis  
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Chapter II: 
Investigating the effects of 
leptin on the HPA axis 
response to stress 
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2.1 Introduction 
2.1.1 The HPA axis as a target of leptin 
As briefly described in Chapter 1, leptin has been reported to exert contradictory effects on 
the HPA axis, both basally and in response to stress (Halaas et al., 1995, Ahima et al., 1998, 
Jethwa et al., 2005).  It also plays an important role in the regulation of appetite by inhibiting 
both secretion of gastric ghrelin and the stimulation of feeding by ghrelin (Kalra et al., 2005), 
and simultaneously reducing orexigenic hypothalamic NPY and increasing anorexigenic 
hypothalamic α-MSH expression (De Vos et al., 1995) (Dhillon et al., 2000).  Below I outline 
the known effects of leptin on individual components of the HPA axis.    
 
2.1.1.1 Leptin and the hypothalamus 
Circulating leptin is thought to cross the BBB to access the brain by a mechanism involving 
its binding to the short form of the leptin receptor, LepRa (Kastin et al., 1999), though other 
LepR isoforms may also be involved (Kastin et al., 1999).  Although the mechanisms are not 
well understood, it is thought that the LepR’s involved are located in non-neuronal cells of 
the choroid plexus, meninges and blood vessels (Price et al., 2010).   
 
The hypothalamus is a major central target of leptin.  LepRb mRNA is widely distributed in 
the hypothalamus, being expressed in the ARC, DMN, VMN, periventricular hypothalamic 
nucleus, LHA, medial mammillary nucleus and posterior hypothalamic nucleus (Elmquist et 
al., 1998b). It is thought that upon binding to leptin, the hypothalamic LepRb is internalized 
via clathrin-coated vesicles into early endosomes (Sweeney, 2002).  Subsequent 
oligomerization of the leptin-LepRb complex allows segregation of JAKs which then 
phosphorylate and activate each other (Sweeney, 2002), LepRb itself (Bjorbaek et al., 1997) 
and STAT proteins (Ghilardi et al., 1996).  Phosphorylated STAT (pSTAT) then dimerizes 
and translocates to the cell nucleus to bind to DNA and activate gene transcription (Roubos 
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et al., 2012) (see Figure 2.1).  Peripheral and intra-hypothalamic injection of leptin induce 
pSTAT3 in the hypothalami of ob/ob and wild type mice (Tartaglia et al., 1995, El-Haschimi 
et al., 2000), suggesting that the hypothalamus is a direct target of leptin (Vaisse et al., 
1996).  In accord with this, ob/ob mice and leptin-deficient humans present with 
hypothalamic neuroendocrine disorders such as hypothalamic hypothyroidism (van der 
Kroon et al., 1981, Ozata et al., 1999) and hypothalamic amenorrhea in humans (von 
Schnurbein et al., 2012).  These abnormalities are reversible via leptin replacement therapy 
(Chan et al., 2006).   
 
The effects of leptin on the stress response are largely thought to be mediated in the 
hypothalamic PVN.  But the actions of leptin on the hypothalamus are a source of 
controversial debate as leptin can both inhibit and stimulate the release of the same neuro-
hormones from the hypothalamus, by acting under different circumstances or differentially on 
specific neuronal circuits.  Leptin can down-regulate CRH expression and CRH release from 
the PVN of adrenalectomized ob/ob mice (Arvaniti et al., 2001), suggesting an inhibitory role 
of leptin on the hypothalamic component of the stress axis.  In obese Zucker rats, a fasting-
induced reduction circulating leptin levels is coupled with increased cellular-fos (c-fos) 
mRNA expression, an early marker of neuronal activation, in the ARC and PVN.  This c-fos 
activation can be by a CRH antagonist (Doyon et al., 2007), suggesting a stimulatory role of 
leptin on hypothalamic CRH expression. 
 
But there is also evidence that leptin can have a stimulatory effect on the HPA axis, with ICV 
or systemic leptin administration previously shown to increase hypothalamic CRH 2 hrs after 
administration (Uehara et al., 1998) and incubation of rat and mouse hypothalamic explants 
with leptin resulting in enhanced CRH release (Costa et al., 1997, Raber et al., 1997).  
Leptin injection into 40hr-fasted rats increases CRH mRNA levels in the PVN (Schwartz et 
al., 1996).  
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Whilst the PVN is LepRb rich, there is evidence that much of leptin’s control over the PVN 
actually occurs via the ARC (Elmquist et al., 1998a, Elmquist et al., 1998c, Patterson et al., 
2011, Schwartz et al., 1996).  Lesioning ARC-to-PVN projecting fibres in rats increases 
plasma leptin concentrations and reduces HPA-axis activity, as demonstrated by reduced 
plasma ACTH concentrations in response to restraint stress (Bell et al., 2000).  These 
lesioned rats also show increased food intake, weight gain, and loss of α-MSH in the ARC.  
This strongly suggests that the ARC plays a role in leptin regulation of the PVN (Bell et al., 
2000). 
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FIGURE 2.1 Leptin and LepRb activation of the JAK/STAT intracellular signalling 
pathway.  Leptin binds to LepRb and causes a conformational change that allows 
segregation of JAKs, which then become activated and tyrosine-phosphorylate other JAKs, 
LepRb’s and STAT’s.  This phosphorylation of STATs leads to their dissociation from LepRb, 
dimerization and then translocation to the cell nucleus to regulate gene expression by 
binding to promoter regions of target genes.  Abbreviations: LepRb, leptin receptor B; JAK, 
janus kinase; STAT3, signal transduction and transcription 3; P; phosphate, L; leptin.  
Adapted from (Fruhbeck, 2006).  
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2.1.1.2 Leptin actions on the pituitary gland 
Leptin regulation of hypothalamic CRH, whether inhibitory or stimulatory, affects ACTH 
secretion from corticotroph cells of the anterior pituitary and thus glucocorticoid production 
and secretion from the adrenal glands (Heiman et al., 1997, Jethwa et al., 2006).  However, 
it is also possible that leptin acts directly on the pituitary gland.  Zamorano et al showed that 
LepR mRNA is expressed in the rat anterior pituitary, albeit at low levels (Zamorano et al., 
1997), and others have shown LepR immunoreactivity in corticotroph cells of the ovine 
anterior pituitary (Iqbal et al., 2000).  Furthermore, obese humans that lack leptin signalling 
have pituitary dysfunction (Clement et al., 1998), though this may reflect a lack of leptin 
signalling in the hypothalamus rather than defective signalling in the pituitary itself.  Other 
studies show that incubation of rat primary pituitary cells with leptin in vitro does not affect 
ACTH release (Heiman et al., 1997).  Leptin is also found in corticotroph cells and in the 
posterior pituitary (Louis et al., 2011, Ogasawara et al., 2008, Jin et al., 1999, Morash et al., 
1999, Siawrys et al., 2007), suggesting that cells of the pituitary gland may self-regulate by 
autocrine or paracrine leptin-based mechanisms.  
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2.1.1.3 Leptin and the adrenal gland 
As mentioned above, evidence suggests that leptin can indirectly suppress glucocorticoid 
secretion from the adrenal gland by inhibiting hypothalamic CRH and pituitary ACTH release 
in rats (Malendowicz et al., 2007).  But the  adrenal gland may also be a direct target of 
leptin as LepRa-f mRNA and protein have been found in human, rat and bovine 
adrenocortical cells(Glasow and Bornstein, 2000, Pralong et al., 1998, Hoggard et al., 1997, 
Malendowicz et al., 1997, Bornstein et al., 1997).  Pre-incubation of human primary 
adrenocortical cells with leptin inhibits ACTH-stimulated cortisol release, while leptin inhibits 
ACTH-stimulated corticosterone secretion from primary rat adrenocortical cells (Pralong et 
al., 1998).  The authors suggest these effects are likely mediated by LepRb as  its transcript 
was found to be expressed in the adrenal tissue and leptin had no inhibitory effect in adrenal 
glands obtained from db/db mice (Pralong et al., 1998).  A similar effect is seen in primary 
bovine adrenocortical cells which, after incubation with leptin at concentrations comparable 
to those observed in obese individuals, have reduced basal cortisol secretion and attenuated 
ACTH-stimulated cortisol release (Bornstein et al., 1997).   
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2.1.2 Interactions of leptin with appetite regulating neuropeptides and 
hormones 
Leptin interacts with many appetite-regulating neuropeptides and hormones (see Figure 2.2).  
While leptin inhibits the activity of orexigenic NPY /AgRP-releasing neurons (Hahn et al., 
1998), it stimulates the activity of anorexigenic CART/POMC-derived α-MSH releasing 
neurons of the ARC, thus promoting a state of negative energy balance (Elias et al., 1998, 
Elias et al., 1999).  The melanocortin system is a neural system that regulates energy 
homeostasis, and within the hypothalamus, controls body weight (Cone, 1999, Hagan et al., 
1999).  While the melanocortin system is involved in leptin-appetite regulation, it is also 
thought to interact with the stress axis as both α-MSH and AgRP stimulate the HPA axis 
(Dhillo et al., 2002).       
 
Leptin also influences peripheral appetite-regulating hormones such as ghrelin, the 
orexigenic gut hormone (Inui et al., 2004).  Circulating leptin and ghrelin demonstrate a 
reciprocal relationship with ghrelin levels rising and leptin levels falling before a meal and 
vice versa postprandially (Crowley et al., 2005, Xu et al., 1999).  There is little evidence to 
suggest leptin directly inhibits ghrelin, with the majority of evidence suggesting that leptin 
restrains the ghrelin induced activation of hypothalamic appetite-stimulating circuits.  Leptin 
can directly inhibit ghrelin transcription in vitro (Zhao et al., 2008) and decrease ghrelin 
release from isolated rat stomach (Kamegai et al., 2004).  In the hypothalamic ARC, ghrelin 
binds to ghrelin receptors to stimulate NPY/AgRP-releasing neurons (Kalra et al., 2003) to 
release NPY, AgrP, and GABA in the PVN and ultimately induce feeding (Kalra et al., 2003, 
Kalra et al., 1999, Kalra and Kalra, 2004, Bagnasco et al., 2003, Yokosuka et al., 1998).  
Leptin counteracts this by suppressing NPY synthesis, release, and action in the ARC and 
PVN (Kalra et al., 1999), as demonstrated in Figure 2.2.   
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FIGURE 2.2 Diagrammatic representation of leptin and ghrelin modulation of the 
hypothalamic appetite-regulating circuitry.  NPY/AgRP and GABA-expressing neurons in 
the ARC project into the PVN where NPY, AgrP, and GABA stimulate appetite by activating 
Y1/Y5, MC4R, and GABA-R respectively.  Simultaneously, NPY, AgRP, and GABA released 
in the ARC act on Y1/Y5, MC3R, and GABA-R to suppress POMC/α-MSH/CART-expressing 
neurons’ restraint on appetite.  Leptin inhibits appetite by restraining NPYergic signalling and 
stimulating melanocortin signalling, while ghrelin stimulates appetite enhancing NPYergic 
signalling.  Abbreviations: PVN, paraventricular nucleus; ARC, arcuate nucleus; NPY, 
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neuropeptide Y; GABA, gamma-aminobutyric acid; AgRP, agouti related peptide; α-MSH, α-
melanocyte-stimulating hormone; CART, cocaine and amphetamine regulated transcript; 
Y1/Y5, NPY receptor type 1 and type 5 respectively; GABA-R, GABA receptor; Y2R, NPY 
receptor type 2; MC4R, melanocortin 4 receptor; MC3R, melanocortin 3 receptor.  Adapted 
from (Kalra et al., 2003).  
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2.1.3 Bacterial Lipopolysaccharide 
Lipopolysaccharide (LPS) is an endotoxin that elicits a strong immune response in mammals 
and which at very high doses can cause septic shock (Priest et al., 1989). It is a major 
component of the outer surface membrane of gram-negative bacteria (Webster et al., 1955) 
and plays a role in maintaining the structural integrity of the bacteria as well as protecting 
their cell membrane from attack.  LPS consists of a polysaccharide component, covalently 
bonded to a lipid moiety called lipid A which anchors the polysaccharide into the outer 
bacterial membrane (Seydel et al., 2003).   
     
2.1.4.1 Lipopolysaccharide signalling 
The LPS signalling pathway, illustrated in Figure 2.3, begins with circulating LPS being 
recognized by LPS-binding protein (LBP) (Schumann et al., 1990), which chaperones LPS to 
soluble cluster of differentiation 14 (CD14), forming a ternary complex (Hailman et al., 1994, 
Tobias et al., 1995).  LBP and CD14 then aid the loading and docking of LPS onto the LPS 
receptor complex, which is composed of dimerized toll-like receptor 4 (TLR4) receptors and 
two molecules of the extracellular adapter myeloid differentiation factor-2 (MD-2), all situated 
at the cell membrane (Tobias et al., 1995, Hailman et al., 1994).  The LPS-LPS receptor 
complex utilizes adapter proteins in order to operate, including myeloid differentiation factor 
88 (MyD88), MyD88 adaptor-like protein (MAL), toll-IL-1 receptor (TIR)-containing adapter 
molecule (TRIF) and TRIF-related adapter molecule (TRAM) (Wesche et al., 1997, Jiang et 
al., 2003, Fitzgerald et al., 2001, Yamamoto et al., 2003a, Yamamoto et al., 2003b).   
 
Once activated, TLR4 signalling follows an early a) MyD88-dependent pathway and a 
delayed b) MyD88-independent pathway, with both resulting in the activation of NF-kB and 
interferon regulatory factor 3 (IRF3) pathways (Palsson-McDermott and O'Neill, 2004, Jiang 
et al., 2003, Yamamoto et al., 2003a, Fitzgerald et al., 2003b).  For the early phase MyD88-
dependent pathway, TLR4 recruits MyD88 and MAL to the receptor complex, an action 
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negatively regulated by single immunoglobulin IL-1 receptor-related molecule (SIGIRR), ST2 
and MyD88-splice variant (MyD88s) (Jiang et al., 2003, Oshiumi et al., 2003a, Horng et al., 
2002, Horng et al., 2001, Wald et al., 2003, Thomassen et al., 1999, Brint et al., 2004).  
MyD88 then facilitates an association with interleukin-1 receptor-associated kinase 4 
(IRAK4), leading to the phosphorylation of interleukin-1 receptor-associated kinase 1 
(IRAK1) and the binding of tumour necrosis factor receptor-associated factor 6 (TRAF6) to 
this complex (Suzuki et al., 2002) (Qin et al., 2004, Cao et al., 1996).  The IRAK1-TRAF6 
complex breaks away from the receptor and interacts with a transforming growth factor-β-
activated kinase 1 (TAK1)-TAK-1 binding protein 1 (TAB1)-TAB2 complex at the plasma 
membrane (Yamaguchi et al., 1995, Shirakabe et al., 1997, Ninomiya-Tsuji et al., 1999). 
 
The adaptors TRIF and TRAM are responsible for facilitating the late phase LPS response.  
TLR4 recruits TRIF and TRAM to the receptor complex, an action negatively regulated by 
TRIAD3A (Yamamoto et al., 2003a, Oshiumi et al., 2003b, Chuang and Ulevitch, 2004).  
TRIF then binds to either TRAF6 or TRAF-binding protein (TANK)-binding kinase 1 (TBK1), 
with the TRIF-TRAF6 complex resulting in NF-kB release (Sato et al., 2003, Fitzgerald et al., 
2003a) and the TRIF-TBK1 complex resulting in the activation of IRF3 by acting as an IRF3 
kinase (Fitzgerald et al., 2003a).  Once phosphorylated, IRF3 can then bind to the interferon-
sensitive response element (ISRE)(Wietek et al., 2003) and the transcription factor, p65, to 
induce interferon β (IFNβ) release (Schafer et al., 1998, Kim et al., 2000, Wathelet et al., 
1998).  
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FIGURE 2.3 The LPS intracellular signalling cascade.  Soluble LBP chaperones LPS to 
CD14.  CD14 loads the LPS-LBP complex onto the LPS receptor, made of dimerized TLR4’s 
and two molecules of MD-2.  MyD88 and MAL-dependent TLR4 signalling results in the NF-
kB release while TRIF and TRAM-dependent signalling results in NF-kB and IFNβ release.  
Abbreviations: LBP, LPS-binding protein; CD14, cluster of differentiation 14; LPS, 
lipopolysaccharide; MD-2, myeloid differentiation factor-2; TLR4, toll-like receptor 4; TRIF, 
toll-IL-1 receptor-containing adapter molecule; TRAM, Toll-IL-1 receptor-containing adapter 
molecule-related adapter molecule; MAL, MyD88 adaptor-like protein; MyD88, myeloid 
differentiation factor 88; SIGIRR, single immunoglobulin interleukin-1 receptor-related 
molecule; IRAK4, IL-1 receptor-associated kinase 4; TBK1, tumour necrosis factor receptor-
associated factor binding protein-binding kinase 1; TRAF6, tumour necrosis factor receptor-
associated factor 6; TAB1, transforming growth factor-β-activated kinase 1 binding protein 1; 
TAK1, transforming growth factor-β-activated kinase 1; NF-kB, nuclear factor kappa B; IkB, 
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NF-kB inhibitor; IRF3, interferon regulatory factor 3; ISRE, interferon-sensitive response 
element; IFNβ, interferon β. Adapted from (Palsson-McDermott and O'Neill, 2004).      
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2.1.4.2 Effects of lipopolysaccharide on the HPA axis  
As mentioned above, LPS induces strong immune responses in mammals, and acute 
administration of LPS stimulates the HPA axis (Leshin and Malven, 1984, Rivier et al., 
1989).  The stimulatory effects of LPS on the HPA axis are mediated partly by pro-
inflammatory mediators such as IL-1, Il-6 and TNF-α, which stimulate the release of CRH 
and AVP that instigate the neuroendocrine stress cascade (John and Buckingham, 2003, 
Turnbull and Rivier, 1999).  Both systemically and centrally administered LPS increase CRH 
mRNA levels in the PVN (Kakucska et al., 1993), as well as CRH release (Givalois et al., 
1995), and both lesions of the hypothalamus (Yasuda and Greer, 1978) and 
pharmacological blockade of CRH-R1 (Moberg, 1971) inhibit the effects of LPS on the 
pituitary-adrenocortical response.  Centrally administered LPS can stimulate AVP 
heteronuclear RNA levels in the magnocellular and parvocellular areas of the PVN (Xia and 
Krukoff, 2003), and can also  stimulate AVP release from hypothalamic SCh neurons ex vivo 
(Nava et al., 2000).  Furthermore, LPS can directly stimulate ACTH release from primary 
pituitary cells (Elenkov et al., 1992).  LPS-stimulated IL-6 release from folliculostellate (FS) 
cells in the anterior pituitary acts with hypothalamic CRH to stimulate ACTH release from 
pituitary corticotroph cells (Gloddek et al., 2001).  The effects of LPS on all cells are mainly 
exerted via NF-kB (Libermann and Baltimore, 1990).  Evidence for this includes  LPS 
stimulation of IL-6 release from FS cells via a glucocorticoid-sensitive, NF-kB -dependent 
mechanism, and LPS-stimulated activation of NF-kB in corticotroph cells  (Mehet et al., 
2012).  In vivo, LPS increases intrapituitary NF-kB, whereas an NF-kB inhibitor attenuates 
the LPS-induced release of ACTH (Mehet et al., 2012) in rats. 
 
Repeated LPS challenge dampens the HPA response, as shown by reduced ACTH and 
corticosterone release in mice injected with LPS for 5 days compared to mice that received 
one individual LPS injection on day 1 only (Hadid et al., 1995).  Rats repeatedly injected with 
LPS demonstrate reduced c-fos mRNA, PVN CRH mRNA and pituitary POMC mRNA levels 
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compared to rats receiving a single LPS challenge (Takemura et al., 1997).  It is thought that 
this decreased pituitary-adrenal responsiveness is partly due to a reduced hypothalamic 
drive (Takemura et al., 1997). 
 
As described above, leptin’s influences on basal and activated HPA activity (Ahima et al., 
1998, Heiman et al., 1997, Jethwa et al., 2006) are controversial.  As a potent stimulator of 
the HPA axis, LPS may be a reliable stressor with which to examine the role of leptin in the 
HPA axis response to stress.   
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2.1.4 Hypothesis 
I hypothesize that leptin will modulate the acute HPA response to LPS treatment in rats. 
2.1.5 Aims 
To elucidate the effects of leptin on the HPA axis I will determine: 
 The effects of a low dose of acute leptin administration on basal and acute LPS-
stimulated HPA axis activity in male rats, using an established dose of LPS    
 The effects of different doses of acute LPS stimulation on neuronal activation, as 
measured by c-fos protein expression, in regions of the hypothalamus and brain stem 
implicated in the stress response and/or energy homeostasis    
 The effects of a higher dose of acute leptin administration on basal and acute LPS-
stimulated HPA axis activity in male rats. 
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2.2 Methods 
2.2.1 Animals and housing 
All animal procedures undertaken were approved by the British Home Office Animals 
Scientific Procedures Act 1986 (Project License Number: 70/6623).  On arrival, specific 
pathogen free (SPF) male Wistar rats (Charles River, Kent, UK) were group housed in fours 
and maintained at 21-23˚C on a 12 hr light: 12 hr dark cycle (light period 07:00-19:00 hrs) 
with ad-libitum access to RM1 standard chow (RM1 diet, Special Diet Services Ltd., Witham, 
Essex) and water.  After the 72 hour acclimatization period, all rats were handled daily for 3 
minutes each for two weeks to minimize the risk of neuronal activation due to environmental 
stressors, as acute restraint stress has been shown to induce high levels of c-fos in rats 
(Trneckova et al., 2006).  At two weeks, the experiments were carried out in the early light 
phase.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
2.2.2 Materials 
2.2.2.1 Injectables 
Recombinant human leptin (NIDDK, Bethesda, USA) 
Recombinant rat leptin (R&D Systems, Abingdon, UK) 
Lipopolysaccharide from Escherichia coli Serotype 0111:B4 (Sigma-Aldrich, Dorset, UK) 
Saline (B. Braun Medical Ltd., Sheffield, UK) 
 
2.2.2.2 Plasma hormone immunoassay kits 
Rat leptin enzyme-linked immunosorbent assay (ELISA) (Crystal Chem Inc., Illinois, USA)  
ACTH immunoradiometric assay (IRMA) (DiaSorin, Dublin, Ireland) 
Corticosterone enzyme immunoassay (EIA) (Cayman Chemical Company, Michigan, USA) 
Rat IL-1β Quantikine ELISA (R&D Systems) 
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2.2.2.3 Materials for immunohistochemistry 
0.01M Phosphate buffered saline (PBS) (see Appendix I) 
0.2M PBS (see Appendix I) 
PBS Formaldehyde (PBS FA) solution (see Appendix I)  
4% (v/v) Formaldehyde (VWR International Ltd., Dorset, UK)  
40% (w/v) Sucrose solution (see Appendix I)  
Antifreeze (see Appendix I)  
Net-well meshed-insert wells and Net-well reagent trays (VWR International Ltd)  
PBS Tween (PBST) solution (see Appendix I)  
Methanol-Hydrogen peroxide (H2O2) solution (see Appendix I)  
Blocking solution (see Appendix I)   
Primary antibody diluent (same as blocking solution)  
Rabbit anti c-fos (AB-5) primary antibody (Merck Chemicals Ltd., Nottinghamshire, UK)  
Secondary antibody diluent (see Appendix I) 
Biotinylated goat anti-rabbit IgG secondary antibody (Vector Laboratories, Peterborough, 
UK) 
0.05M (hydroxymethyl)aminomethane Hydrogen Chloride (TrisHCl) solution (pH 7.6) (see 
Appendix I)  
Streptavidin-Biotin complex (ABC)-HRP conjugated kit (Dako UK Ltd., Cambridgeshire, UK)  
3,3' Diaminobenzidine (DAB) solution (see Appendix I)  
Poly-L-lysine-coated slides (VWR International Ltd)  
50% (v/v), 70% (v/v) and 100% Ethanol solutions (see Appendix I)  
Xylene (BDH, Dorset, UK)  
Di-N-Butyl Phthalate in Xylene (DPX) mounting medium (BDH) 
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2.2.3 Study designs 
2.2.3.1 The effect of low dose leptin on the HPA axis response to high dose 
lipopolysaccharide 
Method 
Forty eight male Wistar rats, weighing 300g after two weeks of housing, were randomized 
into 6 body weight matched groups of 8.  Rats were first i.p. injected with either 100µl saline, 
100µg/kg recombinant human leptin, or were not injected at all, and were then returned to 
their cages.  One hour and 45 minutes later rats were i.p. injected with 250µg/kg LPS or 
were not injected at all, and were again returned to their cages.  This resulted in the 
following treatment groups (n = 8): saline, leptin, saline + LPS, leptin + LPS, LPS and no 
treatment.  Leptin and LPS were reconstituted in water and aliquots were stored at -20˚C 
prior to the study.  On the day of the study, leptin and LPS were further diluted in saline, to 
be administered at a final volume of 100µl. 
 
Maximum c-fos protein expression occurs 90 minutes after stimulation by a stressor, and 15 
minutes was considered a reasonable time for the LPS to generate a stress response (Gillen 
and Briski, 1997). All rats were therefore decapitated by guillotine another 1 hr and 45 
minutes later. Trunk blood was collected into ethylenediaminetetraacetic acid (EDTA) lined 
tubes and spun at room temperature at 6000rpm (Boeco Centrifuge S-8, Boeco, Hamburg, 
Germany) for 10 minutes to separate the plasma.  Samples were stored at -20˚C until 
measurement of plasma leptin and IL-1β concentrations by ELISA, and plasma 
corticosterone by EIA and plasma ACTH concentrations by IRMA, as described in 2.2.4.  
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2.2.3.2 The dose response effect of lipopolysaccharide on the HPA axis stress 
response 
Method 
This study was carried out to determine the lowest dose of LPS capable of inducing a robust 
stress response, as the dose of 250µg/kg induced an extremely high stress response in rats 
from study 2.2.3.1.   
 
Forty male Wistar rats, weighing 300-390g after two weeks of housing, were randomized into 
5 body weight matched groups of 8.  Rats were i.p. injected with either 100µl saline or LPS 
at concentrations of 10, 25, 100 or 250µg/kg, before being returned to their cages.  Aliquots 
of reconstituted LPS had been stored at -20˚C prior to injection.  LPS was administered at a 
final volume of 100µl.  Two hours later all rats were decapitated by guillotine.  This time point 
allowed for maximum c-fos protein expression, which as described earlier occurs 90 minutes 
after stimulation by a stressor.  This 2 hr time point is also in line with an earlier study 
investigating the effect of leptin on the HPA axis response to acute restraint stress (Heiman 
et al., 1997).  So for this study (2.2.3.2) as well as study 2.2.3.3 it was decided to use the 
same 2 hr time point between leptin administration, the acute stress procedure and 
decapitation, making it possible to compare results from multiple studies.  The study was 
completed within the early light phase to avoid ultradian rhythmic changes in circulating 
plasma stress hormones.  Trunk blood was collected and plasma was separated and stored 
as described in 2.2.3.1, for measurement of plasma corticosterone and ACTH 
concentrations by EIA and IRMA respectively, as described in 2.2.4.2 - 2.2.4.3.  Whole rat 
brains were removed and separated from their brainstems.  Brains and brainstems were 
then submerged in 4% formaldehyde (FA) solution overnight at 4˚C to allow fixation of the 
tissue.  Brains were then transferred in to a 40% sucrose solution for 4 days at 4˚C to 
dehydrate them for cryopreservation.  Finally they were frozen in isopentane chilled to -45˚C, 
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before being stored at -80˚C until sectioning and immunohistochemical staining for c-fos at a 
later stage, as described in 2.2.5.   
 
2.2.3.3 The effect of a high dose of leptin on the HPA axis response to a low 
dose of lipopolysaccharide  
Forty male Wistar rats, weighing 300-390g after two weeks of housing, were randomized into 
4 body weight matched groups of 10.  Rats were first i.p. injected with either saline or 
2mg/kg recombinant rat leptin and returned to their cages.  Two hours later rats were i.p. 
injected with either saline or 25µg/kg LPS and again returned to their cages.  This resulted in 
the following treatment groups (n = 10): saline + saline (saline), leptin + saline (leptin), saline 
+ LPS (LPS) and leptin + LPS.  Leptin and LPS had been reconstituted with water and 
aliquots stored at -20˚C prior to the study.  All LPS injections were administered at a final 
volume of 100µl, while leptin was administered in a final volume of 700µl. 
 
Two hours after being returned to their cages, all rats were decapitated by guillotine.  Trunk 
blood was collected and plasma was separated and stored as described in 2.2.3.1, for 
measurement of plasma leptin, corticosterone and IL-1β concentrations by ELISA, and 
plasma ACTH concentrations by IRMA, as described in 2.2.4.   
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2.2.4 Leptin, ACTH, corticosterone and interleukin-1β assays 
2.2.4.1 Leptin enzyme-linked immunosorbent assay  
A commercial rat leptin ELISA kit was used for the quantitative determination of plasma 
leptin levels, following the manufacturer’s instructions.  Standards, buffers and reference 
preparations were supplied.  Each kit provided a 96-well rabbit anti-leptin antibody pre-
coated plate.  Lyophilised leptin standard was reconstituted with 100μl of sample diluent to 
make up the leptin stock solution.  Leptin standards of a known concentration were made up 
by serial dilution of the stock solution using the sample diluent.  Each well was washed twice 
with wash buffer, after which 45μl of sample diluent and 50μl of guinea pig anti-leptin serum 
was added to each well. To this, 5μl of sample or standard was added to the plate in 
duplicates (samples were diluted to concentrations of 1:5 for samples from study 2.2.3.1, 
and 1:50 and 1:1000 for samples from study 2.2.3.3) and left to incubate at 4ºC for 16-20 
hours.  During this incubation period the leptin in the standards and plasma samples bound 
to the rabbit anti-leptin antibody pre-coated on the plate, as well as simultaneously binding to 
the anti-leptin Immunoglobulin G (IgG) of the guinea pig anti-serum.  After the incubation 
period any unbound material was removed by washing five times, before adding 100μl of a 
horse radish peroxidase (HRP)-conjugated anti-guinea pig IgG antibody, which bound to the 
guinea pig anti-leptin IgG of the complex already immobilized to the wells.  This was left to 
incubate at room temperature for three hours, after which further washing the plate seven 
times removed excess HRP-conjugated antibody.  This was followed by an enzyme reaction 
in which the bound HRP-conjugated antibody in the wells was detected by adding a 3,3’,5,5’-
tetramethylbenzidine (TMB) substrate solution.  This reaction was incubated for 30 minutes 
at room temperature in the dark and was stopped by addition of 100μl 1M sulphuric acid.  
The absorbance was measured using a Labsystems Multiscan RC plate reader (Thermo 
Scientific, Massachusetts, USA) at a wavelength of 450nm while the background was read 
at 630nm.  Leptin concentrations were determined via interpolation of the unknown 
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concentrations against the standard curve generated from the known standard 
concentrations.    
 
2.2.4.2 ACTH immunoradiometric assay 
A commercial human ACTH IRMA kit, that cross-reacts with rat ACTH and is highly specific 
for ACTH 1-39, was used for the quantitative determination of plasma ACTH levels following 
the manufacturer’s instructions.  Calibrators, controls, buffers and reference preparations 
were supplied.  Lyophilised ACTH calibrators and standards of a known concentration were 
reconstituted with 2ml GDW.  Two hundred microlitres of calibrators, controls and samples 
were added to 12 x 17 mm polypropylene tubes, along with 50μl of iodinated tracer and one 
mouse anti-goat coated polystyrene bead in each tube.  In this assay two ACTH antibodies 
are used; each one specific for different regions of the ACTH molecule.  The iodinated tracer 
contains a purified polyclonal goat antibody specific for ACTH 26-39 and an iodine-125 
labelled monoclonal antibody specific for ACTH 1-17.  When calibrators, controls and 
samples are incubated with the tracer and mouse anti-goat coated polystyrene beads, the 
ACTH-specific antibodies bind to the ACTH present in the calibrators, controls and samples.  
Only ACTH 1-39 present in the calibrators, controls and samples binds to both antibodies to 
form an antibody complex.  To allow sufficient time for this reaction to occur, the tubes were 
covered with para-film and left at room temperature for 20 hours.  Following the 20 hour 
incubation period, tubes were washed three times to remove any unbound radioactivity, 
before all radioactivity bound to each bead was measured using a gamma counter for 60 
seconds.  The counts per minute (CPM) from the calibrators were then used to construct a 
standard curve in order to interpolate the unknown ACTH concentrations of the plasma 
samples.  All calibrators, controls and samples were measured in duplicate and the average 
reading used in subsequent analysis.   
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2.2.4.3 Corticosterone enzyme immunoassay 
A commercial corticosterone EIA kit was used for the quantitative determination of plasma 
corticosterone levels, following the manufacturer’s instructions.  Standards, buffers and 
reference preparations were supplied.  Each kit provided a 96-well rabbit anti-sheep IgG pre-
coated plate.  A corticosterone stock standard solution was serially diluted in assay buffer to 
make up further corticosterone standards of known concentrations.  Eight wells of each plate 
were prepared as controls, with three containing nothing (2 x ‘Blank’ wells + 1 x ‘Total 
Activity’ well), two ‘Non-specific Binding’ wells that contained 100μl of assay buffer + 50μl of 
corticosterone acetyl cholinesterase (AChE) tracer and three ‘maximum Binding’ wells called 
B0 that contained 50μl of assay buffer + 50μl of corticosterone AChE tracer + 50μl of sheep 
antiserum.  To the remainder of the plate, 50μl of standards or samples (samples diluted to 
concentrations of 1:10 for samples from study 2.2.3.1, 1:750 for samples from study 2.2.3.2 
and 1:500 for samples from study 2.2.3.3) were added in duplicate, followed by 50μl of 
corticosterone AChE tracer and 50μl of sheep antiserum.  The plates were then covered in 
plastic film and incubated at room temperature on a flat orbital shaker at 400rpm for 2 hours.  
This assay is based on the competition between corticosterone and a corticosterone AChE 
conjugate for a limited number of corticosterone-specific sheep antiserum binding sites.  
Because the concentration of the AChE tracer is constant while the concentration of 
corticosterone varies, the amount of AChE tracer that is able to bind to the sheep antiserum 
is inversely proportional to the concentration of corticosterone in the well.  This sheep 
antiserum-corticosterone complex binds to the rabbit polyclonal anti-sheep IgG previously 
attached to the well.  After the 2 hour incubation step, the plates were washed five times to 
remove any unbound reagents and then 200μl of an AChE substrate was added to each 
well.  At the same time 5μl of AChE tracer was added to the ‘Total Activity’ well of each 
plate, after which the plates were covered with plastic film and incubated at room 
temperature, on a flat orbital shaker at 400rpm and in the dark, for 60 minutes.  The product 
of this enzymatic reaction has a distinct yellow colour and its absorbance was measured 
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spectrophotometrically using a Labsystems Multiscan RC plate reader at a wavelength of 
420nm.  The intensity of the colour is proportional to the amount of AChE tracer bound to the 
well, which is inversely proportional to the amount of free corticosterone present in the well 
during the incubation.  Corticosterone concentrations were determined via interpolation of 
the unknown concentrations against the standard curve generated from the known standard 
concentrations.   
 
2.2.4.4 Interleukin-1β enzyme immunoassay  
A commercial rat IL-1β quantikine ELISA kit was used for the quantitative determination of 
plasma IL-1β levels, following the manufacturer’s instructions.  Controls, standards, buffers 
and reference preparations were supplied.  Each kit provided 2 x 96-well rat IL-1β-specific 
polyclonal antibody pre-coated plates.  A lyophilised rat IL-1β control was reconstituted with 
1ml of GDW and a lyophilised rat IL-1β standard was reconstituted with 2ml of calibrator 
diluent to create a standard stock solution.  This solution was further serially diluted with 
calibrator diluent to produce 6 more standards of known concentrations of IL-1β. Fifty 
microlitres of assay diluent was then added to each well, followed by 50μl of standard, 
control or sample per well (samples were diluted with calibrator diluent to a concentration of 
1:3 as per kit instructions).  The plates were then covered with plastic film and incubated at 
room temperature for 2 hours.  This allowed any IL-1β in the samples, controls or standards 
to bind to the immobilized antibody already bound to the wells.  After the 2 hour incubation 
step, all the wells were washed five times to remove any unbound reagents before adding 
100μl of a rat IL-1β conjugate, an enzyme-linked polyclonal antibody that is specific for rat 
IL-1β, and incubating again at room temperature for 2 hours.  After this second incubation 
step, all the wells were washed again five times to remove any unbound IL-1β conjugate and 
then 100μl of a light-sensitive substrate solution was added to each well.  This was 
incubated for 30 minutes at room temperature, away from light.  Then 100μl of a stop 
solution was added to each well and the optical density of each well was measured using a 
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Labsystems Multiscan RC plate reader at a wavelength of 450nm.  Samples were measured 
in duplicate and the average reading used in subsequent analysis.  IL-1β concentrations 
were determined via interpolation of the unknown concentrations against the standard curve 
generated from the known standard concentrations.        
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2.2.5 Immunohistochemistry 
2.2.5.1 Cellular fos-like immunoreactivity 
C-fos was named after the viral oncogene (v-fos) encoded by the Finkel-Biskis-Jinkins 
murine osteosarcoma virus, and is itself encoded by the fos gene (Morgan and Curran, 
1991).  Fos is a proto-oncogene of the immediate early gene family of transcription factors 
which, in response to stimulation, is rapidly and temporarily expressed in specific neurons.  
Hence it is used as an early marker of neuronal activity in the CNS (Morgan and Curran, 
1991).  The fos gene is transcribed within minutes of neuronal stimulation, leading to peak c-
fos mRNA accumulation at approximately 30 minutes after stimulation, and peak c-fos 
protein levels accumulating at 90 minutes after stimulation (Gillen and Briski, 1997).  C-fos 
protein is routinely detected using immunohistochemical methods.  Several different types of 
stimulus, including many pharmacological agents, have been shown to induce c-fos 
expression in neurons of the CNS (Herrera and Robertson, 1996). The c-fos like 
immunoreactivity observed following peripheral administration of LPS would indicate the 
neurons this agent activates either directly or indirectly.  Furthermore, leptin treatment may 
affect such neuronal activation of LPS-injected rats and indicate which stress or non stress-
related neurons are sensitive to leptin action. 
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2.2.5.2 Immunohistochemical staining for cellular-fos 
Thirty micrometers coronal sections of the whole brain and brainstem were cut using a 
freezing sled microtome (Shandon Southern Products Ltd., Cheshire, UK) and collected into 
24-well plates containing antifreeze.  Sections were stored in antifreeze at -20°C until IHC 
analysis.  For IHC, selected sections were transferred into net-well meshed-insert wells held 
in net-well reagent trays and first washed in PBS three times for five minutes each time. 
They were then incubated in a H2O2-methanol solution for 15 minutes to quench 
endogenous peroxidase enzyme activity.  Sections were then washed in PBS a further three 
times before being incubated in a blocking solution for two hours, in an effort to reduce 
background staining due to non-specific binding.  A 1:20,000 dilution of a rabbit anti c-fos 
primary antibody (AB-5) was prepared in primary antibody diluent.  The sections were then 
incubated overnight in the primary antibody solution, after which they were washed with 
PBST three times for five minutes each.  A 1:400 dilution of a biotinylated goat anti-rabbit 
IgG secondary antibody was prepared in secondary antibody diluent.  The sections were 
then incubated in the secondary antibody solution for two hours and then washed in PBST 
three times for five minutes each time.  A working solution of ABC-HRP was prepared by 
diluting (1:200) the separate streptavidin and biotin reagents from the ABC-HRP kit in a 
TrisHCl solution.  The biotin on the secondary antibody binds to sites available on the avidin, 
which is already conjugated with an enzyme.  Sections were incubated in the ABC-HRP 
solution for one hour, before being washed in PBST three times again.  Horseradish 
peroxidase activity was then visualized by staining the sections in a DAB solution for 
approximately ten minutes or until darkened sufficiently, before being washed with PBS to 
stop excessive darkening of the sections.  The DAB chromogen reacts with the enzyme on 
the streptavidin-biotin complex to reveal a dark brown stain representing c-fos.  The sections 
were then floated onto poly-L-lysine-coated slides and allowed to dry for a few hours before 
being dehydrated in 50, 70 and then 100% ethanol, delipidated in xylene and mounted and 
cover-slipped using DPX mounting medium.  The slides were then allowed to dry overnight.   
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For quantification of c-fos-like positive nuclei, slides were observed under a light microscope 
and manual blinded cell counting was carried out.  The numbers were counted within defined 
hypothalamic nuclei using the rat brain atlas of Paxinos and Watson (Paxinos and Watson, 
2007).   
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2.2.6 Statistics 
Plasma hormone data and immunohistochemical c-fos analyses were analyzed using one 
way analysis of variance (ANOVA) with a post-hoc Tukey’s test to identify statistical 
significance between all relevant pairs of treatment groups.  The Pearson’s correlation 
coefficient was used to determine whether a correlation existed between LPS dose and c-fos 
counts, where 1 is total positive correlation, 0 is no correlation, and −1 is total negative 
correlation.  All data is expressed as mean ± SEM and significance was taken at P ≤ 0.05 
throughout.  All data were analyzed using GraphPad Prism version 5 for Windows 
(GraphPad Software, San Diego, CA).      
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2.3 Results 
2.3.1 The effect of a low dose of leptin on the HPA axis response to a high 
dose of lipopolysaccharide: Plasma leptin, ACTH, corticosterone and 
interleukin-1β concentrations 
 
There was no significant difference in body weight between any of the experimental groups 
prior to experimentation (Control: 294±5.41g, Saline: 294±4.89g, Leptin: 300±5.23g, Saline + 
LPS: 304±5.98g, LPS: 303±5.42g, Leptin + LPS: 294±4.30, P = 0.51, n = 8).  Rats that 
received only leptin demonstrated a significant increase in plasma leptin levels compared to 
controls, 3.5 hrs after leptin administration.  Rats that received leptin + LPS demonstrated 
significantly higher plasma leptin concentrations compared to all other experimental groups 
that did not receive leptin.  LPS alone did not influence plasma leptin concentrations (Figure 
2.4A).   
 
Saline + LPS and leptin + LPS significantly increased plasma ACTH levels 1 hr and 45 
minutes after injection.  LPS alone caused a non-significant rise in plasma ACTH levels.  
Leptin alone had no effect on plasma ACTH concentrations and did not significantly 
influence LPS-induced ACTH secretion.  Plasma ACTH concentrations were significantly 
greater in rats that received saline + LPS compared to rats receiving leptin + LPS (P ≤ 0.01) 
(Figure 2.4B).   
 
LPS significantly increased plasma corticosterone levels 105 minutes after injection.  Leptin 
alone had no effect on basal plasma corticosterone levels.  Leptin in combination with LPS 
did result in a reduced plasma corticosterone increase compared to LPS-injected rats, but 
this result was not statistically significant (Figure 2.4C). 
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Plasma IL-1β levels were significantly increased by injection of LPS, but were not influenced 
by injection of leptin alone.  Co-injection of leptin + LPS did not influence LPS-induced 
increases in IL-1β levels (Figure 2.4D).  No other significant differences were observed 
between any of the experimental groups.           
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FIGURE 2.4 The effect of i.p. administration of leptin on LPS-stimulated increases in 
plasma (A) leptin, (B) ACTH, (C) corticosterone and (D) IL-1β concentrations.  Male 
Wistar rats received one of the following i.p. treatments; saline at 0 minutes, 100μg/kg leptin 
at 0 minutes, saline at 0 minutes and 250µg/kg LPS at 1 hr and 45 minutes, 250µg/kg LPS 
at 1 hr and 45 minutes, or 100μg/kg leptin at 0 minutes and 250µg/kg LPS at 1 hr and 45 
minutes.   Rats were decapitated 3 hrs and 30 minutes after the first injection at 0 minutes.  
Data are presented as mean ± SEM; one way ANOVA with post-hoc Tukey’s tests.  * = P ≤ 
0.05 vs. control, *** = P ≤ 0.001 vs. control, $$ = P ≤ 0.01 vs. saline, $$$ = P ≤ 0.001 vs. 
saline, bb = P ≤ 0.01 vs. leptin, bbb = P ≤ 0.001 vs. leptin, ££ = P ≤ 0.01 vs. LPS, ^ = P ≤ 
0.05 vs. saline + LPS, ^^ = P ≤ 0.01 vs. saline + LPS; n = 3-8.  
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2.3.2 The dose response effect of lipopolysaccharide on the HPA axis stress 
response 
2.3.2.1 Plasma ACTH and corticosterone concentrations 
 
There was no difference in body weight between any of the experimental groups prior to 
experimentation (Saline: 346±6.25g, 10μg/kg LPS: 350±7.79g, 25μg/kg LPS: 356±6.62g, 
100μg/kg LPS: 353±9.30g, 250μg/kg LPS: 345±7.65, P = 0.83, n = 10).  Doses of LPS 
ranging from 25μg/kg to 250μg/kg induced a neuroendocrine stress response.  One hundred 
micrograms per kilogram and 250μg/kg LPS induced the strongest responses in plasma 
ACTH levels compared to the saline-treated group (P ≤ 0.05 and P ≤ 0.01 respectively), 120 
minutes after injection (Figure 2.5A).  Twenty five micrograms per kilogram and 250μg/kg 
LPS induced greatest plasma corticosterone response compared to the saline-treated group 
(P ≤ 0.05 and P ≤ 0.01 respectively) (Figure 2.5B).  The lowest dose of LPS tested, 10μg/kg, 
induced small rises in plasma ACTH and corticosterone but these changes were not 
statistically significant.  No other significant differences were observed between any of the 
experimental groups.         
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FIGURE 2.5 The dose response effect of i.p. LPS on plasma (A) ACTH and (B) 
corticosterone concentrations.  Rats received either i.p. saline or i.p. LPS at 10, 25, 100 
or 250μg/kg LPS.  Data are presented as mean ± SEM; one way ANOVA with post-hoc 
Tukey’s tests.  * = P ≤ 0.05 vs. saline, ** = P ≤ 0.01 vs. saline; n = 10.  
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2.3.2.2 C-fos-like immunoreactivity in the hypothalamus and brainstem 
 
Intraperitoneal injection of different doses of LPS increased hypothalamic c-fos expression in 
the ARC and VMN compared to saline-treated rats; with level of expression increasing 
alongside dose, albeit insignificantly (Table 2.1 and Figure 2.6A and D).  LPS also induced 
c-fos expression in the PVN (Table 2.1 and Figure 2B) but not in a dose-dependent manner.  
Twenty five and 250μg/kg LPS induced an increase in c-fos expression in the hypothalamic 
SON but this was also not statistically significant (Table 2.1 and Figure 2.6C).  Sections from 
rat hypothalami from the 100μg/kg LPS treated group were not available for inclusion in the 
analysis due to the lack of matched sections from this treatment group.   
 
In the rat brainstem, LPS appeared to induce c-fos expression in the caudal and rostral 
nucleus of the solitary tract (NTS), parabrachial nucleus (PBN), area postrema (AP) and 
locus coeruleus (LC), but these effects were not statistically significant (Table 2.2 and Figure 
2.7A-E).  Note that the absence of bars above named treatment groups on the graphs 
reflects c-fos-like counts of 0, and the absence of an error bar on the 250μg/kg LPS-injected 
group within the PVN reflects that only a single section from this group was analyzed. 
 
  
104 
 
TABLE 2.1 The dose-response effect of i.p. LPS on c-fos protein expression in rat 
hypothalamic areas.  Table summarizing c-fos-like positive cell counts observed in 
hypothalamic areas following i.p. injection of saline or LPS at 10, 25, 100 or 250μg/kg.  Data 
are presented as mean ± SEM; one way ANOVA with post-hoc Tukey’s test, non significant, 
n = 2-4. 
 
Hypothalamic 
nucleus 
c-fos-like positive counts 
Saline 10μg/kg 
LPS 
25μg/kg 
LPS 
100μg/kg 
LPS 
250μg/kg 
LPS 
ARC 69±10.6 142±38 215±87.5 258±43 281±57.6 
PVN 20.5±11.9 215±48.5 176±149 116±76.5 177±13.5 
SON 5.33±5.33 5.50±5.50 14±14 no sections 
available 
54.3±32.8 
VMN 108±48.5 192±10.5 242±37.5 255±56 294±39.5 
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FIGURE 2.6 The dose-response effect of i.p. LPS on c-fos protein expression in the rat 
hypothalamic (A) ARC, (B) PVN, (C) SON and (D) VMN.  Rats received either i.p. saline or 
i.p. LPS at 10, 25, 100 or 250µg/kg.  Values are measured in arbitrary units (AU) and 
presented as mean ± SEM; one way ANOVA with by post-hoc Tukey’s test, ns; n=2-4.  
Pearson’s correlation coefficient between LPS dose and c-fos expression = 0.   
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TABLE 2.2 The dose-response effect of i.p. LPS on c-fos protein expression in rat 
brainstem areas.  Table summarising c-fos-like positive cell counts observed in brainstem 
areas following i.p. injection of saline or LPS at 10μg/kg, 25μg/kg, 100μg/kg or 250μg/kg.  
Data are presented as mean ± SEM; one way ANOVA with post-hoc Tukey’s test, ns; n = 1-
4.  
 
Brainstem 
nucleus 
c-fos-like positive counts 
Saline 10μg/kg 
LPS 
25μg/kg 
LPS 
100μg/kg 
LPS 
250μg/kg 
LPS 
Caudal NTS 0±0 15.3±7.86 no 
sections 
available 
51±16 96 (1 
section) 
Rostral NTS 6.75±2.66 45.7±13.9 120±120 177±42 78.5±78.5 
PBN 0±0 0±0 0±0 56.3±29.9 83±21 
AP 1±1 14.5±5.50 no 
sections 
available 
10.5±2.50 no 
sections 
available 
LC 8.5±4.5 0±0 0±0 13.3±9.61 12.3±7.88 
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FIGURE 2.7 The dose-response effect of i.p. LPS on c-fos protein expression in the (A) 
caudal NTS, (B) rostral NTS, (C) PBN, (D) AP and (E) LC of the rat brainstem.  Rats 
received either i.p. saline or i.p. LPS at 10, 25, 100 or 250µg/kg.  Values are measured in 
arbitrary units (AU) and presented as mean ± SEM; one way ANOVA with by post-hoc 
Tukey’s test, ns; n=1-4.   
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2.3.3 The effect of a high dose of leptin on the HPA axis response to a low 
dose of lipopolysaccharide: Plasma leptin, ACTH, corticosterone and 
interleukin-1β concentrations  
 
There was no difference in body weight between any of the experimental groups prior to 
experimentation (Saline + saline: 346±6.97g, Leptin + saline: 345±4.79g, Saline + LPS: 
346±5.54g, Leptin + LPS: 3464±6.72g, P = 0.99, n = 9-10).  Rats that received only leptin 
demonstrated a significant increase in plasma leptin levels 4 hrs after leptin administration 
compared to saline-injected rats (P ≤ 0.001), whilst LPS alone had no effect on plasma leptin 
levels (Figure 2.8A).  Rats that received LPS demonstrated significantly higher plasma 
ACTH and corticosterone levels compared rats that did not receive LPS (P ≤ 0.05 and P ≤ 
0.001 respectively) (Figure 2.8B and C respectively).  Leptin, whether injected alone or 
whether co-administered with LPS, did not affect plasma ACTH or corticosterone levels 
(Figure 2.8B and C respectively).  Plasma IL-1β levels were significantly increased in rats by 
injection of LPS (P ≤ 0.01), but were not influenced by injection of leptin alone (Figure 2.8D), 
and co-administration of leptin + LPS did not influence LPS-induced increases in IL-1β levels 
(Figure 2.8D).  No other significant differences were observed between any of the 
experimental groups.     
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FIGURE 2.8 The effect of i.p. administration of leptin on LPS-stimulated increases in 
plasma (A) leptin, (B) ACTH, (C) corticosterone and (D) IL-1β concentrations.  Male 
Wistar rats received one of the following i.p. treatments; saline at 0 and 120 minutes, 2mg/kg 
leptin at 0 minutes + saline at 120 minutes, saline at 0 minutes + 25μg/kg LPS at 120 
minutes or 2mg/kg leptin at 0 minutes + 25μg/kg LPS at 120 minutes.  Data are presented 
as mean ± SEM; one way ANOVA with post-hoc Tukey’s test.  * = P ≤ 0.05 vs. saline, ** = P 
≤ 0.01 vs. saline, *** = P ≤ 0.001 vs. saline, $ = P ≤ 0.05 vs. leptin, $$ = P ≤ 0.01 vs. leptin, 
$$$ = P ≤ 0.001 vs. leptin, bbb = P ≤ 0.001 vs. LPS; n = 8-10.  
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2.4 Discussion 
The studies described in this chapter aimed to elucidate the effects of leptin on the HPA 
response to stress.  They suggest that peripheral leptin administration does not influence 
basal HPA activity or influence the HPA response to acute endotoxin challenge. 
 
Two mg/kg leptin (Figure 2.8A), but not 100μg/kg leptin (Figure 2.4A), significantly raised 
circulating plasma leptin levels in adult male Wistar rats.  LPS, at doses above 25μg/kg, 
induced a strong stress response as demonstrated by significantly elevated plasma stress 
hormones, ACTH and corticosterone, as well as significantly elevated plasma levels of the 
cytokine IL-1β.  At doses above 25μg/kg, LPS appeared to drive neuronal activation in the 
hypothalamic ARC, PVN, SON and VMN, and at doses above 100μg/kg, neuronal activation 
in the NTS, PBN, AP and LE of the brainstem.  However, these effects on neuronal 
activation were not statistically significant in the current studies.  Neither 2mg/kg nor 
100μg/kg leptin influenced the HPA response to acute LPS challenge.   
 
 
The effects of LPS on HPA activity are mediated via a number of cytokines (Uehara et al., 
1987, Sharp et al., 1989, Sapolsky et al., 1987).   Leptin is a cytokine itself, and some have 
reported a stimulatory effect of LPS on leptin secretion (Landman et al., 2003, Mastronardi et 
al., 2001).  For example, LPS has been reported to restore the leptin in fasted rats to levels 
observed in the fed state (Sarraf et al., 1997).  However, it is perhaps unsurprising that LPS 
alone had no effect on plasma leptin levels in LPS-injected rats in study 2.2.3.1 (Figure 
2.4A).  This is because most studies that report a stimulatory effect of LPS on leptin are only 
able to demonstrate a statistically significant rise in plasma or serum leptin levels in LPS-
injected mice and rats, compared to controls, at time points of 4 hrs or longer after LPS 
injection (Sarraf et al., 1997, Wang et al., 2004, Kim et al., 2007, Finck et al., 1998).   
 
111 
 
In addition to measurement of plasma stress hormones, IL-1β was measured as an early 
marker of endotoxemia in studies 2.2.3.1 and 2.2.3.2, as it is one of the cytokines most 
strongly associated with endotoxemia, and has been shown to act as an 'initiator' cytokine 
that stimulates a cytokine cascade, ultimately driving many of the physiological changes 
seen in endotoxemia, in both human and experimental endotoxemic models (Blackwell and 
Christman, 1996).  Plasma ACTH, corticosterone and IL-1β reached extremely high levels in 
response to this endotoxin challenge and it is therefore possible that these stress hormones 
may have reached a maximum level of release due to optimal steroidogenesis.  This may 
have masked any inhibitory, or possibly any additive effect, that leptin may have had on the 
HPA response to this acute challenge.  Therefore the next experiment (2.2.3.2) was 
designed to determine the lowest dose of LPS capable of inducing a robust stress response.  
Such a response might be more amenable to modulation by leptin than the effect observed 
in the earlier high dose LPS study.   
 
The results from this study show that while LPS doses from 25μg/kg upwards did stimulate 
the HPA axis (Figure 2.5), they did not do so in a dose dependent manner, and some effects 
did not achieve statistical significance.  It is well known that after a stress response plasma 
ACTH levels start to normalise from 30 minutes, whilst corticosterone levels return to resting 
levels much later.  Therefore it is possible that this study missed any significant effect of the 
25μg/kg LPS dose on circulating ACTH at the 2 hr time point for plasma collection.  C-fos 
protein levels in the hypothalamic ARC, PVN, SON and VMN and the caudal and rostral 
NTS, PBN, AP and LC were measured (Tables 2.3 and 2.4 and Figures 2.6 and 2.7).  
Although LPS induced c-fos protein in the hypothalamus and brainstem, there was no 
statistical significance between treatment groups.  The lack of statistical significance likely 
stems from the use of low ‘n’ numbers of sliced brain and brainstem sections in the statistical 
analyses; in some cases resulting in the loss of specific treatment groups usable in the 
analyses.  The main reason for the use of low ‘n’ numbers was the lack of matched sections 
across treatment groups.  This was largely due to damage caused to brain tissues during the 
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processes of cryoprotection and slicing.  In conclusion, the measurement of c-fos protein 
levels in the hypothalamus indicated that 25ug/kg LPS was the lowest dose to i) stimulate all 
the hypothalamic nuclei we investigated and ii) induce a statistically significant hormonal 
response compared to saline-injected rats.   
 
The variability of the stress response between individual animals and between cohorts is a 
problem in stress studies. For example, corticosterone levels were higher for all doses of 
LPS in the dose response study (Figure 2.5B) than in study 2.2.3.1 (Figure 2.4C).  This was 
not the case with ACTH levels.  The difference between corticosterone responses between 
these two studies may have arisen from batch variability between the LPS used, as similar 
doses of LPS have been reported in the literature to induced variable stress responses 
(Huang et al., 1998, Castanon et al., 2003).  There are also known age-related changes in 
adrenal sensitivity to stress (Heidinger et al., 2008), though the age difference of only 4 
weeks in our study is unlikely to be sufficient to explain the differences observed.  Based on 
the results of the LPS dose-response study, an LPS dose of 25ug/kg was chosen to 
investigate the effects of a higher dose of leptin on the HPA response to acute LPS 
challenge.  In support of this, other studies have shown that 25μg/kg LPS induces a strong 
but reversible stress response, as demonstrated by the inhibition of LPS-induced fever by 
systemic administration of α-MSH in rats (Huang et al., 1998).  Study 2.2.3.3 was therefore 
carried out wherein rats were administered leptin at a dose of 2mg/kg which has previously 
been shown to i) result in circulating plasma leptin levels well above those seen in obese 
rats (Beck and Richy, 2009), ii) reduce basal corticosterone levels in rats (Clark et al., 2008), 
and iii) inhibit the HPA response to restraint stress in rats (Heiman et al., 1997).  Rats were 
then injected with 25μg/kg LPS.  The results show that plasma ACTH and corticosterone 
concentrations in LPS-treated rats (Figure 2.8B-C) reached similar levels to those observed 
in the study by Huang and colleagues (Huang et al., 1998).  Plasma IL-1β levels achieved in 
LPS-treated rats (Figure 2.8D)  were also similar to levels observed in septic humans (Kurt 
et al., 2007, Sankar and Webster, 2012) and fell into the range of IL-1β levels observed in 
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animal models of endotoxemia (Rodrı et al., 2002).  But again, this higher dose of leptin 
failed to influence the LPS-induced increase in LPS-induced ACTH, corticosterone and IL-1β 
levels (Figure 2.8B-D).      
 
To date, all other studies have investigated the effects of leptin on the HPA response to 
milder stressors such as fasting and restraint stress, whereas the studies described in this 
chapter have focused on the effects of leptin on the HPA response to a powerful 
immunological stressor.  It is interesting to note that whilst different stressor types e.g. head 
trauma (Ott et al., 1987), stroke (Kang et al., 2008), autoimmune diseases (Hu et al., 1993) 
and psychological stress (Connor and Leonard, 1998) ultimately activate the HPA axis via a 
convergence at the hypothalamus to precipitate the CRH-ACTH-glucocorticoid cascade, 
there is surprisingly little overlap in the sets of genes within the brain that are induced or 
repressed by severe immunological stress compared to mild psychological stressors such as 
restraint stress (Reyes et al., 2003).  In addition to the convergent effect at the 
hypothalamus, LPS can also act directly at the pituitary gland to stimulate the inter-pituitary 
release of IL-6, which subsequently upregulates ACTH secretion (Gloddek et al., 2001, 
Watanobe and Yoneda, 2003).  LPS can also act directly on the adrenal gland to stimulate 
cortisol release which is mediated via cyclooxygenase-dependent mechanisms, and LPS 
can also increase IL-1 receptor (IL-1R) and IL-1α and β mRNA expression in the mouse 
adrenal gland (Mohn et al., 2011, Pournajafi Nazarloo et al., 2003, Andreis et al., 1991).  
Thus the fact that LPS induces a different activational response within the brain compared to 
mild stressors, and activates the HPA axis at multiple levels may provide an explanation as 
to why leptin failed to attenuate the LPS induced HPA response in my studies.   
 
In conclusion, these findings suggest that the stimulation of the HPA axis by a commonly 
used endotoxin is not affected by peripheral leptin administration.  Due to the observed lack 
of effect of leptin on the HPA axis response to stress in the current studies, I decided to 
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concentrate on the effects of a long-term stressor, namely SI, on the HPA axis response to 
acute stress in rats.  
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Chapter III: 
Investigating the effects of 
SI on the HPA axis 
response to stress 
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3.1 Introduction 
SI, known more commonly as loneliness, is a chronic form of distress (Weiss, 1974).  
Longitudinal studies in humans have identified behavioural, neural, hormonal, cellular and 
genetic changes as a result of loneliness in humans (Cacioppo et al., 2006, Cacioppo and 
Hawkley, 2009).  SI in humans has been linked to stress-associated increases in vascular 
resistance (Cacioppo et al., 2002b), blood pressure (Hawkley et al., 2006, Hawkley et al., 
2010) and morning cortisol (Adam 2006), as well as reduced quality of sleep (Hawkley et al., 
2010, Cacioppo et al., 2002a), and sedentary lifestyles (Hawkley et al., 2009).  SI has also 
been linked to increased blood pressure in rats (Andrews et al., 2003).  The effect of SI in 
nonhuman social mammals is evident from studies that show isolation can cause stress-
associated changes such as increased sympathetic tone and HPA activation, and decreased 
immunity and expression of glucocorticoid-regulating genes (Adam et al., 2006, Cole et al., 
2007, Cole, 2008).  SI is indeed a stressful experience in rodents as it can result in 
increased aggression and anxiety in response to human handling (Hatch et al., 1965).   
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3.1.1 Effects of SI on HPA function  
3.1.1.1 Changes in circadian patterns of stress hormone release 
SI of 5-week old male rats for four weeks increases corticosterone secretion and alters its 
24-hour pattern of release (Perello et al., 2006).  Isolated rats demonstrate a slight drop in 
plasma corticosterone at 2100 h and then a sharp increase in corticosterone levels at     
0100 h, suggesting they are more stressed then control rats during their active phase 
(Perello et al., 2006).  This is not accompanied by changes in the plasma ACTH profile, 
suggesting that isolation stress may affect adrenal cell function directly, either through 
autonomic innervations of the adrenal gland or through circulating catecholamines (Kalsbeek 
et al., 2003, Perello et al., 2006).  The circadian patterns of circulating levels of the pituitary-
released stress hormones, PRL and GH, are also altered as a result of SI, and their total 
release is decreased (Perello et al., 2006). 
. 
3.1.1.2 Behavioural changes 
Many changes in behaviour have been observed in animal models of SI, notably including 
several that are comparable to the negative symptoms seen in humans with psychiatric 
disorders.  One of the most profound changes that occur in isolated rats and mice is the 
increase in aggression, after even just brief periods of individual housing (Brain, 1975, 
Baumel et al., 1970).  Another study found that group size has an impact on multiple aspects 
of behaviour, particularly during the first two months of housing after rats are first introduced 
to each other.  Here it was found that isolated rats spend more time sniffing, chewing cage 
bars and dashing around their cages- behaviours attributed to escape attempts- whilst group 
housed rats spend more time sleeping and feeding (Hurst et al., 1999).  In post-weaning 
male Wistar rats, 13 weeks of SI causes an anxiogenic behavioural profile and behavioural 
hyperactivity under basal and stressful conditions.  Specifically, isolated rats demonstrate a 
60% reduction in entries into the open arms of a plus maze during a plus maze test, as well 
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as reduced locomotion on the entire maze, compared to group housed rats (Weiss et al., 
2004).  Furthermore, during a startle session comprised of a restraint stress session followed 
by high intensity acoustic stimulation, isolated rats showed a trend towards higher startle 
reactivity compared to group housed rats (Weiss et al., 2004).  
           
3.1.2 Effects of SI on activated HPA function: Hypo-reactivity or hyper-
reactivity? 
3.1.2.1 HPA Hypo-reactivity 
A few studies have demonstrated HPA hypoactivity in response to a novel stressor after 
periods of SI (Brain and Nowell, 1971, Viveros et al., 1988).  Sanchez et al. showed that long 
term SI reduces the corticosterone response to restraint stress in rats, resulting in fewer 
ACTH-immunoreactive pituitary corticotrophs in response to a restraint stress procedure in 
11-week old isolated rats, compared to group housed rats.  Corticotrophs were significantly 
smaller in isolated rats and exhibited less ACTH immunoreactivity than control rats (Sanchez 
et al., 1998).  It is suggested that SI, in this case, either caused desensitization to stressful 
stimuli, or that the reduced activation of corticotrophs in response to acute restraint stress 
was due to changes in the normal maturation of these cells, as rats in this study were 
prematurely weaned at the age of 16 days (Sanchez et al., 1998).   
 
3.1.2.2 HPA Hyper-reactivity 
Most of the literature points to HPA hyperactivity in response to a novel stressor following 
periods of SI.  In male rats, SI results in a higher stress hormone response to an acoustic 
stimulation-restraint stress challenge compared to their group-housed counterparts (Weiss et 
al., 2004, Holson et al., 1991).  Chronic SI also enhances HPA responsiveness to a range of 
new stressors such as immobilization, cold stress and foot shock.  One study shows that SI 
exaggerates the proinflammatory cytokine response to cardiac arrest and exacerbates 
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stroke-induced depressive-like behaviour in mice (Akana et al., 1992, Norman et al., 2010).  
This is supported by studies showing that long-term SI increases the corticosterone 
response to acute stress in mice, rats and hamsters compared to their group housed 
counterparts (Hermes et al., 2006, Dronjak et al., 2004, Ferland and Schrader, 2011, Toth et 
al., 2011, Weiss et al., 2004).  SI can also increase the cortisol response to stress in larger 
mammals such as pigs and cattle (Creel and Albright, 1988, Kanitz et al., 2009). 
 
Evidence suggests that HPA hyperactivity has profound negative effects on glucocorticoid-
regulated processes, such as neuronal activity in the brain.  In group housed rats, running 
induces hippocampal neurogenesis, but has the opposite effect in isolated rats (Stranahan et 
al., 2006).  Immobilization stress results in increased cortisol and impaired wound healing in 
isolated hamsters but not pair-housed hamsters.  Removal of endogenous cortisol via 
adrenalectomy eliminates the effects of immobilization stress on wound healing in isolated 
hamsters, whilst blocking of the cortisol stress response by oxytocin injection facilitates 
wound healing (Detillion et al., 2004).  This shows that removal of the primary source of 
glucocorticoids or blocking the effects of glucocorticoids downstream can abolish the effect 
of SI on wound healing, suggesting the response to immobilization stress observed in 
isolated hamsters is due to increased cortisol release.  These wound healing effects are 
consistent with the known immunosuppressive effects of cortisol.  This work is relevant to 
impaired immunity in lonely humans; elevated urinary cortisol levels were accompanied by 
lower natural killer cell activity and poorer T-lymphocyte responses to mitogen stimulation in 
lonely psychiatric patients compared to non-lonely psychiatric patients (Kiecolt-Glaser et al., 
1984a, Kiecolt-Glaser et al., 1984b).  In non-human animals, increased prenatal exposure to 
glucocorticoids reduces birth weight and causes hypertension, hyperglycaemia and 
increased HPA activity in the offspring in later life, whilst in humans it causes low birth weight 
and increased HPA activity, and high blood pressure, insulin resistance, glucose intolerance 
and hyperlipidemia in subsequent adulthood (Seckl and Meaney, 2004).  All these conditions 
have an inflammatory component and accord with findings that link perceived isolation in 
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humans with a pro-inflammatory gene expression profile (Cole et al., 2007).  This supports 
the notion that chronically lonely individuals are at increased risk of inflammatory disease 
(Cole et al., 2007, Cole et al., 2012, Fredrickson et al., 2013).             
 
As described in chapter 1, loneliness can promote the pathogenesis of psychiatric disorders 
such as schizophrenia and depression (Pariante and Lightman, 2008, Kaye et al., 1987, 
Corcoran et al., 2003), and an overactive HPA axis is implicated in major depression 
(Nemeroff and Vale, 2005, Sanchez et al., 2001).  Many depressed patients have increased 
plasma cortisol levels, as well as enlarged and hyperactive pituitary and adrenal glands 
(Nemeroff and Vale, 2005).  This is thought to be due to an impaired glucocorticoid feedback 
mechanism, as studies have shown that the HPA axis is insensitive to orally administered 
dexamethasone in depressive patients compared to healthy subjects (Pariante, 2006).  HPA 
axis hyperactivity is also found in patients with anxiety disorders (Abelson et al., 2007, 
Condren et al., 2002).  It is thought that both glucocorticoid insensitivity and CRH over-
expression may contribute to overall HPA axis hyperactivity in these patients (Kunugi et al., 
2006).  It has also been found that stressful life events increase the risk of schizophrenia 
(Ellenbroek et al., 1998), and that schizophrenic patients have elevated plasma cortisol 
levels (Meltzer, 1987) and a higher stress hormone response to a novel stressor (Lammers 
et al., 1995).   
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3.1.2.3 Age-related differences in HPA dysregulation 
The developmental timing of SI is key, and pre-weaning effects of isolation may differ from 
post-weaning effects (Weiss et al., 2001), as may the effects measured sometime after the 
SI procedure compared with immediately after SI.  In evolutionary terms, this may reflect that 
SI presents different survival challenges to an infant animal compared to an adult animal.  
For infants, protection against the negative effects of excess glucocorticoid exposure on the 
developing CNS (Sapolsky and Meaney, 1986) may be the reason hypo-responsiveness in 
response to an acute stress is seen in pre-weaning animals (Sapolsky and Meaney, 1986).  
On the other hand, sexually mature animals or post-weaning animals are no longer 
protected from the stress of these survival challenges, which may explain why these animals 
exhibit HPA hyper-reactivity in response to novel stressors.   
 
There is much inconsistency between, and within, animal species in studies of SI and HPA 
stress responsiveness.  Hawkley et al. have reviewed and summarized the major studies 
done to date in this area (Table 3.1) (Hawkley et al., 2012).  Inconsistencies arise because 
of experimental differences such as the timing of glucocorticoid measurements or the source 
of cortisol samples e.g. plasma or saliva.  These inconsistencies make it difficult to draw 
conclusions regarding the effects of SI on HPA-regulated physiological processes in social 
mammals, and thus to translate them into human studies.  More definitive studies 
investigating the effects of SI on the HPA response to stress are needed in a commonly 
used social mammal.  This would allow such invasive experimental studies that are required, 
to provide more detailed information into the mechanisms involved in SI induced HPA 
dysfunction.  One such mammal is the rat.    
  
122 
 
TABLE 3.1 Effects of SI on HPA functioning in social mammals.  n.s.; non significant.  Adapted from (Hawkley et al., 2012).  
 
Species 
 
Reference  
Age at 
isolation 
Isolation duration 
Age at 
testing 
Basal Glucocorticoid + ACTH  
Glucocorticoid  reactivity 
to stress 
Mice 
 
(Chida et al., 
2005) 
Post-weaning 
(5 weeks) 
9 weeks Adult 
n.s. glucocorticoid different at baseline. Greater glucocorticoid increase from baseline in 
isolated than group housed animals at 9 weeks; group housed animals continued to 
show glucocorticoid increase; at 19 weeks, control glucocorticoid > isolated 
glucocorticoid  
Not investigated 
Mice 
 (Williams et al., 
2009) 
Post-weaning Chronic Adult 
 
Increased glucocorticoid 
response to stress 
Voles 
 (Grippo et al., 
2007a) Adult 60 days Adult n.s. difference 
Increased glucocorticoid 
response to resident 
intruder 
Voles  
 (Grippo et al., 
2007b) Adult 4 weeks Adult n.s. difference 
Increased glucocorticoid 
response to resident 
intruder 
Voles 
 (Pournajafi-
Nazarloo et al., 
2011) 
Adult 
1 h, or 4 weeks of daily 1h 
(separated from same-sex 
sibling partner) 
Adult Increased glucocorticoid  Not investigated 
Voles 
 (Pournajafi-
Nazarloo et al., 
2011) 
Adult 4 continuous weeks  Adult n.s. difference Not investigated 
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TABLE 3.1 Continued  
 
Species  Reference  Age at 
isolation Isolation duration 
Age at 
testing Basal Glucocorticoid + ACTH  Glucocorticoid  reactivity to stress 
Voles 
 (Ruscio et al., 
2007) 
Post-weaning 4 or 21 days Juvenile 
Increased glucocorticoid (and 
increased CRH in hypothalamus) 
Not investigated 
Voles 
 (Stowe et al., 
2005) 
adult, 3-4 
months of age 
24 h or 2 weeks 
Adult, 3-4 
months of age 
n.s. difference Not investigated 
Rats  (Djordjevic et al., 2010) Adult 
21 days individual housing, followed, or not, by 30' 
immobilization Adult Decreased glucocorticoid  n.s. different in cortisol response to immobilization 
Rats 
 
(Dronjak et al., 
2004) Adult long-term Adult 
Increased glucocorticoid relative 
to long-•term crowded animals 
Increased glucocorticoid response to acute 
immobilization and cold stressors relative to long-
•term crowding 
Rats 
 (Ferland and 
Schrader, 2011) Adult (56 days) 
Overnight for 14 consecutive nights, with or without 
chronic variable stress (warm/cold swim, cold room, 
rotation) 
Adult 
 
Increased glucocorticoid in response to separation 
with or without chronic variable stress 
Rats  (Hermes et al., 2006) 
Post-weaning 
(~ 28 days) 3 months 
Adult, 4 
months Decreased glucocorticoid  
Increased glucocorticoid response to restraint 
stress in females 
Rats  (Lukkes et al., 2009) 
Juvenile, day 
21 3 weeks, followed by 2 weeks group housing 
Adult (8 
weeks)  
n.s. difference in cortisol response to restraint 
stress 
Rats 
 (Perello et al., 
2006) 
Post-puberty 
(35 days) 4 weeks 
Adult, 9 
weeks 
Glucocorticoid increased in 
plasma, decreased in adrenal 
gland 
Not investigated 
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TABLE 3.1 Continued  
 
Species 
 
Reference  
Age at 
isolation 
Isolation duration Age at testing 
Basal Glucocorticoid + 
ACTH  
Glucocorticoid  reactivity to stress 
Rats 
 (Sanchez et al., 
1998) 
Post-weaning 
(early at 16 
days) 
2 months Adult Decreased glucocorticoid  Decreased glucocorticoid response to immobilization stress 
Rats  (Scaccianoce et al., 2006) 
Adult (2 
months) 8 weeks  
Glucocorticoid n.s. different 
from pair housed rats Not investigated 
Rats 
 (Serra et al., 
2005) Early life chronic, 4 weeks Adult Decreased basal ACTH Not investigated 
Rats   (Toth et al., 2011) 
Post-weaning 
(21days)  7-8 weeks  Adult  
Glucocorticoid n.s. differently 
than socially housed animals  Increase response to aggressive encounter  
Rats  
 
(Weintraub et 
al., 2010) 
Adolescent (30 
days)  
3 weeks (days 30-
50); then housed in 
same-sex groups  
Adolescent (50 
days) and adult 
(70 days)   
Adolescence: greater glucocorticoid recovery in males and less 
glucocorticoid recovery in females following acute restraint stress.  Adult: 
decreased glucocorticoid response in males and increased glucocorticoid 
response in females following restraint stress.   
Rats 
 (Weiss et al., 
2004) Post-weaning Chronic Adult (4 months) 
ACTH increased in males, 
but not females 
Increased glucocorticoid and ACTH response to (open field and elevated 
plus maze) stress in males, but not females 
Hamsters, 
Siberian 
dwarf  
 (Castro and 
Matt, 1997) Adult 
Males separated 
from mate for 4 
weeks 
Adult 
Increased glucocorticoid in 
isolated relative to mate 
housed animals? 
Not investigated 
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TABLE 3.1 Continued  
 
Species 
 
Reference  
Age at 
isolation 
Isolation 
duration 
Age at testing Basal Glucocorticoid + ACTH  Glucocorticoid  reactivity to stress 
Hamsters, 
Siberian dwarf 
 (Detillion et al., 2004) Post-weaning (2-3 months)  
Adult glucocorticoid n.s. different than pair housed animals Increased response to immobilization 
Cattle 
 (Creel and Albright, 
1988) Neonatal 10 weeks 
Post-puberty, 1 
year of age 
n.s. glucocorticoid increase relative to control calves at 10 
weeks of age 
Increased response to acute stress 
(approach and flight distances from humans) 
at 10 weeks of age 
Pigs 
 (Kanitz et al., 2009, 
Tuchscherer et al., 
2010) 
Pre-weaning Single 4 h bout 
Infant: 7, 21, 
and 35 days of 
age  
Increased glucocorticoid response to 
immobilization 
Pigs  (Kanitz et al., 2004) Pre-weaning 2 h daily, Days 3-11  Pre-weaning Increased glucocorticoid  Not investigated 
Pigs 
 (Tuchscherer et al., 
2004) Pre-weaning 
2 h daily, 
Days 3-11  Pre-weaning 
glucocorticoid and ACTH increased at Day 12 and Day 56 vs. 
control piglets n.s. different cortisol response to peripheral LPS 
in isolated vs. control animals 
Not investigated 
Marmosets  (Cross et al., 2004) Adult 15 min Adult Increased glucocorticoid  Not investigated 
Marmosets  (Smith et al., 2011) Adult 6 to 20 weeks Adult Increased glucocorticoid  Not investigated 
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TABLE 3.1 Continued  
 
Species 
 
Reference  
Age at 
isolation 
Isolation duration Age at testing Basal Glucocorticoid + ACTH  Glucocorticoid  reactivity to stress 
Marmosets 
 (Smith and 
French, 1997) Adult 
11 h; 11 h plus 5 min 
handling stress after 
net capture 
Adult Increased glucocorticoid  Not investigated 
Monkeys 
(rhesus) 
 
(Feng et al., 
2011) 
Pre-weaning (at 
birth) 
1 month, then peer or 
mother-reared Puberty: 2 and 3.5 years 
Basal hair cortisol lower at both time points in peer than 
mother-reared animals 
Delayed plasma cortisol recovery from 
capture and restraint stress in peer 
reared relative to mother-reared 
animals. 
Monkeys 
(rhesus) 
 
(Higley et al., 
1992) 
Juvenile: 6 and 
18 months 
4 sequential 4-day 
separation from 
mothers or peer 
group 
Juvenile: 6 and 18 
months (prior to and on 
last day of separation) 
See glucocorticoid reactivity to isolation stress 
Increased plasma cortisol response to 
social separation; persistently elevated 
cortisol throughout separation 
Monkeys 
(squirrel) 
 (Levine and 
Mody, 2003) Pre-weaning 
4-6 h bouts for 2 
months Adult (2-3 years of age) Decreased glucocorticoid  Not investigated 
Monkeys 
(squirrel) 
 (Lyons et al., 
1995) Juvenile 
7 days individual 
housing Juvenile glucocorticoid increased; ACTH decreased Not investigated 
Monkeys 
(squirrel) 
 
(Lyons et al., 
1999) 
Adolescent, late 
(31-33 months) 
6 days housed alone 
(vs. in pairs and in 4-
monkey groups) 
Adolescent, late 
glucocorticoid increased 1 day after separation vs. paired 
condition; ACTH increased up to 1 h post-separation, then 
decreased 1 day post separation vs. paired condition (cortisol 
inversely related to ACTH) 
Not investigated 
Monkeys 
(squirrel) 
 (Mendoza and 
Mason, 1986) Adult 
1h in home cage 
separated from pair-
mate  
Adult See glucocorticoid reactivity to isolation stress No effect on plasma corticosteroid 1 h post separation 
Monkeys 
 (Mendoza and 
Mason, 1986) Adult 
1h in home cage 
separated from pair-
mate  
Adult See glucocorticoid reactivity to isolation stress Increased plasma cortisol 1 h post-separation 
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TABLE 3.1 Continued  
 
Species 
 
Reference  
Age at 
isolation 
Isolation duration Age at testing Basal Glucocorticoid + ACTH  
Glucocorticoid  reactivity to 
stress 
Baboons  (Sapolsky et al., 1997) Adult and juvenile 
SI relative to median 
values Adult and juvenile Increased glucocorticoid  Not investigated 
Humans 
 
(Arnetz et al., 1983) Adult, older 
Senior citizen housing 
(social activity program 
vs. control) 
Adult, older Increased glucocorticoid  Not investigated 
  (Ebrecht et al., 2004) Adult Loneliness Adult n.s. association with morning rise in cortisol Not investigated 
Humans 
 
(Grant et al., 2009) 
Adult, 
middle-
aged 
Smaller social network Adult, middle-aged Increased glucocorticoid (daily integrated “area-under-the curve”  Not investigated 
Humans 
 (Kiecolt-Glaser et al., 
1984a, Kiecolt-Glaser et 
al., 1984b) 
Adult Loneliness in psychiatric patients Adult Increased glucocorticoid (urinary) Not investigated 
Humans  (Pressman et al., 2005) Adult, young Loneliness Adult, young increased glucocorticoid  Not investigated 
Humans 
 
(Adam et al., 2006) 
Adult, 
middle-
aged 
Loneliness adult, 
middle-aged 
Increased morning rise in cortisol as a 
function of trait loneliness and as a 
function of daily fluctuations in loneliness  
Not investigated 
Humans 
 
(Steptoe et al., 2004) 
Adult, 
middle-
aged 
Loneliness Adult, middle-aged 
Increased morning rise in cortisol as a function of 
trait loneliness; n.s. association with total cortisol 
or cortisol slope over working day 
n.s. association with cortisol 
response to Stroop mirror-
tracing tasks 
Humans 
 (Doane and Adam, 
2010) 
Adult, 
middle-
aged 
Loneliness Adult, young 
Increased morning rise in cortisol as a function of 
daily fluctuations in loneliness, and flatter diurnal 
slope as a function of trait loneliness 
Not investigated 
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3.1.3 Hypothesis 
SI can alter the HPA axis response to a novel acute stress in the adult rat, by sensitizing 
and/or desensitizing specific components of the axis. 
 
3.1.4 Aims 
To test this hypothesis I aim to: 
 Investigate the effects of 7-day and 3-week SI on HPA function within multiple HPA 
tissues in adult rats, examining basal HPA activity, HPA axis responsiveness to acute 
stress and neuronal activation in stress related hypothalamic centres. 
 Examine the stress hormone profiles of isolated rats compared to group-housed rats. 
 Investigate possible SI-induced changes in the HPA-glucocorticoid feedback 
mechanism. 
 Investigate possible SI-induced changes in the expression of stress-related genes in 
specific components of the HPA axis. 
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3.2 Methods 
3.2.1 Animals and housing 
All animal procedures were carried out under the British Home Office Animals Scientific 
Procedures Act 1986 (Project License Number: 70/6623).  On arrival, specific pathogen free 
(SPF) male Sprague Dawley rats (Charles River) were either group housed in fours or 
individually housed, and maintained at 21-23˚C on a 12 hr light: 12 hr dark cycle (light period 
07:00-19:00 hrs) with ad-libitum access to RM1 standard chow (Special Diet Services Ltd) 
and water.  After the 72 hour acclimatization period, all rats were handled daily for 3 minutes 
each for 7 days or 3 weeks depending on the study designs outlined in 3.2.2.  This was to 
minimize the risk of non-specific stress-induced increases in HPA activation, as this could 
confound experimental stress-induced activation of the HPA axis.  At 7 days or 3 weeks, the 
experiments were carried out in the early light phase.  
  
3.2.2 Materials 
3.2.2.1 Restraint apparatus 
Tailveiner Restrainer (Braintree Scientific Inc., Massachusetts, USA).  
 
3.2.2.2 Hormone immunoassay kits 
ACTH IRMA and corticosterone EIA kits were obtained, as listed in chapter 2 (2.2.2.2). 
 
3.2.2.3 Materials for immunohistochemistry 
As listed in chapter 2 (2.2.2.3). 
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3.2.2.4 Materials for primary adrenal culture 
Earle’s Balanced Salt Solution – phenol red free (EBSS) (+2.2g/l sodium bicarbonate and 
pregassed with O2) (Sigma-Aldrich) 
Collagenase from Clostridium Histolyticum (Sigma-Aldrich)  
Trypan Blue (Sigma-Aldrich) 
 
3.2.2.5 Materials for hypothalamic qPCR 
RNA extraction: 
Tri-reagent (Sigma-Aldrich)  
1-Bromo-3-chloropropane (BCP) (Sigma-Aldrich) 
70% (v/v) ethanol (see Appendix I) 
PureLink RNA Mini Kit (Invitrogen, Paisley, UK) 
Wash Buffer 1 
Wash buffer 2 
RNase free water 
27.3 U/ul PureLink DNase (Invitrogen) 
10% DNase I reaction buffer 
12.5% DNase  
77.5% RNase free water 
 
Agarose gel electrophoresis: 
1% Agarose Gel (see Appendix I) 
50x TAE Buffer (see Appendix I) 
Ethidium Bromide (EtBr) (Thermo Scientific) 
Running Buffer (see Appendix I) 
6 x Orange DNA loading dye (Thermo Scientific) 
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Reverse transcription: 
Rat hypothalamic RNA (at a concentration of 10µg/µl) 
High Capacity complementary DNA (cDNA) Reverse Transcription (RT) Kit (Invitrogen) 
2 x RT master mix (20µl reaction per sample): 
2ul 10x RT buffer 
0.8ul 25x deoxyribonucleotide triphosphate (dNTP) Mix (100mM) 
2ul 10x RT Random primers 
1ul Multiscribe Reverse Transcriptase 
10.2ul Nuclease-free H2O 
 
Quantitative polymerase chain reaction (qPCR): 
Rat hypothalamic cDNA  
Taqman gene expression Master mix (Applied Biosystems, Texas, USA) 
β-actin primer (ID: Rn00667869_m1) (Invitrogen) 
Glucocorticoid receptor (GR) primer (ID: Rn00561369_m1) (Invitrogen) 
CRH primer (ID: Rn01462137_m1) (Invitrogen) 
RNase-free H2O 
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3.2.2 Study design 
3.2.2.1 The effect of 7-day SI on the HPA axis response to acute restraint 
stress 
Twenty male Sprague Dawley rats weighing approximately 200g were split into two groups 
of ten, with one group housed in fives and the others housed individually to isolate them, for 
7 days.  Rats were weighed everyday to monitor body weight gain.  After 7 days, rats 
underwent experimentation in which 5 rats from each group (group housed and isolated) 
were restrained in a Tailveiner Restrainer (Braintree Scientific Inc) for 15 minutes before 
being returned to their cages, whilst the other 5 rats from each group were left in their cages.  
Two hours after being returned to their cages, all restrained rats, as well as all non-
restrained rats, were decapitated by guillotine.  This time point not only took into account the 
90 minute time point at which maximum c-fos protein expression is reached after stimulation 
by a stressor, as described in chapter 2, but is also in line with time points investigated after 
stress exposure in isolated rats in other studies (Dronjak et al., 2004, Lukkes et al., 2009, 
Weiss et al., 2004, Ferland and Schrader, 2011).  This made it possible to draw direct 
comparisons with other studies, as discussed later in this chapter.  All tissues and blood 
were collected within the early light phase to minimize ultradian rhythmic changes in 
circulating plasma stress hormones.   
 
Trunk blood was collected and plasma was separated and stored for measurement of 
plasma corticosterone and ACTH concentrations by EIA and IRMA respectively, as 
described in chapter 2 (2.2.3.1, 2.2.4.2 - 2.2.4.3).  Whole rat brains were removed and 
separated from their brainstems.  Brains were then fixed, dehydrated and stored as 
described in chapter 2 (2.2.3.2) until sectioning and immunohistochemical staining for c-fos 
at a later stage, also described in chapter 2 (2.2.5).  Adrenal glands were dissected and 
placed into 5ml of pre-prepared EBSS.  Adrenals were kept at room temperature in this 
solution until dispersion and culture for measurement of basal corticosterone release from 
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adrenal cells.  This was conducted immediately after tissues and blood had been taken from 
all the rats.    
 
3.2.2.2 The effect of 7-day SI on total plasma stress hormone release in 
response to acute restraint stress 
This study aimed to investigate the temporal profile of HPA hormone release in response to 
stress in group housed and isolated rats.  It sought to determine whether there is an 
increase in total hormone release in response to restraint stress, or whether the response 
has been temporally shifted and is in fact of a similar magnitude between the two housing 
groups. 
 
Seventy-two male Sprague Dawley rats, weighing approximately 170g were split into two 
groups of 36, with one group housed in fours and the others housed individually to isolate 
them, for 7 days.  Rats were weighed every day to monitor body weight gain.  After 7 days, 
rats underwent experimentation in which 18 rats from each group (group housed and 
isolated) were restrained in a Tailveiner Restrainer for 15 minutes before being returned to 
their cages, whilst the other 18 rats from each group were left in their cages.   Restrained 
rats were decapitated by guillotine 0, 15, 30, 60 or 180 minutes after cessation of the 
restraint stress procedure; rats from the 0 time point group were not returned to their cages 
and were decapitated immediately after cessation of restraint stress.  All rats, including those 
that had not undergone restraint stress, were decapitated during the early light phase to 
minimize ultradian rhythmic changes in circulating plasma stress hormones.   
 
The chosen time points allowed collection of plasma from the point at which stress hormone 
levels were expected to increase, all the way through to the point at which stress hormone 
levels were expected to return to resting levels (Vahl et al., 2005, Krause et al., 2011).  This 
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allowed a complete time profile of the stress response, as well as calculation of the total 
amount of stress hormone release from each group.   
 
Trunk blood was collected and plasma was separated and stored for measurement of 
plasma corticosterone and ACTH concentrations by EIA and IRMA respectively, as 
described in chapter 2 (2.2.3.1, 2.2.4.2 - 2.2.4.3). 
 
3.2.2.3 The effect of 7-day, 7-day overnight or 3-week SI on the HPA response 
to acute restraint stress   
The lack of difference in total stress hormone release in group housed rats compared to 
isolated rats in study 3.2.2.2 suggested that short term SI does not affect the stress 
response to restraint, but this finding was not in line with the results from study 3.2.2.1.  As 
discussed, in section 3.4.2, group housed rats may have undergone additional stress due to 
factors such as cage-mate separation during the restraint stress procedure.  The amount of 
time this additional stress response may have lasted and the extent to which it may have 
activated the HPA axis is unknown and may have influenced the time profile response 
observed after a restraint stress procedure.  Therefore this particular study design may not 
be suitable for such investigations.   
 
Others have shown that 3 weeks of SI (Dronjak et al., 2004, Ruscio et al., 2007, Smith et al., 
2011) and intermittent overnight SI (Ferland and Schrader, 2011) cause dysregulation of the 
basal and acutely activated HPA axis, yet the mechanism by which these changes occur 
have not yet fully been investigated.  Thus the study described in this section (3.2.2.3) was 
designed to investigate the mechanism by which the changes in the HPA response to 
restraint stress in isolated rats, in study 3.2.2.1, occurred.  This study also investigated the 
effects of short term overnight SI and 3 weeks of SI on HPA responses to restraint stress in 
rats, as well as the mechanism by which these changes occur. 
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Sixty male Sprague Dawley rats, weighing approximately 145g were split into two groups of 
36 and 24; with the first group being group housed in fours and the second group being 
housed individually to isolate each rat.  Twelve group housed rats were maintained for 7 
days and 12 were maintained for 3 weeks, and 12 isolated rats were maintained for 7 days 
and 12 were maintained for 3 weeks. An additional group of 12 group housed rats were 
isolated only in the active dark phase (19:00 hrs to 07:00 hrs) but returned to their original 
groups during the inactive light phase (07:00 hrs to 19:00 hrs).  This resulted in 5 groups; 7-
day group housed, 3-week group housed, 7-day isolated, 3-week isolated and 7-day 
overnight isolated rats.  Rats were weighed every day to monitor body weight gain, and 
behavioural observations were carried out on all rats at 07:30 hrs and 18:30 hrs every other 
day.  The behaviours monitored are listed in Table 3.2 and were scored according to this 
classification to determine whether there was a difference in behaviours exhibited between i) 
group housed and isolated rats and ii) group housed and overnight isolated rats, when 
overnight isolated rats were returned to their original groups.     
 
After 7 days or 3 weeks, rats underwent experimentation in which 6 rats from each group 
(group housed, isolated and overnight isolated) were restrained in a Tailveiner Restrainer for 
15 minutes before being returned to their cages, whilst the other 6 rats from each group 
were left in their cages.  One hour and 45 minutes later, restrained rats, as well as all non-
restrained rats were decapitated by guillotine. These studies were carried out during the 
early light phase to minimize ultradian rhythmic changes in circulating plasma stress 
hormones.  Rats that had not undergone restraint stress were also decapitated during the 
early light phase.  Trunk blood was collected and plasma was separated and stored for 
measurement of plasma corticosterone and ACTH concentrations by EIA and IRMA 
respectively, as described in chapter 2 (2.2.3.1, 2.2.4.2 - 2.2.4.3).  Whole brains were 
removed from brainstems and trimmed to reveal the hypothalamus.  Hypothalami were snap 
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frozen in liquid nitrogen and stored at -80˚C prior to RNA extraction and qPCR, to determine 
hypothalamic GR and CRH mRNA levels (described in section 3.2.8).    
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3.2.3 Behavioural Observations 
Behavioural observations were carried out every other day.  Once overnight isolated rats 
were returned to their groups, behaviours were observed at 07:30 hrs and 18:30 hrs.  
Behaviours were classified into one of 12 categories: feeding, drinking, rearing, locomotion, 
grooming, stationary, pica, head down, sleeping, burrowing, climbing or bed-making (Table 
3.2), adapted from (Abbott et al., 2001).  Within 30 minutes of the time points stated above 
(07:30 hrs and 18.30 hrs), each rat was observed for 5 seconds, 6 times each, and the 
behaviour displayed most within those 5 seconds was recorded.    
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TABLE 3.2 Classification of behaviours monitored for scoring of rat behaviours.  
Adapted from (Abbott et al., 2001).  
 
Behaviour Description of Behaviour 
Feeding Rat eating chow 
Drinking Rat drinking from water bottle 
Rearing Rat with front paws off floor 
Locomotion Rat with all four legs moving 
Grooming Rat grooming 
Stationary Rat standing or sitting still 
Pica Rat eating something other than chow 
Head Down Rat standing with nose lowered 
Sleeping Rat sleeping 
Burrowing Rat burrowing in cage floor covering 
Climbing Rat climbing cage 
Bed Making Rat bed making with paper strips 
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3.2.4 ACTH immunoradiometric assay 
Plasma ACTH levels were measured using a commercial human ACTH IRMA kit as 
described in chapter 2 (2.2.4.2). 
 
3.2.5 Corticosterone enzyme immunoassay 
Plasma and cell culture media corticosterone levels were measured using a commercial 
corticosterone EIA kit as described in chapter 2 (2.2.4.3). 
 
3.2.6 Immunohistochemical staining for cellular-fos 
Brain sections were stained for c-fos using IHC methods described in chapter 2 (2.2.5.2). 
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3.2.7 Primary Adrenal Culture 
The method described by Cover et al., (Cover et al., 2001) was modified for the culture of 
primary adrenal cells.  Adrenals were grouped together dependent on experimental groups 
and chopped into small fragments using a razor blade on a glass Petri dish.  The adrenal 
fragments were transferred to 2ml EBSS (+2.2g/l sodium bicarbonate) with collagenase from 
Clostridium histolyticum (2mg/ml) and incubated at 37ºC with a minimal flow of            
95%O2 / 5%CO2 for 60 minutes.  During this incubation, cells were mechanically dispersed 
every 10 minutes using a P1000 Gilson pipette with a trimmed 1000μl tip.  The cells were 
filtered through a 100μm gauze and subsequently centrifuged at 1000g for 15min.  The 
supernatant was removed and the cell suspension was resuspended in 2ml EBSS and 
centrifuged again as above.  The cell suspension was then resuspended in 3ml EBSS and a 
10μl sample was taken for staining with Trypan blue for cell counting.  A cell count was 
performed with a haemocytometer and automated counter.  Trypan blue stained any dead 
cells a medium-dark blue colour and cell viability was calculated as follows:  
 
                                Live cell count        x 100 = percentage viability  
                                Total cell count  
 
The target cell count was 106 cells/ml and the volume of the cell suspension was adjusted 
accordingly with EBSS.  Two hundred microlitres of the cell suspension was transferred to a 
96 well plate which was pre-incubated in a humidifying chamber with a flow of             
95%O2 / 5%CO2 for 60 minutes.  Plates were removed, covered and centrifuged at 2000g for 
10 seconds in a Hettich Rotina 420R centrifuge (Hettich Lab Technology, Tuttlingen, 
Germany), and the supernatant discarded by upturning the plates and blotting on tissue 
paper.  Two hundred microliters of fresh EBSS was then added to each well and the plates 
were then incubated as above for 2 hrs, followed by centrifugation at 2000g for 10 seconds 
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and finally the supernatant was collected and stored at -20ºC until analysis of corticosterone 
levels by EIA.  
 3.2.8 Hypothalamic qPCR  
3.2.8.1 RNA extraction 
Frozen tissue was homogenized in 1ml/100mg Tri-reagent (Sigma-Aldrich) using a 
Tissuelyser II (Qiagen, Venlo, Netherlands) and RNA was separated by adding 100µl BCP 
(Sigma-Aldrich) to each sample and spinning at 12000rpm for 10 minutes.  Total RNA was 
then extracted using a PureLink RNA Mini Kit, according to the manufacturer’s protocol.  
Briefly, 350µl of 70% ethanol was added to each RNA sample and the solutions were 
transferred to filter cartridges.  The cartridges were spun at 10700rpm for 15 seconds in a 
Microcentrifuge 5417R (Eppendorf, Hamburg, Germany).  The flow-through was disposed of 
and 350µl wash buffer 1 was then added to each RNA sample.  This wash solution was 
passed through the filter cartridges by spinning and the flow-through discarded again.  
Eighty microlitres PureLink DNase was then added to each sample and incubated at room 
temperature for 15 minutes.  Three hundred and fifty microlitres of wash buffer 1 was again 
added to each cartridge and spun again for 15 seconds, the flow-through discarded and 
500µl wash buffer 2 was added to each cartridge and also spun for 15 seconds.  The flow-
through was discarded and another wash step using wash buffer 2 was carried out.  
Cartridges were then spun for 1 minute to remove excess flow-through, before being 
inserted into recovery tubes.  Thirty microlitres of RNase free water was added to the centre 
of each spin cartridge, incubated at room temp for 1minute and then spun a final time for 1 
minute.  For each sample, purified RNA in 30µl RNase free water was stored at -20˚C for 
determination of quantity and quality of RNA, and RT at a later date. 
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3.2.8.2 Agarose gel electrophoresis 
The RNA concentration of samples was determined using a NanoDrop Lite 
Spectrophotometer (Thermo Scientific).  One microlitre of RNA from each sample was 
pipetted onto the measuring platform and RNA concentration was measured twice for each 
sample, for the calculation of an average reading.  The integrity of the RNA was confirmed 
by running 10µg of each RNA sample on a standard 1% agarose gel (Appendix I).  Briefly for 
2 large gels, 3.3g agarose and 330ml GDW were heated in a glass beaker until bubbling, 
allowed to cool and then mixed with 7ml 50 x TAE buffer (Appendix I) and 16.5µl EtBr.  This 
mixture was poured into two gel frames and allowed to set for 30 minutes.  Ten micrograms 
of RNA from each sample was heated to 70˚C for 1 minute, mixed with 5µl loading dye and 
kept on ice until loaded on to the gel.  Once all samples were loaded, the gel frames were 
filled with running buffer (Appendix I) and run at 110 volts for 1 hour.  The gels were then 
viewed on an ultraviolet (UV) light box to confirm the presence of two sharp bands for each 
intact total RNA sample; representing the 28s and 18s bands which are subunits of 
ribosomal RNA (rRNA) in eukaryotic RNA.  The 28s rRNA band should be approximately 
twice the intensity of the 18s rRNA band, indicating fully intact RNA; whereas partially 
degraded RNA will either be smeared, lack sharp rRNA bands, or will not exhibit the correct 
difference in intensity between the 28s and 18s bands.  Completely degraded RNA will 
appear as a very low molecular weight smear (Imbeaud et al., 2005).  
   
3.2.8.3 Reverse transcription 
Complementary DNA (cDNA) was synthesized from rat hypothalamic RNA using a High 
Capacity cDNA RT Kit.  Briefly, 16µl 2x RT master mix (Appendix I) and 500ng RNA sample 
were added to PCR tubes in triplicates.  Each tube was made up to 20µl with RNase free 
water and loaded into a PTC-100 Programmable Thermal Controller (MJ Research Inc., 
Quebec, Canada) under the following conditions: 25˚C for 10 minutes, 37˚C for 120 minutes, 
85˚C for 5 seconds, and 4˚C until transferred to -20˚C for storage for qPCR at a later stage. 
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3.2.8.4 qPCR 
Ten microlitres of Taqman gene expression Master mix and 8μl RNase-free water was 
added to each well of a 384-well reaction plate.  One microlitre of cDNA sample 
(approximately 31ng) was then added to each well, in triplicate.  One microlitre of β-actin 
primer, GR primer or CRH primer was then added to each corresponding well depending on 
the gene of interest, with β-actin used as the endogenous reference gene.  The 384-well 
reaction plate was covered with optical adhesive film and centrifuged briefly to minimize air 
bubbles.  The reaction well plate was then loaded into a 7900HT Fast Real-Time PCR 
machine (Applied Biosystems) and PCR performed using the following conditions: i) 50ºC for 
2 minutes, ii) 95ºC for 10 minutes, iii) 95ºC for 15 seconds and iv) 60ºC for 1 minute (steps iii 
and iv were repeated for 40 cycles).  Data was analyzed using RQ Manager Software 
(Applied Biosystems) and gene expression levels were quantified relative to β-actin RNA 
and using the 2-ΔΔC T method.  The 2-ΔΔC T method calculates the fold change in gene 
expression (in this case GR or CRH) normalized to an endogenous reference gene (β-actin) 
and relative to the control (group-housed rats that did not undergo restraint stress). 
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3.2.9 Statistics 
Body weight data was analyzed using the unpaired t-test.  Behavioural data are represented 
as median frequency and interquartile range, with Kruskal-wallis and post-hoc Dunn’s test 
for 7-day housed rats, and Mann-Whitney U test for 3-week housed rats, as data is non-
parametric. 
 
Plasma and primary adrenal culture stress hormone data, immunohistochemical c-fos counts 
and mRNA expression data were analyzed using two way analysis of variance (ANOVA) 
with a post-hoc Bonferroni test.  Incremental area under the curve (AUC) analysis was used 
for measurement of total stress hormone release, followed by an unpaired t-test.  Data is 
expressed as mean ± SEM. 
 
Significance was taken at P ≤ 0.05 throughout.  All data were analyzed using GraphPad 
Prism version 5 for Windows (GraphPad Software).    
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3.3 Results 
3.3.1 The effect of 7-day SI on the HPA axis response to acute restraint stress 
3.3.1.1 Body weight 
There was no difference in average body weight gain between group housed and isolated 
rats after 7 days of housing (Figure 3.1). 
                         
 
FIGURE 3.1 Average body weight gain in group housed and isolated rats.  Male 
Sprague Dawley rats were group housed in fives or individually housed, for 7 days.  Data are 
presented as mean ± SEM. unpaired t-test, ns; n = 10. 
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3.3.1.2 Plasma ACTH and corticosterone concentrations 
Fifteen minutes of restraint induced a neuroendocrine stress response in rats.  Isolated-
restraint rats had significantly higher plasma ACTH levels than group housed-restraint and 
isolated-no restraint rats (P ≤ 0.05), 2 hrs after cessation of restraint stress (Figure 3.2A).  
Group housed-restraint rats had significantly higher plasma corticosterone levels than their 
no-restraint controls (P ≤ 0.05), while isolated-restraint rats had significantly higher plasma 
corticosterone levels than their no-restraint controls (P ≤ 0.01) and group housed-restraint 
rats (P ≤ 0.01) (Figure 3.2B).  Two-way ANOVA revealed a significant interaction effect of 
housing on the response to restraint stress for both ACTH and corticosterone responses (P 
≤ 0.05).  However there was no difference in basal ACTH or corticosterone levels between 
group housed and isolated rats (Figure 3.2A and B respectively).  No other significant 
differences were observed between any of the experimental groups. 
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FIGURE 3.2 The effect of 15 minutes of restraint stress on plasma (A) ACTH and (B) 
corticosterone concentrations in group housed and isolated male Sprague Dawley 
rats.  Rats were decapitated 2 hrs after cessation of restraint stress.  Data are presented as 
mean ± SEM; two-way ANOVA with post-hoc Bonferroni correction.  * = P ≤ 0.05 vs. group 
housed-no restraint, x = P ≤ 0.05 vs. group housed-restraint, xx = P ≤ 0.01 vs. group 
housed-restraint, £ = P ≤ 0.05 vs. isolated-no restraint, ££ = P ≤ 0.01 vs. isolated-no 
restraint; Bonferroni interaction value = P ≤ 0.05 for both A-B; n = 4-5. 
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3.3.1.3 Basal corticosterone release from rat primary adrenal cells 
Primary adrenal cells from group housed-restraint rats demonstrated a significantly higher 
basal corticosterone release than those from group housed-no restraint rats (P ≤ 0.001), as 
did adrenal cells from isolated-restraint rats compared to those from isolated-no restraint rats 
(P ≤ 0.001) and group housed-restraint rats (P ≤ 0.001) (Figure 3.3).  Two-way ANOVA 
showed there was no interaction effect of housing on corticosterone release from adrenal 
cells of all experimental groups.  There was no significant difference in corticosterone 
release between adrenal cells from group housed-no restraint and isolated-no restraint rats 
(Figure 3.3). 
 
 
 
FIGURE 3.3 The effect of SI on basal corticosterone release from primary adrenal cells 
in male Sprague Dawley rats.  Adrenals were dissected and grouped together dependant 
on treatment group.  Adrenals were dispersed and cultured before being incubated for 2 hrs.  
Data are presented as mean ± SEM; two-way ANOVA with post-hoc Bonferroni correction.  
*** = P ≤ 0.001 vs. group housed-no restraint, xxx = P ≤ 0.001 vs. group housed-restraint, 
£££ = P ≤ 0.001 vs. isolated-no restraint; Bonferroni interaction value = ns and P ≤ 0.01; n = 
9-11.
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3.3.1.4 C-fos-like immunoreactivity in the hypothalamus 
Fifteen minutes of restraint significantly increased c-fos expression in the hypothalamic ARC 
of group housed-restraint and isolated-restraint rats (P ≤ 0.05 compared to their respective 
no-restraint controls) (Table 3.3, Figure 3.4A and Figure 3.5a-d), 2 hours after cessation of 
the restraint stress procedure.  Restraint also significantly increased c-fos expression in the 
hypothalamic PVN of group housed-restraint and isolated-restraint rats (P ≤ 0.001 and P ≤ 
0.01 respectively, compared to their no-restraint controls) (Table 3.3, Figure 3.4B and Figure 
3.5e-h).  Isolated rats demonstrated a significantly higher c-fos response in the PVN than 
group housed rats after restraint stress (P ≤ 0.05) (Table 3.3, Figure 3.4B and Figure 3.5f 
and h respectively).  There was no difference in c-fos protein expression in the ARC 
between group housed-no restraint and isolated-no restraint rats (Table 3.3, Figure 3.4A and 
Figure 3.5a and c respectively).  There was also no difference in c-fos protein expression in 
the PVN between group housed-no restraint and isolated-no restraint rats (Table 3.3, Figure 
3.4B and Figure e and g respectively).  Two-way ANOVA revealed a significant interaction 
effect of housing on restraint stress induced c-fos protein expression in the PVN (P ≤ 0.05) 
but not the ARC.  
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TABLE 3.3 The effect of 15 minutes of restraint on c-fos protein expression in rat 
hypothalamic areas of the group housed and isolated rats.  Table summarizing c-fos-
like positive cell counts observed in hypothalamic areas following 15 minutes of restraint 
stress in group housed and isolated male Sprague Dawley rats.  Data are presented as 
mean ± SEM; two-way ANOVA with post-hoc Bonferroni correction; * = P ≤ 0.05 vs. group 
housed-no restraint, *** = P ≤ 0.001 vs. group housed-no restraint, x = P ≤ 0.05 vs. group 
housed-restraint, £ = P ≤ 0.05 vs. isolated-no restraint, ££ = P ≤ 0.01 vs. isolated-no 
restraint; Bonferroni interaction value = ns and P ≤ 0.05 for ARC and PVN respectively, n = 
2-4.  
 
Hypothalamic 
nucleus  
c-fos-like positive counts  
Group housed                            Isolated  
No 
restraint 
Restraint  No 
restraint 
Restraint  
ARC  34 ± 19  125.7 ± 
35.86*  
52 ± 16.11  187.50 ± 51.50£  
PVN  16.50 ± 1.50  198 ± 11.80***  34 ± 7.02  467.33 ± 82.93x, 
££  
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FIGURE 3.4 The effect of 15 minutes of restraint on c-fos protein expression in the 
hypothalamic (A) ARC and (B) PVN in group housed vs. isolated male Sprague Dawley 
rats.  Rats were decapitated 2 hrs after cessation of restraint stress and hypothalami were 
immunostained for c-fos protein.  Counts are represented as arbitrary units and data are 
presented mean ± SEM two-way ANOVA with post-hoc Bonferroni correction.  * = P ≤ 0.05 
vs. group housed-no restraint, *** = P ≤ 0.001 vs. group housed-no restraint, x = P ≤ 0.05 vs. 
group housed-restraint, £ = P ≤ 0.05 vs. isolated-no restraint, ££ = P ≤ 0.01 vs. isolated-no 
restraint; Bonferroni interaction value = ns and P ≤ 0.05 for A and B respectively; n = 2-4. 
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FIGURE 3.5 Representative photomicrographs of c-fos protein in coronal sections of 
the hypothalamic (a-d) ARC and (e-h) PVN.  Images derived from (a and e) group housed-
no restraint, (b and f) group housed-restraint, (c and g) isolated-no restraint and (d and h) 
isolated-restraint rats.  The level in relation to the Bregma of the illustrated sections is Arc; -
2.52mm and PVN; -1.72mm, according to the rat brain atlas (Paxinos and Watson 2007).  
Scale bar = 100µm.  
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 3.3.2 The effect of 7-day SI on total plasma stress hormone release in 
response to acute restraint stress 
3.3.2.1 Body weight 
Isolated rats gained significantly more body weight compared to group housed rats after 7 
days of housing (P ≤ 0.001) (Figure 3.6).   
 
 
 
 
FIGURE 3.6 Average body weight gain (g) in group housed and isolated rats.  Male 
Sprague Dawley rats were group housed in fours or individually housed, for 7 days.  Data 
are presented as mean ± SEM. unpaired t-test, P ≤ 0.001; n = 36. 
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3.3.2.2 Plasma ACTH and corticosterone concentrations 
Basal plasma ACTH concentrations of group housed rats were significantly higher than 
those of isolated rats (P ≤ 0.05) (Figure 3.7A), but there was no difference in basal plasma 
corticosterone concentrations between group housed and isolated rats.  Fifteen minutes of 
restraint induced a strong stress response in both group housed and isolated rats, with 
plasma ACTH and corticosterone peaking at 15 and 30 minutes respectively, and returning 
close to resting levels at 75 minutes after the start of the restraint stress procedure (Figure 
3.7A and C).   
 
Restraint significantly increased plasma ACTH concentrations in isolated rats compared to 
group housed rats, 45 minutes after the start of the restraint procedure (P ≤ 0.05) (Figure 
3.7A).  At 75 and 195 minutes, plasma ACTH levels of group housed rats were significantly 
higher than those of isolated rats (P ≤ 0.01 and P ≤ 0.001 respectively) (Figure 3.7A).  A two-
way ANOVA revealed no significant interaction effect of housing on ACTH response to 
restraint stress.  Incremental AUC analysis revealed no significant difference in total ACTH 
release from 0-195 minutes between group housed and isolated rats (Figure 3.7B).          
 
Plasma corticosterone concentrations were significantly higher in group housed rats than 
isolated rats, 15 minutes after the start of the restraint procedure (P ≤ 0.05) (Figure 3.7C).  
At 45 minutes, plasma corticosterone levels of isolated rats were significantly higher than 
those of group housed rats (P ≤ 0.001), but at 75 minutes group housed rats had 
significantly higher corticosterone levels than isolated rats (P ≤ 0.01) (Figure 3.7C).  Two-
way ANOVA revealed a significant interaction effect of housing on corticosterone response 
to restraint stress (P ≤ 0.05).  But again, incremental AUC analysis revealed no significant 
difference in total corticosterone release from 0-195 minutes between group housed and 
isolated rats (Figure 3.7D).  As both plasma ACTH and corticosterone concentrations return 
to resting levels at 75 minutes after the start of the restraint stress procedure, for both group 
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housed and isolated rats (Figure 3.7A and C), analysis of total plasma ACTH and 
corticosterone release from 0-75 minutes was also considered.  But this also revealed no 
difference in total plasma ACTH and corticosterone release from 0-75 minutes between 
group housed and isolated rats.   
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FIGURE 3.7 Time profile (A and C) and AUC (B and D) of plasma (A-B) ACTH and (C-D) 
corticosterone release, after 15 minutes of restraint stress in group housed and 
isolated male Sprague Dawley rats.  Rats were decapitated immediately after cessation of 
restraint stress (15 minutes) or 30, 45, 75 and 195 minutes after the start of restraint stress.  
Red time-points refer to the start (0 minutes) and cessation (15 minutes) of the restraint 
stress period.  A and C: data are presented as mean ± SEM; two-way ANOVA with post-hoc 
Bonferroni correction; * = P ≤ 0.001, ** = P ≤ 0.01, *** = P ≤ 0.05; Bonferroni interaction 
value = ns and P ≤ 0.05 for A and C respectively.  B and D: unpaired t-test; ns.  n = 6. 
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3.3.3 The effect of 7-day, 7-day overnight or 3-week SI on the HPA response to 
acute restraint stress   
3.3.3.1 Body weight 
There was no significant difference in body weight gain between group housed, isolated and 
overnight isolated rats after 7 days of housing (Figure 3.8A), or between group housed and 
isolated rats after 3 weeks of housing (Figure 3.8B).   
 
 
 
FIGURE 3.8 Average body weight gain (g) in (A) 7-day group housed, isolated and 
overnig 
ht isolated and (B) 3-week group housed and isolated male Sprague Dawley rats.  Rats 
were grouped in fours or housed individually for 7 days or 3 weeks.  Overnight isolated rats 
were grouped in fours during the light phase and housed individually during the dark phase, 
for 7 days.  Data are presented as mean ± SEM. unpaired t-test, ns.  n = 12.   
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3.3.3.2 Behavioural Observations  
Morning behavioural observations revealed that from day 2 to day 4 of housing, 7-day 
isolated rats had significantly reduced time spent sleeping (P ≤ 0.001) compared to group 
housed rats (Figure 3.9).  Overnight isolated rats had significantly increased locomotive 
behaviour (P ≤ 0.05) and significantly reduced time spent sleeping (P ≤ 0.001) compared to 
group housed rats (Figure 3.9).  Although overnight isolated rats increased time spent 
climbing, this was not significant in comparison to group housed or isolated rats (Figure 3.9).  
All three housing groups reduced time spent remaining stationary from day 2 to day 4, with 
isolated rats reducing this behaviour more than group housed rats, and overnight isolated 
rats reducing this behaviour more than both isolated and group housed rats (Figure 3.9).  
However these differences were not statistically significant.   
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FIGURE 3.9 Light phase behaviour in 7-day group housed, isolated and overnight 
isolated male Sprague Dawley rats.  Rats were housed in fours (group housed), 
individually (isolated), or in fours during the light phase and individually during the dark 
phase (overnight isolated).  Rats were observed at the start of the light phase (07:30 hrs), 
after overnight isolated rats had been returned to their original groups.  Within 18 minutes of 
the time point stated above (07:30 hrs), each rat was observed for 5 seconds, 6 times.  Data 
are presented as median change from day 2 (interquartile range); Kruskal-Wallis one-way 
ANOVA on ranks with post-hoc Dunn’s test.  * = P ≤ 0.05 vs. group housed, xxx = P ≤ 0.001 
vs.  isolated, £££ = P ≤ 0.001 vs. overnight isolated; n = 12. 
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Evening behavioural observations revealed that from day 2 to day 6 of housing, 7-day 
isolated rats had significantly increased time spent remaining stationary (P ≤ 0.05) compared 
to group housed rats (Figure 3.10).  Both group housed and overnight isolated rats spent 
reduced time remaining stationary, but this was not significant between the two groups, or 
between overnight isolated and isolated rats (Figure 3.10).  Overnight isolated rats spent 
increased time feeding and drinking, while group housed and isolated rats spent increased 
time grooming, but these differences were not statistically significant (Figure 3.10).        
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FIGURE 3.10 Dark phase behaviour in 7-day group housed, isolated and overnight 
isolated male Sprague Dawley rats.  Rats were housed in fours (group housed), 
individually (isolated), or in fours during the light phase and individually during the dark 
phase (overnight isolated).  Rats were observed at the end of the light phase (18:30 hrs), 
before overnight isolated rats were housed individually for the duration of the dark phase.  
Within 18 minutes of the time point stated above (18.30 hrs), each rat was observed for 5 
seconds, 6 times.  Data are presented as median change from day 2 (interquartile range); 
Kruskal-Wallis one-way ANOVA on ranks with post-hoc Dunn’s test.  * = P ≤ 0.05 vs. group 
housed; n = 12. 
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Morning behavioural observations revealed that from day 2 to day 18 of housing, 3-week 
isolated rats had spent significantly reduced time grooming (P ≤ 0.001), remaining stationary 
(P ≤ 0.01), pica (P ≤ 0.05) and climbing (P ≤ 0.001) compared to group housed rats (Figure 
3.11).  Although group housed rats demonstrated an increase in feeding, locomotive and 
burrowing behaviours, these differences were not statistically significant (Figure 3.11). 
 
 
 
FIGURE 3.11 Light phase behaviour in 3-week group housed and isolated male 
Sprague Dawley rats.  Rats were housed in fours (group housed) or individually (isolated).  
Rats were observed at the start of the light phase (07:30 hrs).  Within 12 minutes of the time 
point stated above (07:30 hrs), each rat was observed for 5 seconds, 6 times.  Data are 
presented as median change from day 2 (interquartile range); Mann-Whitney U test.  * = P ≤ 
0.05 vs. group housed, ** = P ≤ 0.01 vs. group housed, *** = P ≤ 0.001 vs. group housed; n 
= 12. 
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Evening behavioural observations revealed that from day 2 to day 18 of housing, 3-week 
isolated rats had spent significantly increased time feeding (P ≤ 0.05) compared to group 
housed rats, with group housed rats in fact reducing the amount of time spent feeding 
(Figure 3.12).  Isolated rats spent significantly increased time grooming (P ≤ 0.05) compared 
to group housed rats, and significantly reduced time climbing (P ≤ 0.01) compared to group 
housed rats, with group housed rats in fact increasing their time spent climbing over the 
housing period (Figure 3.12).  Group housed rats demonstrated a greater increase in 
rearing, locomotive and burrowing behaviour, while isolated rats exhibited a larger reduction 
in time spent remaining stationary and a greater increase in pica behaviour.  However these 
differences in behaviour were not statistically significant (Figure 3.12).  
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FIGURE 3.12 Dark phase behaviour in 3-week group housed and isolated male 
Sprague Dawley rats.  Rats were housed in fours (group housed) or individually (isolated).  
Rats were observed at the end of the light phase (18:30 hrs).  Within 12 minutes of the time 
point stated above (18:30 hrs), each rat was observed for 5 seconds, 6 times.  Data are 
presented as median change from day 2(interquartile range); Mann-Whitney U test.  * = P ≤ 
0.05 vs. group housed, ** = P ≤ 0.01 vs. group housed; n = 12. 
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3.3.3.3 Plasma ACTH and corticosterone concentrations 
In 7-day housed rats, basal plasma ACTH concentrations were surprisingly significantly 
lower in isolated rats compared to group-housed rats (P ≤ 0.05), but there was no difference 
between isolated and overnight isolated rats, or group housed and overnight isolated rats 
(Figure 3.13A).  Restraint did not cause a significant increase in plasma ACTH 
concentrations in any of the housing groups.  Isolated-restraint rats demonstrated 
significantly lower plasma ACTH levels compared to group housed-restraint rats (P ≤ 0.001), 
2 hours after cessation of a 15 minute restraint procedure (Figure 3.13A).  There was no 
difference between isolated-restraint rats and overnight isolated-restraint rats.  Two-way 
ANOVA revealed no significant interaction effect of housing on the ACTH response to 
restraint stress. 
 
In 3-week housed rats, restraint induced a significant rise in plasma ACTH levels in group 
housed rats (P ≤ 0.01 compared to group housed-no restraint rats) but not in isolated rats 
compared to their no-restraint controls (Figure 3.13B).  ACTH concentrations were 
significantly higher in group housed-restraint rats compared to isolated-restraint rats (P ≤ 
0.01) (Figure 3.13B).  There was no difference in basal ACTH levels between group housed 
and isolated rats.  Two-way ANOVA revealed a significant interaction effect of housing on 
the ACTH response to restraint stress (P ≤ 0.01).   
 
In 7-day housed rats, restraint did not induce an increase in plasma corticosterone in group 
housed or overnight isolated rats compared to their no-restraint controls, but did induce a 
significant rise in corticosterone levels in isolated rats (P ≤ 0.01) (Figure 3.13C).  Basal 
plasma corticosterone concentrations were significantly lower in isolated rats compared to 
group housed rats (P ≤ 0.05), but there was no difference between isolated and overnight 
isolated rats, or group housed and overnight isolated rats (Figure 3.13C).  Plasma 
corticosterone concentrations were significantly lower in overnight isolated-restraint rats 
167 
 
compared to isolated-restraint rats (P ≤ 0.01) but there was no difference between overnight 
isolated-restraint rats and group housed-restraint rats, or isolated-restraint rats and group 
housed-restraint rats (Figure 3.13C).  Two-way ANOVA revealed no significant interaction 
effect of housing on the corticosterone response to restraint stress. 
 
In 3-week housed rats, restraint induced a rise in plasma corticosterone levels in group 
housed rats but this was not significantly different to group housed-no restraint rats.  
Restraint induced a significant rise in plasma corticosterone levels in isolated rats compared 
to their no-restraint controls (P ≤ 0.05) (Figure 3.13D).  There was no significant difference 
between corticosterone concentrations in group housed-restraint rats and isolated-restraint 
rats, and there was also no difference between basal corticosterone levels in group housed 
and isolated rats (Figure 3.13D).  Two-way ANOVA revealed no significant interaction effect 
of housing on the corticosterone response to restraint stress.   
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FIGURE 3.13 The effect of 15 minutes of restraint stress on plasma (A-B) ACTH and 
(B-D) corticosterone concentrations in (A and C) 7-day group housed, isolated and 
overnight isolated and (B and D) 3-week group housed or isolated male Sprague 
Dawley rats.  Rats were decapitated 2 hrs after cessation of restraint stress.  Data are 
presented as ± SEM; two-way ANOVA with post-hoc Bonferroni correction.  * = P ≤ 0.05 vs. 
group housed-no restraint, ** = P ≤ 0.01 vs. group housed-no restraint, xx = P ≤ 0.01 vs. 
group housed-restraint, xxx = P ≤ 0.001 vs. group housed-restraint, £ = P ≤ 0.05 vs. isolated-
no restraint, ££ = P ≤ 0.01 vs. isolated-no restraint; 0 = P ≤ 0.05 vs. isolated-restraint.  
Bonferroni interaction value = (A, C-D) ns, (B) P ≤ 0.01; n = 5-6. 
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3.3.3.4 Glucocorticoid receptor and corticotrophin-releasing hormone mRNA 
expression in the hypothalamus 
The quality of RNA extracted from each sample was determined by visualizing samples on a 
1% agarose gel.  All samples, except 12-14 and E3, presented two bands representing the 
28s and 18s rRNA subunits of total RNA, suggesting good quality RNA had been extracted 
(Figure 3.14).  Samples 12-14 were smudged suggesting possible degradation of RNA or, as 
the three smudged samples are directly next to each other, there may have been problems 
with loading samples on that particular section of the gel.  No band was visible for sample E3 
suggesting there may have been an error when loading the gel with this sample.  Therefore 
all 60 samples were included in the RT and qPCR stages to follow.   
 
 
 
FIGURE 3.14 Agarose gel electrophoresis of total RNA isolated from hypothalami of 
male Sprague Dawley rats.  Following RNA isolation, the quality of RNA was determined 
by running RNA samples on a 1% agarose gel with 50 x TAE buffer and EtBr.  Each intact 
total RNA sample should present two bands, representing the 28s and 18s rRNA subunits.  
Sample numbers are denoted under each set of bands.    
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In 7-day housed rats, basal hypothalamic GR mRNA expression levels were not significantly 
different between group housed and isolated rats.  Basal GR mRNA expression was lower in 
overnight isolated rats compared to group housed and isolated rats, but this effect was not 
statistically significant (Figure 3.15A).  Restraint increased GR mRNA expression in all three 
housing groups, but this effect did not achieve statistical significance when compared to their 
respective no-restraint controls (Figure 3.15A).  GR mRNA levels were significantly higher in 
overnight isolated-restraint rats compared to group housed-restraint and isolated-restraint 
rats (P ≤ 0.01 and P ≤ 0.05 respectively), but there was no difference in GR mRNA 
expressions levels between group housed-restraint and isolated-restraint rats (Figure 
3.15A).   
 
In 3-week housed rats, there was no difference between basal hypothalamic GR mRNA 
expression levels in group housed and isolated rats.  Restraint increased GR expression in 
both group housed and isolated rats, but this difference was not statistically significant when 
compared to their respective no-restraint controls (Figure 3.15B).  GR mRNA expression 
was higher in isolated-restraint rats compared to group housed-restraint rats, but again this 
difference was not statistically significant (Figure 3.15B).   
 
In 7-day housed rats, there was no difference between basal hypothalamic CRH mRNA 
expression levels in group housed and isolated rats, but basal CRH mRNA expression was 
significantly higher in overnight isolated rats compared to isolated rats (P ≤ 0.01) (Figure 
3.15C).  Restraint increased CRH mRNA expression levels in group housed and isolated 
rats (P ≤ 0.05 compared to their respective no-restraint controls) but did not affect CRH 
mRNA expression levels in overnight isolated rats (Figure 3.15C).  There was no difference 
between CRH mRNA expression levels in group housed-restraint, isolated-restraint and 
overnight isolated-restraint rats (Figure 3.15C).   
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In 3-week housed rats, there was no difference between basal hypothalamic CRH mRNA 
expression levels in group housed and isolated rats.  Restraint only increased CRH 
expression in isolated rats, but this difference was not statistically significant when compared 
to isolated-no restraint rats (Figure 3.15D).  CRH mRNA expression was significantly higher 
in isolated-restraint rats compared to group housed-restraint rats (P ≤ 0.05) (Figure 3.15D).   
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FIGURE 3.15 The effect of 15 minutes of restraint stress on hypothalamic (A-B) GR 
and (C-D) CRH mRNA expression in (A and C) 7-day group housed, isolated and 
overnight isolated and (B and D) 3-week group housed or isolated male Sprague 
Dawley rats.  Rats were decapitated 2 hrs after cessation of restraint stress.  Data are 
presented as mean ± SEM; two-way ANOVA with post-hoc Bonferroni correction.  * = P ≤ 
0.05 vs. group housed-no restraint, x = P ≤ 0.05 vs. group housed-restraint, xx = P ≤ 0.01 vs. 
group housed-restraint, ££ = P ≤ 0.01 vs. isolated-no restraint; 0 = P ≤ 0.05 vs. isolated-
restraint.  Bonferroni interaction value = ns for A-D; n = 5-6. 
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3.4 Discussion 
3.4.1 Summary of findings 
The stress response to 15 minutes of restraint in male Sprague Dawley rats was altered in 7-
day isolated rats when compared to group housed rats.  Seven days of SI resulted in: 
 significantly increased plasma ACTH and corticosterone concentrations, 
 significantly increased corticosterone release from primary adrenal cells, 
 increased c-fos protein expression in the hypothalamic ARC and PVN, in response to 
acute restraint stress.   
 
However 7-day isolation did not affect basal plasma stress hormone concentrations, basal 
adrenal corticosterone release or basal hypothalamic c-fos protein expression levels.   
 
Time profiles of plasma stress hormone release in response to a 15 minute restraint 
procedure showed that plasma ACTH and corticosterone were significantly higher at 45-195 
minutes and 45-75 minutes after the start of the restraint procedure, respectively, in 7-day 
isolated rats compared to group housed rats.  However incremental AUC analyses showed 
that 7-day isolation does not affect total ACTH or corticosterone release in response to 15 
minutes of restraint stress in male Sprague Dawley rats.    
 
Both 7-day and 3-week isolation paradigms caused increases in depressive-like behaviours 
in male Sprague Dawley rats, by Days 2-6 and Day 18 of housing respectively.  Feeding, 
grooming, locomotion, remaining stationary, sleeping, climbing and pica were the behaviours 
affected by SI, but differently so between 7-day and 3-week housed rats.  Seven-day 
isolation and overnight isolation-induced stress caused a general increase in activity, and 
reduced sleeping in response to morning awakening.  On the other hand, 3-week-isolation 
induced stress caused a general reduction in activity when startled with morning awakening, 
and excessive stress-associated grooming in the evenings.           
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Seven-day isolation and overnight isolation caused behavioural changes in male Sprague 
Dawley rats by day 4-6, in both the light and dark phase.  This was demonstrated by 
reduced time sleeping and increased locomotive behaviour during the light phase, and 
increased time spent remaining stationary in overnight isolated rats during the dark phase.  
Seven days of overnight isolation reduced the ACTH and corticosterone response to 15 
minutes restraint stress in male Sprague Dawley rats, compared to 7-day group housed rats, 
and in the case of corticosterone 7-day isolated rats.  Overnight isolation reduced basal, and 
significantly reduced restraint-induced, GR mRNA expression compared to group housed 
and isolated rats.  Seven days of isolation increased restraint-induced hypothalamic CRH 
mRNA expression compared to group housed rats, while overnight isolation increased basal 
CRH mRNA expression but had no effect on restraint-induced CRH mRNA expression.   
 
Three-week isolation also caused behavioural changes in rats, in both the light and dark 
phase.  This was demonstrated by reduced time spent remaining stationary, reduced 
grooming and climbing, and less pica during the light phase, and increased feeding and 
grooming and reduced time spent climbing during the dark phase.  In response to restraint 
stress, 3-week isolation reduced the ACTH and corticosterone response and increased 
hypothalamic GR mRNA expression 2 hours after cessation of restraint stress, compared to 
group housed rats.  Three-week isolation also significantly increased hypothalamic CRH 
mRNA expression in response to restraint stress. 
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3.4.2 Detailed discussion 
The studies described in this chapter investigated the effects of SI on the HPA axis response 
to acute stress, in rats.  They suggest that SI can cause hyper-activation or hypo-activation 
of the HPA axis response to acute restraint stress, depending on the length of the SI period.  
This hyper-activation is evident at the hypothalamic and adrenal level, and is demonstrated 
peripherally by changes in circulating plasma stress hormone concentrations.  
 
Acute restraint stress produces a robust HPA response in rats, making it a reliable acute 
stressor (Hermes et al., 2006, Lukkes et al., 2009, Weintraub et al., 2010).  Individual 
restraint stress periods lasting 30, 60, and 120 minutes have been found to trigger the 
induction and phosphorylation of several signalling molecules in the hypothalamic PVN and 
ARC, as measured by increased c-fos, phosphorylated extracellular cell-regulated protein 
kinase (pERK), phosphorylated calcium/calmodulin dependent protein kinase II (pCaMKII) 
and phosphorylated cyclic-AMP response element binding protein (pCREB) 
immunoreactivity (Kwon et al., 2006).  Restraint stress also increases the number of CRH 
immunoreactive fibres in the hypothalamic ME, stimulates ACTH production in the anterior 
pituitary as measured by increased ACTH immunoreactive cells, and increases plasma 
ACTH and corticosterone concentrations, compared with control animals (Sanchez et al., 
1998, Gadek-Michalska and Bugajski, 2003).      
 
To date, all major SI studies in rats have housed rats for three weeks or more (reviewed in 
(Hawkley et al., 2012), but studies in other species such as voles (Pournajafi-Nazarloo et al., 
2011, Ruscio et al., 2007, Stowe et al., 2005), pigs (Kanitz et al., 2009, Tuchscherer et al., 
2010, Kanitz et al., 2004, Tuchscherer et al., 2004)  and monkeys (Higley et al., 1992, Lyons 
et al., 1995, Lyons et al., 1999, Mendoza and Mason, 1986) show significant effects of short-
term SI on the HPA axis.  Study 3.2.2.1 was carried out to determine the effects of short-
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term SI on the HPA axis response to stress after just seven days of SI in rats.  In all three 
studies outlined in this chapter, rats from all housing groups demonstrated excessive 
defecation and urination during the restraint procedure, suggesting acute restraint was 
certainly a stressful experience for them.  Figure 3.2 shows that group housed rats 
responded to 15 minutes of restraint with significant increases in plasma corticosterone 
concentrations.  Although plasma ACTH concentrations were not higher in group housed-
restraint rats than group housed-no restraint rats (Figure 3.2A), their significantly higher 
corticosterone concentrations (Figure 3.2B) suggest there was a significantly different 
plasma stress hormone response between the two groups and thus that restraint stress is 
indeed stressful for group housed rats.  Seven days of SI did not affect basal activity of the 
HPA axis, but it did cause hyper-activation of the HPA axis response to restraint as seen by 
significantly increased plasma ACTH and corticosterone concentrations, compared to group 
housed rats.  As mentioned in chapter 2, it is well known that after a stress response, 
plasma ACTH levels start to normalise from 30 minutes, whilst corticosterone levels return to 
resting levels much later.  Therefore it is possible that a significant effect of restraint stress 
on circulating ACTH levels was missed at the 2 hr time point.  Nevertheless, these results 
are in line with other studies that support the notion that SI can cause hyper-activation of the 
HPA axis.  For example, Ferland and Schrader show that three weeks of SI in rats increases 
the corticosterone response to cage-mate separation stress (Ferland and Schrader, 2011), 
while Weiss et al., show that 13-week isolated rats have increased ACTH and corticosterone 
responses to open field and elevated plus maze stress tests (Weiss et al., 2004).   
 
Increased corticosterone release from cultured primary adrenal cells of isolated rats (Figure 
3.3) suggests that the adrenal gland is more sensitive to acute restraint stress after a period 
of SI.  This correlates with available evidence suggesting that a dysfunctional adrenal gland 
may be involved in the pathogenesis of disease associated with HPA dysregulation.  
Fourteen day chronic variable stress - hypoxia, warm swim, cold swim, cold room, shaker 
platform, restraint and overnight isolation - has been found to cause hyperplasia and 
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hypertrophy of the adrenal gland, leading to increased corticosterone responses to ACTH 
(Ulrich-Lai et al., 2006).  Interestingly, depressed patients have been found to have enlarged 
and hyperactive adrenal glands (Nemeroff and Vale, 2005), and the adrenal glands of 
isolated rats have been shown to be larger than those of group housed rats. In addition, the 
adrenal glands of isolated rats are more responsive to electric shock stress compared to 
those of group housed rats (Viveros et al., 1988).      
 
To determine whether the hypothalamic component of the HPA axis is directly affected by 
SI, hypothalamic c-fos protein expression in response to 15 minutes of restraint stress was 
also measured in isolated and group housed rats.  The ARC and PVN are hypothalamic 
nuclei known to be activated in response to restraint stress (Kwon et al., 2006), and by 
others stressors such as LPS (Dallaporta et al., 2007) and air jet stress (Porter and 
Hayward, 2011).  Restraint significantly increased c-fos protein expression in the ARC 
(Figure 3.4A) and PVN (Figure 3.4B) of both SI and group housed rats, supporting the above 
finding that restraint is a stressful experience for rats.  But increased ARC, and significantly 
higher PVN c-fos protein expression, is evident in isolated-restraint rats when compared to 
group housed-restraint rats, suggesting that the hypothalamus is hyper-responsive to acute 
stress following a period of SI.  This is in accord with other studies reporting 6 weeks of SI in 
prairie voles increases CRH mRNA expression in the PVN in response to an elevated plus 
maze test, suggesting enhanced hypothalamic activity in response to acute stress (Pan et 
al., 2009).    
 
Collectively, the results (3.3.1) from study 3.2.2.1 suggested that 7-day SI caused hyper-
activation of the HPA axis response to acute restraint stress, and that this hyper-activation 
was occurring at the hypothalamic and adrenal level.  However, it was unknown whether 
isolated rats had a higher amount of total peripheral ACTH and corticosterone release, in 
response to 15 minutes of restraint stress, compared to group housed rats, or whether SI 
caused a time-shift in HPA responsiveness to acute stress, and thus the effects we observed 
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in 3.3.1 were the result of an earlier peak in HPA responsivity in isolated rats.  Therefore 
study 3.2.2.2 was designed to investigate this by measuring plasma ACTH and 
corticosterone levels in male Sprague Dawley rats at 0 15, 30, 45, 75 and 195 minutes after 
the start of a 15 minutes restraint stress period, in group housed and isolated rats.  Unlike 
the previous study, SI influenced body weight in these rats; the body weight of isolated rats 
was significantly higher than that of group housed rats, after just seven days of SI.  This 
could be because isolated rats had much more time available to feed as they were not 
interacting with other rats, because they were not being disturbed when feeding by other 
rats, or because they may have been less physically active, possibly because of the lack of 
interaction or ‘playtime’ with other rats or their housing in a single level cage, rather than the 
double-levelled cage that the group housed rats were housed in.  The ACTH time profile 
(Figure 3.7A) revealed that although plasma ACTH levels were significantly higher in 
isolated rats compared to group housed rats at 45 minutes after the start of the restraint 
stress procedure, total ACTH release was not different from that of  group housed rats 
(Figure 3.7B).  A similar pattern in the corticosterone time profile and AUC (Figure 3.7C-D) 
suggested that SI did not have a large effect on this particular cohort’s HPA response to 
acute restraint stress.  ACTH and corticosterone levels peaked at the same time for both 
group housed and isolated rats, and followed a very similar profile returning to resting levels 
(Figure 3.7), though there were differences at specific time points.  At time point 0 minutes, 
group housed rats had significantly higher plasma ACTH levels than isolated rats, yet 
isolated rats displayed a significantly higher ACTH response to restraint up to 75 minutes 
after the start of the restraint stress.  But at 75 and195 minutes group housed ACTH levels 
were significantly higher than those of isolated rats.  This suggests that any significant 
difference in total ACTH release may have been masked by these significant differences in 
basal (Figure 3.7A) and resting concentrations.  Based on the results of study 3.3.1, in which 
levels of both stress hormones were still significantly higher in isolated rats than in group 
housed rats at 2 hrs after cessation of restraint stress, it is surprising that in study 3.3.2 both 
plasma ACTH and corticosterone were significantly higher in group housed rats than in 
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isolated rats at a similar time point on the profile (Figure 3.7).  A possible reason for this 
could be a differing environmental experience that both housing groups may have 
encountered to the previous experiments, particularly on the day of the study.  As mentioned 
in chapter 2, it is very difficult to control for external events that can affect social stress in any 
animal.  It is possible that loud noises, abnormal changes in lighting or rough handling by 
animal facility staff may have contributed to stress in these rats, and therefore could have 
acted as long-term stressors themselves.  Another reason could be the stress of removing 
rats from grouped cages for the restraint procedure on the day of experimentation.  This is 
particularly important in the case of group housed rats because they temporarily lose cage 
mates whilst some are being restrained and others returned to their cages.  Cage mate 
separation has been found to induce an acute stress response in rats (Ferland and 
Schrader, 2011) and in the rats in study 3.3.2 this may have exaggerated the stress 
responses observed.  Of course this may also be true for rats in study 3.3.1, but it is difficult 
to determine the extent to which such additional stressors may have affected these two 
cohorts.  The amount of time this additional stress response may have lasted and the extent 
to which it may have activated the HPA axis is unknown and could have influenced the time 
profile response observed after a restraint stress procedure.  Any possible effects of cage 
mate separation were not evident in study 3.3.1 as stress levels were not measured before 
or throughout the study period on the day of experimentation.  In conclusion, the results of 
study 3.3.2 were difficult to interpret, and it was therefore decided that investigation of 
different and potentially more stressful SI paradigms was required to support the findings of 
study 3.3.1, as well as to investigate the mechanisms by which SI might influence HPA 
responsiveness and which might mediate the putative changes observed in study 3.3.1.   
 
Building upon the 7-day isolation paradigm in study 3.2.2.1, study 3.2.2.3 investigated the 
effects of 7 days of overnight isolation on the HPA axis response to acute restraint stress, 
and compared this to the previously investigated paradigm of 7-day isolated rats.  Another 
arm of this study investigated the effects of 3-week chronic SI on the HPA response to acute 
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restraint stress in rats.  Similar experimental paradigms have previously triggered different 
HPA responses to acute stress.  Fourteen days of intermittent SI has been shown to 
increase plasma corticosterone levels (Ferland and Schrader, 2011, Pournajafi-Nazarloo et 
al., 2011), increase hypothalamic CRH mRNA expression, and increase CRH-R1 mRNA but 
decrease CRH-R2 mRNA expression in the pituitary gland after each isolation session in 
rats (Pournajafi-Nazarloo et al., 2011).  On the other hand, three weeks of chronic SI in the 
vole increases basal plasma corticosterone levels and CRH immunoreactivity in the PVN, 
and reduces basal AVP immunoreactivity in the PVN compared to pair-housed control 
animals (Ruscio et al., 2007).  The HPA response to acute stress was not investigated in 
these chronically stressed animals.  In rats, 3 weeks of SI also reduces basal corticosterone 
levels, but investigation of the HPA response to acute stress in these rats shows that chronic 
3-week SI does not affect the corticosterone response to acute immobilization stress, 
compared to group housed rats (Djordjevic et al., 2010).  The mechanisms by which these 
changes occur were not investigated in this study.  Therefore study 3.2.2.3 compared the 
effects of intermittent SI, but for 7 days instead of 14 days, on the HPA axis response to 
acute restraint stress.  This 7-day paradigm allows direct comparison with the results of 
study 3.2.2.1.  The 3-week chronic SI paradigm was chosen as a longer chronic stress 
period that had previously been shown to induce changes in the HPA response to acute 
stress in rats, and which may be more stressful than just 7 days of chronic SI as investigated 
in study 3.2.2.1.   
 
Firstly, morning and evening behaviour was observed in these rats.  Behavioural changes in 
rats have been attributed to SI, such as increased aggression in response to handling as a 
consequence of isolation housing.  Such behaviours can be categorized into stressful or not-
stressful behaviours, and further characterised as depressive-like or anxiolytic behaviours 
that may be linked to psychiatric disorders such as schizophrenia, depression and anxiety 
(Weiss et al., 2004, Lukkes et al., 2009, Landgraf and Wigger, 2002, Djordjevic et al., 2012, 
Qi et al., 2006, Burman et al., 2008, Kalueff and Tuohimaa, 2005).  In study 3.3.3, 
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behavioural observations were carried out with the aim of establishing whether SI caused 
behavioural changes which were attributable to stress.  Other studies observe behaviour 
during specific stress-tests, such as the open field test, elevated plus maze test and forced-
swim test  (Einon and Morgan, 1977, Djordjevic et al., 2012, Qi et al., 2006).  But the 
observations made during these tests cannot solely be attributed to SI, as these tests 
themselves may affect behaviour (Weiss et al., 2004).  This is because additional stress may 
be caused by the new test-environment and equipment, as well as momentary isolation of 
animals that are used to being group housed at all times.  The behavioural observation 
technique described in this chapter is an adaptation of a technique used in two previous 
studies (Fray et al., 1980, Molloy and Waddington, 1987), and is a novel approach that 
observes grouped rats whilst still in their respective cages.  This method allows observations 
to be made in a non-invasive manner and attributes any stressful behaviour observed to the 
housing paradigm alone.    
 
Although morning and evening behaviours were both observed throughout study 3.2.2.3, the 
evening behaviours are of particular interest as rats are nocturnal animals and are therefore 
active during the dark phase.  It is notable that methodological differences between morning 
and evening observations also contribute to the possibility that the morning observations 
may be unreliable.  As mentioned above, before morning observations were carried out, 
overnight isolated rats were returned to their original grouped cages.  This was an 
interruption to their natural routine as rats are usually sleeping at this point in the light phase, 
therefore adding to the possibility that any behaviour recorded at this time point may have 
been unnatural.  To control for this additional disturbance in overnight isolated rats, group 
housed rats and chronically isolated rats were also briefly picked up and returned to their 
cages immediately at this time point.  A further limitation to the analysis of morning 
behavioural data was that Day 6 behavioural data for 7-day housed rats was, although 
initially recorded, not available due to loss of data.  Thus morning behavioural observations 
presented in Figure 3.9 included the change in behaviour between days 2 and 4 only, 
182 
 
whereas evening behavioural observations presented in Figure 3.10 included the change in 
behaviour between days 2 and days 6.  Collectively, these confounding factors suggest 
evening behavioural observations may be more reliable than morning observations.     
 
The increased activity and reduced sleeping time of overnight isolated rats and 7-day 
isolated rats in the morning (Figure 3.9) could perhaps be attributed to increased startle-
response to the awakening procedure and increased time taken to overcome this startle-
effect when compared to other housing groups.  This suggests that both isolation and 
overnight isolation are stressful, with overnight isolation more so, as increased activity and 
restlessness has been linked to an anxiolytic behavioural phenotype in rats (Hilakivi et al., 
1989, Varty et al., 2000).  Although not significantly different, the increased evening 
grooming behaviour observed in 7-day isolated rats (Figure 3.10) indicates a possible pro-
depressive phenotype of these rats, as increased grooming is linked to a depressive 
behavioural profile in rats (Landgraf and Wigger, 2002), and is thought to be a coping 
mechanism for rats exposed to stress (Smolinsky et al., 2009). 
 
Morning behavioural observations revealed that 3-week isolated rats significantly reduced 
time spent grooming and climbing compared to group housed rats (Figure 3.11). Isolated 
rats also demonstrated a greater reduction in time spent remaining stationary compared to 
group housed rats (Figure 3.11). This is surprising because of the links between increased 
grooming and stress described above.  However this could be explained by the fact that 
waking the rats immediately before morning observations startles them, as they are usually 
sleeping at that point.  Isolated rats may remain startled for longer while group housed rats 
may overcome the startle-effect more quickly, allowing them to engage in normal behaviours 
immediately after being startled. 
 
Significantly increased evening feeding behaviour in 3-week isolated rats compared to 3-
week group housed rats (Figure 3.12) may suggest isolated rats were more stressed as 
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excessive feeding can be associated with stress (Badiani et al., 1996). Hyperphagia has 
been associated with depression and isolation so increased feeding could be indicative of 
this (Hall et al., 1998, Nakhate et al., 2011). Isolated rats groomed more than group housed 
rats in the evening (Figure 3.12), again suggesting they are more stressed than their 
grouped counterparts and possibly pro-depressive (Landgraf and Wigger, 2002, Smolinsky 
et al., 2009). Reduced climbing in isolated rats compared to group housed rats in the 
evening, coupled with the lack of a difference in other activity behaviours such as rearing 
and burrowing between the two housing groups (Figure 3.12), suggests isolated rats were 
overall less active than group housed rats. This is in line with more classic associations of 
depression and stress with reduced locomotion (Strekalova et al., 2005) and increased 
immobility (Griebel et al., 2005, Elizalde et al., 2008, Griebel et al., 2002). 
 
In conclusion, both 7-day and 3-week isolation paradigms caused increases in depressive-
like behaviours in male Sprague Dawley rats.  Feeding, sleeping, grooming, locomotion, 
remaining stationary and climbing were the behaviours most affected, but differently so 
between 7-day and 3-week housed rats.  Seven-day isolation and overnight isolation-
induced stress caused an exaggerated and elongated startle response to morning 
awakening, and a general increase in activity in the morning.  Three weeks of SI induced 
stress caused a general reduction in activity when startled with morning awakening, and 
excessive stress-associated grooming in the evenings. 
 
The reduced basal and restraint-induced ACTH and corticosterone response in overnight 
isolated rats (Figure 3.13A and C) suggests hypo-activation of the HPA axis and contrasts 
the HPA hyperactivity in response to restraint stress seen in 7-day chronically isolated rats, 
in study 3.3.1 (Figure 3.2) and study 3.3.3 (Figure 3.13 A and C).  It is notable that the 
hormonal responses of 7-day group housed rats in study 3.3.3 (Figure 3.13A and C) were 
extremely high compared to those seen in all previous experiments, suggesting that this 
group of rats was particularly stressed before or during experimentation.  This is likely due to 
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the putative environmental reasons discussed above, in which case it can be assumed that 
these results for group housed rats are distorted.  This makes it difficult to compare the 
hormonal responses of 7-day isolated rats and overnight isolated rats to group housed 
controls.  Basal and restraint stress-induced hypothalamic GR mRNA expression was 
reduced in overnight isolated rats compared to group housed and 7-day isolated rats (Figure 
3.15A).  The HPA axis is partly regulated by a glucocorticoid negative feedback mechanism, 
with some of this feedback occurring  at the level of the hypothalamus via the GR (Jones et 
al., 1977).  Glucocorticoids bind to the GR to promote normalization of plasma glucocorticoid 
levels after stress exposure.  This results in down regulation of CRH and vasopressin 
expression in PVN neurons, and therefore a dampening of the downstream mechanisms that 
are initially activated after stress exposure (de Kloet et al., 2008c).  Reduced GR expression 
in the hypothalami of overnight isolated rats would therefore suggest a down-regulated 
glucocorticoid feedback mechanism.  Basal hypothalamic CRH mRNA expression was 
increased in overnight isolated rats compared to 7-day isolated rats (Figure 3.15C).   
 
During an acute stress response, CRH is released from the parvocellular neurons of the 
PVN and stimulates ACTH secretion from pituitary corticotrophs (Vale et al., 1981, Lamberts 
et al., 1984), and thus activation of the HPA axis.  Increased CRH expression in the 
hypothalami of overnight isolated rats would therefore suggest an overactive CRH feed-
forward output.  Collectively, these GR and CRH mRNA expression levels would suggest an 
overactive HPA response with a less effective glucocorticoid mechanism in overnight 
isolated rats, yet the reduced plasma stress hormone levels of these rats suggests another 
regulatory mechanism is responsible for this hypo-activation observed in overnight isolated 
rats.  This is at odds with the findings of previous studies by other groups showing that 
fourteen days of intermittent SI causes  hyper-activation of the HPA axis in rats (Ferland and 
Schrader, 2011, Pournajafi-Nazarloo et al., 2011) and increases hypothalamic CRH mRNA 
and pituitary CRH-R1 mRNA expression (Pournajafi-Nazarloo et al., 2011).  However GR 
expression was not measured in these studies.  One explanation for the HPA hypo-
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activation in overnight isolated rats could be that the increased CRH output may be 
ineffective due to a possible reduction in pituitary CRH-R1 expression, which would accord 
with the reduced GR expression in the hypothalamus, as a hypo-active HPA axis would not 
require high levels of GR for normalization of a stress response.  In 7-day isolated rats, GR 
mRNA expression was comparable to that seen in group housed rats, while CRH mRNA 
expression was significantly higher in response to restraint, when compared to group housed 
rats (Figure 3.15A and C).  This would suggest that an overactive CRH feed-forward 
mechanism is responsible for the HPA hyper-activation seen in 7-day isolated rats, and that 
the glucocorticoid feedback mechanism is not altered in these rats.  This is the first study to 
investigate the effects of just 7 days of SI in rat HPA activity and is therefore not directly 
comparable to other SI paradigms.        
 
The decreased plasma ACTH and corticosterone response to restraint in 3-week isolated 
rats, compared to 3-week group housed rats, suggests hypo-activation of the HPA axis in 
response to acute novel stress (Figure 3.13A and D).  The increased GR and CRH mRNA 
expression levels in response to restraint in 3-week isolated rats suggest an increased 
stress response which is down-regulated by an exaggerated glucocorticoid feedback 
mechanism.  This feedback could be occurring at multiple levels of the HPA axis, as it is well 
known that glucocorticoids can act directly on GR at the hypothalamus (Jones et al., 1977)  
and pituitary (Russell et al., 2010), as well as upstream limbic structures such as the 
hippocampus (Sapolsky et al., 1984) and the prefrontal cortex (Hill et al., 2011).  This may 
explain the lack of effect of such an increased CRH drive seen in 3-week isolated rats.  
Others have also shown HPA hypo-activation of the HPA axis in rats after 3 weeks of SI 
(Djordjevic et al., 2010), but the mechanism behind these changes has not previously been 
investigated.        
     
Given the potential confounding factors within individual studies described in this chapter, 
such as the possible effects of cage mate separation in study 3.3.2, and the surprisingly 
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increased basal and restraint stress induced plasma ACTH and corticosterone levels in 7-
day group housed rats in study 3.3.3, as well as the limitations described above for the 
analysis of morning behavioural data from study 3.3.3, it is not possible to draw definitive 
conclusions from a) the results of study 3.3.3 or b) direct comparisons of study 3.3.2 to study 
3.3.3.  This reflects the difficulty in controlling for a wide range of environmental stressors in 
stress-related studies, as well as the natural variability of the stress response between 
individual rats of the same species and sex.  Nonetheless, these data are the first to suggest 
that 7-day SI causes hyper-activation of the HPA axis during an acute stress response, and 
that the hypothalamus and the adrenal gland, are both hyper-sensitive after a 7-day period 
of SI.  These data also demonstrate for the first time that 7-day overnight isolation and 3-
week SI cause hypo-activation of the HPA axis response to acute stress, with the former 
regulated by an unknown mechanism and the latter possibly regulated by an overactive 
feedback mechanism. 
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Chapter IV: 
General Discussion 
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4.1 Introduction 
 
The HPA axis plays a crucial role in regulating the response to emotional and physiological 
stressors.  In response to a stressor, hypothalamic hormones, particularly CRH, target the 
anterior pituitary gland to regulate ACTH secretion, which itself targets the adrenal gland to 
stimulate the release of glucocorticoids (Chrousos, 2009, Vale et al., 1981, Lamberts et al., 
1984).  Evidence suggests that a chronically activated HPA axis can lead to the 
pathogenesis of obesity and diabetes (Chrousos, 2009) by altering key physiological 
processes involved in appetite regulation and energy homeostasis (McEwen, 2004), such as 
glucocorticoid regulation of the hypothalamic peptides CRH and AVP (Cavagnini et al., 2000, 
Savontaus et al., 2002) and other metabolically active hormones such as insulin, leptin and 
ghrelin (Brindley and Rolland, 1989, Cavagnini et al., 2000, la Fleur, 2006, Jahng et al., 
2008).  Leptin has a putative role in the regulation of the HPA axis and can signal to the 
hypothalamus, where appropriate downstream circuits are activated to modulate the stress 
response (Maffei et al., 1995).  Some evidence suggests that the obesity-associated 
alterations in the HPA axis may be mediated by leptin (McGregor et al., 1996).     
 
Chronic HPA activation is also implicated in the pathogenesis of psychiatric disorders 
(O'Connor et al., 2000, Gold et al., 1988, Weiss et al., 2004), by disruption of key brain 
functions such as altered hypothalamic and pituitary CRH-R1 expression (Kehne and Cain, 
2010) and disrupted endocannabinoid signalling in upstream brain limbic structures and 
within the hypothalamus (Gorzalka et al., 2008, Finn, 2010).  Loneliness is a specific form of 
chronic stress in humans, and is referred to as SI in animals, whereby social mammals are 
deprived of natural social interactions with animals of the same species.  This form of 
chronic stress can cause changes in HPA function and is implicated in the pathogenesis of 
psychiatric disorders such as schizophrenia and depression (Thornton et al., 2010, Weiss et 
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al., 2004, Hatch et al., 1965, Pariante and Lightman, 2008, Kaye et al., 1987, Corcoran et 
al., 2003).   
   
This thesis has described work investigating the effect of leptin and SI on the HPA axis 
response to acute stress.     
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4.2 Investigating the effects of leptin on the HPA axis response to stress 
 
Discovered in 1994, leptin is a 167 amino acid (Zhang et al., 1994) adipokine, and leptin 
deficiency causes severe obesity, rapid weight gain, hyperphagia, mild diabetes and 
infertility (Ingalls et al., 1950).  Leptin is largely synthesized in WAT (Scherer and Buettner, 
2011),  and the LepR is found in numerous peripheral organs (De Matteis et al., 1998, 
Siegrist-Kaiser et al., 1997) and within the brain, where leptin acts on the choroid plexus, 
VTA and the hypothalamic ARC, PVN, VMN and DMN to signal the extent of the body’s fat 
stores (Collins et al., 1996).  Leptin has a well characterised role in the regulation of body fat 
which it influences by inhibiting food intake and increasing energy expenditure (Ahima et al., 
1998, Halaas et al., 1995, Chua et al., 1996).  My studies focused on the effect of leptin on 
the HPA axis response to acute stress, in the form of acute LPS challenge in male Wistar 
rats.   
 
My work suggests that peripheral leptin administration does not influence basal HPA activity 
or influence the HPA response to acute endotoxin challenge.  LPS induced a strong stress 
response, as demonstrated by increased levels of the plasma stress hormones ACTH and 
corticosterone and the cytokine IL-1β, increased neuronal activation in the hypothalamic 
ARC, PVN, SON and VMN, as well as the NTS, PBN, AP and LC of the brainstem.  
However, pre-treatment with leptin did not influence the HPA response to acute LPS 
challenge.     
 
The studies described in chapter 2 are the first to investigate the effects of leptin on the HPA 
response to a powerful immunological stressor.  Different types of stressors (Ott et al., 1987, 
Kang et al., 2008, Hu et al., 1993, Connor and Leonard, 1998) ultimately activate the HPA 
axis via the hypothalamus, stimulating the CRH-ACTH-glucocorticoid cascade.  However 
different sets of genes within the brain are induced or repressed by severe immunological 
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stress, such as LPS challenge, compared to those induced or repressed by mild 
psychological stress such as restraint stress (Reyes et al., 2003).  Furthermore, LPS has 
been shown to stimulate ACTH and glucocorticoid release from the pituitary and adrenal 
glands respectively (Gloddek et al., 2001, Watanobe and Yoneda, 2003, Mohn et al., 2011, 
Pournajafi Nazarloo et al., 2003, Andreis et al., 1991).  The fact that LPS induces a different 
activational response within the brain compared to mild stressors, and activates the HPA 
axis at multiple levels, may explain why leptin failed to attenuate the LPS induced HPA 
response in my studies, yet was effective in blunting the restraint stress-induced HPA 
response in other studies (Heiman et al., 1997)   
 
To further investigate the role leptin plays in the HPA axis response to stress, it would be 
interesting to determine which stress pathways are influenced by leptin in response to mild 
stressors.  In mice, acute restraint stress induced activation of the HPA axis can be 
influenced by pre-treatment with leptin (Heiman et al., 1997), but the mechanisms behind 
these changes have not yet been investigated.  It would be interesting to test the effects of 
leptin on the stress response of individual components of the HPA axis, ex vivo.  If an 
inhibitory effect of leptin is observed, the exact mechanisms by which these changes occur 
could be examined by investigating expression levels of genes known to be 
activated/repressed by stress in the HPA axis of these mice, and how the expression of 
these genes is affected by leptin.   
 
Extending this to chronically stressed rodent models - specifically in rats because of the 
various stress models available in this species - could shed light on whether acute leptin 
administration influences a chronically activated HPA axis, in response to a new stressor.  It 
is well known that chronic stress-induced HPA axis activation can lead to chronically 
elevated circulating leptin levels (McGregor et al., 1996, Beck and Richy, 2009).  Obese 
rodents also have chronically elevated leptin levels, but suffer from leptin resistance. This 
suggests that acute leptin pre-treatment may not influence the HPA axis response to a novel 
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stressor in chronically stressed rats as they may also be leptin insensitive.  If this is indeed 
the case, then it would be interesting to investigate which of the stress related genes and 
signalling pathways, looked at in the acute stress studies described above, are changed to 
allow this leptin insensitivity to occur.   
 
It would also be interesting to carry out these studies in obese rats and directly compare the 
effects of acute leptin treatment on the HPA response to a novel stressor between 
chronically stressed rats and obese rats.  As obese rats present with a constantly activated 
HPA axis - as evidenced by their chronically elevated circulating glucocorticoid levels 
(Mattsson et al., 2003, Buchenauer et al., 2009) - as well as with elevated basal circulating 
leptin levels (Maffei et al., 1995), it would be interesting to see whether the same signalling 
pathways contribute to chronic HPA activation in both models, and may further our 
understanding of why leptin insensitivity occurs in obese rats.  This could be important in 
understanding the association between chronic psychological stress and the manifestation of 
the metabolic syndrome (Chrousos, 2009).      
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4.3 Investigating the effects of SI on the HPA axis response to stress 
SI is a chronic form of stress in mammals (Weiss, 1974) and causes behavioural, neural, 
hormonal, cellular and genetic changes in humans, rodents and other social mammals 
(Cacioppo et al., 2006, Cacioppo and Hawkley, 2009, Hatch et al., 1965, Weiss et al., 2004, 
Holson et al., 1991).  In rats, SI has generally been shown to result in increased HPA activity 
and increased HPA sensitivity to subsequent stressors (Weiss et al., 2004, Holson et al., 
1991), but some studies suggest that HPA hypo-reactivity in response to a novel stressor 
can also occur (Sanchez et al., 1998) (Serra et al., 2005).  These neuroendocrine changes 
are thought to result from the alterations of neurotransmitter signalling associated with 
stress, such as changes in the serotonergic (Chrousos, 1995, Berton et al., 1997, Flugge, 
1995, McKittrick et al., 1995) dopaminergic, noradrenergic (Sontag et al., 2003) and GABA-
ergic (Romeo et al., 1998) signalling systems.   
 
The results from the studies described in chapter 2 prompted the exploration of a milder 
stressor in rats, and the effects of this stressor on HPA function.  This work is also an 
extension of studies which have investigated SI in rats.  To date all SI studies in rats have 
housed the animals for three weeks or more (reviewed in (Hawkley et al., 2012).  The 
studies described in chapter 3 investigated the effects of intermittent, short term and long 
term chronic SI on the HPA axis response to acute restraint stress in rats.  I am the first to 
show that 7-day chronic SI causes hyperactivity of the HPA in response to acute restraint 
stress, and that the hypothalamus and the adrenal gland are both hyper-sensitive after this 
period of SI.  These data also demonstrate, for the first time that 7-day overnight SI and 3-
week chronic SI cause hypo-activation of the HPA axis response to acute restraint stress, 
with the former regulated by an unknown mechanism and the latter possibly regulated by an 
overactive feedback mechanism.      
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The exploration of acute restraint stress as a mild psychological stressor revealed that it 
indeed produced a robust stress response, and that it resulted in a more reproducible stress 
response compared to LPS challenge.  The same dose of LPS induced hugely different 
levels of stress in rats, as seen by widely variable fold increases in plasma ACTH and 
corticosterone between studies.  On the other hand, restraint stress induced a similar stress 
response in rats across studies that used the same time points, as seen by similar fold 
increases in plasma ACTH and corticosterone between these studies.  Thus restraint stress 
appears a useful model acute stressor for the future leptin experiments described earlier in 
this chapter.    
 
The importance of HPA hyperactivity in disease is still not well understood.  Some evidence 
suggests that HPA hyperactivity has negative effects on glucocorticoid-regulated processes.  
In rodents, SI-induced HPA hyperactivity results in increased circulating basal corticosterone 
levels, which directly reduces hippocampal neurogenesis and impairs wound healing 
(Stranahan et al., 2006, Detillion et al., 2004).  Compared to non-lonely psychiatric patients, 
lonely psychiatric patients have higher urinary cortisol levels and lower natural killer cell and 
T-lymphocyte levels, in response to mitogen stimulation (Kiecolt-Glaser et al., 1984a, 
Kiecolt-Glaser et al., 1984b).  These results suggest an immunosuppressive effect of excess 
cortisol and that HPA hyperactivity can result in impaired immunity.  Prenatal over-exposure 
to glucocorticoids in non-human animals can cause hypertension, hyperglycaemia and 
increased HPA activity in the offspring in later life, whilst in humans it causes increased HPA 
activity all the way from early life, as well as high blood pressure, insulin resistance, glucose 
intolerance and hyperlipidemia in subsequent adulthood (Seckl and Meaney, 2004).  All 
these conditions are pro-inflammatory, which suggests that chronically lonely individuals are 
at increased risk of inflammatory disease (Cole et al., 2007, Cole et al., 2012, Fredrickson et 
al., 2013).             
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An overactive HPA axis is also implicated in major depression (Nemeroff and Vale, 2005, 
Sanchez et al., 2001).  Many depressed patients have increased plasma cortisol levels, as 
well as enlarged and hyperactive pituitary and adrenal glands (Nemeroff and Vale, 2005).  
This is thought to be due to an impaired glucocorticoid feedback mechanism (Pariante, 
2006).  Stressful life events also increase the risk of schizophrenia (Ellenbroek et al., 1998), 
and many schizophrenic patients have elevated plasma cortisol levels (Meltzer, 1987) and a 
higher cortisol response to a novel stressor (Lammers et al., 1995).  Patients with anxiety 
disorders present with HPA hyperactivity (Abelson et al., 2007, Condren et al., 2002) and 
this is thought to be due to glucocorticoid insensitivity and CRH over-expression (Kunugi et 
al., 2006).   
 
The HPA hyperactivity seen in my study of 7-day chronically isolated rats may also be 
caused by an overactive CRH feed-forward mechanism, as hypothalamic GR gene 
expression was not changed and hypothalamic CRH gene expression was significantly 
higher in response to restraint stress in these rats when compared to group housed rats.  
These findings demonstrate a physiological change in gene expression of stress related 
genes by SI, after just 7 days of chronic SI.  Although this duration of SI may not be directly 
applicable to humans, these data do suggest that loneliness in humans could begin 
contributing to the pathogenesis of metabolic and psychiatric diseases after relatively brief 
periods of loneliness.   
 
Some studies have shown that SI causes HPA hypoactivity in response to a novel stressor, 
and that this may be due to desensitization to stressful stimuli (Sanchez et al., 1998) and 
impairment of the mechanism by which glucocorticoids negatively feedback to the 
hypothalamus (Serra et al., 2005).  However, there is little evidence in the current literature 
to suggest that HPA hypoactivity is important in the pathogenesis of metabolic and 
psychiatric disorders.  HPA hypoactivity is seen in patients with rheumatoid arthritis, who 
also often display fatigue and depression (Templ et al., 1996).  Patients with chronic fatigue 
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syndrome also display symptoms of HPA hypoactivity (Demitrack et al., 1991).  The 
mechanisms behind the HPA hypoactivity observed in my study of 7-day overnight isolated 
rats are unknown.  While there was a reduced plasma ACTH and corticosterone response to 
restraint stress, hypothalamic GR gene expression was reduced and hypothalamic CRH 
gene expression was increased.  These gene expression data would suggest a down-
regulated glucocorticoid feedback mechanism and overactive CRH feed-forward 
mechanism, yet this does not accord with the plasma stress hormone responses to restraint 
stress in these rats.  It is therefore important to investigate this further by, as discussed in 
chapter 3, looking at CRH-R1 expression in the pituitary gland.  Reduced CRH-R1 gene 
expression in the pituitary would counteract an increased hypothalamic CRH output, and 
may explain the reduced GR expression in the hypothalami of these rats.  This is because a 
hypo-active HPA axis would not require high levels of GR for normalization of a stress 
response. 
 
Rats chronically isolated for three weeks demonstrated HPA hypoactivity, with increased 
hypothalamic GR and CRH gene expression.  This suggests that although there is an 
increased stress response in these rats, an exaggerated glucocorticoid feedback mechanism 
may have dampened this response.  As this feedback mechanism could be occurring at 
multiple levels of the HPA axis, (Jones et al., 1977, Russell et al., 2010), as well as at 
upstream limbic structures (Sapolsky et al., 1984, Hill et al., 2011), the increased CRH drive 
may have had little effect on the stress response in these rats.  It would therefore be 
interesting to extend investigations of the mechanisms behind HPA hypoactivity in 3-week 
chronically isolated rats by determining gene expression levels of GR in the pituitary and 
adrenal glands, as well as in the hippocampus and prefrontal cortex.  
 
Throughout all the experiments described in chapter 3, basal corticosterone concentrations 
were not affected by SI, and neither were circulating leptin levels measured in animals from 
the first SI study (data not shown).  As a way of understanding HPA dysfunction in obese 
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rats, it may be interesting to alter the SI paradigm from my studies and create a chronically 
stressed rat model that displays elevated basal circulating corticosterone and leptin 
concentrations, as did Perello et al., (Perello et al., 2006), in an effort to mimic the stress 
hormone profile of obese rats, and then determine the acute stress-induced HPA response 
in both models.  These experiments could be very important in understanding the link 
between chronic stress-associated HPA dysregulation in obesity.   
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4.4 Final Summary 
 
In the work described in this thesis I have shown that the adipokine leptin likely does not 
acutely influence the HPA response to a powerful immunological stressor. This may reflect 
that leptin may only be involved in the regulation of stress signalling pathways activated by 
non-endotoxin stressors.  I have also demonstrated that SI can influence the HPA response 
to acute stress, and that varying lengths of SI can induce different changes in HPA function, 
resulting in HPA hyper/hypoactivity in response to acute stress.  More work is required to 
further understand the long term effects of HPA dysregulation and how this may be 
important in metabolic and psychiatric disease. 
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Appendix I - Solutions 
 
0.01M Phosphate Buffered Saline (PBS) 
0.1M PBS was diluted 1:10 in Glass Distilled Water (GDW) 
0.05M (hydroxymethyl)aminomethane Hydrogen Chloride (TrisHCl) solution (pH 7.6)  
6.05g Trizma base was dissolved in 1 litre GDW and the pH was adjusted to 7.6 with 
HCl  
0.1M PBS 
28.2g Na2HPO4.2H20, 5.44g KH2PO4 and 174g NaCl (VWR International Ltd., Dorset, 
UK) were made up to 2 litres in GDW, the pH was measured and confirmed to be 7.4 
and this solution was stored at 4°C  
0.2M PBS 
56.4g Na2HPO4.2H20, 10.88g KH2PO4 and 348g NaCl (VWR International Ltd., 
Dorset, UK) were made up to 2 litres in GDW, the pH was measured and confirmed 
to be 7.4 and this solution was stored at 4°C  
1% Agarose Gel (for two large gels) 
3.3g Agarose (VWR International Ltd., Dorset, UK) 
330ml GDW 
16.5ul Ethylenediaminetetraacetic acid (EDTA) (VWR International Ltd., Dorset, UK) 
7ml 50 x Tris-acetate - EDTA (TAE) buffer 
3,3' Diaminobenzidine (DAB) solution 
0.01M PBS 
50mg/ml DAB (Sigma-Aldrich, Dorset, UK) 
30% (v/v) Hydrogen Peroxide (H2O2) (VWR International Ltd., Dorset, UK)  
40% Sucrose solution  
400g of sucrose (Tate & Lyle, London, UK) 
Dissolved in GDW up to a volume of 1 litre  
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50% (v/v), 70% (v/v) and 100% Ethanol solutions 
Absolute ethanol was diluted in GDW to obtain various concentrations of ethanol 
50x TAE Buffer 
242g Trizma Base (Sigma-Aldrich, Dorset, UK) 
57.1ml Acetic acid (Sigma-Aldrich, Dorset, UK) 
18.6g EDTA (Sigma-Aldrich, Dorset, UK) 
Made up to 1L with GDW 
Antifreeze  
0.2M PBS 
30% (v/v) Ethylene glycol (VWR International Ltd., Dorset, UK)   
20% (v/v) Glycerol (VWR International Ltd., Dorset, UK)   
GDW 
Blocking solution  
0.01M PBS 
3% (v/v) Goat serum (Generon, Berkshire, UK) 
0.25% (v/v) Triton X-100 (VWR International Ltd., Dorset, UK) 
H2O2-Methanol solution 
Methanol (VWR International Ltd., Dorset, UK) 
0.6% (v/v) H2O2 (VWR International Ltd., Dorset, UK)    
PBS Formaldehyde (FA) solution  
0.01M PBS  
4% (v/v) FA (VWR International Ltd., Dorset, UK)  
PBS Tween solution (PBST)  
0.01M PBS 
0.05% (v/v) Tween-20 (VWR International Ltd., Dorset, UK) 
Primary antibody diluent (same as blocking solution)  
Running Buffer 
20ml 50 x TAE 
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75ul Ethidium Bromide (EtBr) (Fisher Scientific, Loughborough, UK) 
1L GDW 
Secondary antibody diluent 
0.01M PBS 
0.3% (w/v) Bovine serum albumin (BSA) (Sigma-Aldrich, Dorset, UK) 
0.25% (v/v) Triton X-100 (VWR International Ltd., Dorset, UK)  
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Appendix II - List of Suppliers 
 
Applied Biosystems, Texas, USA  
B. Braun Medical Ltd., Sheffield, UK 
BDH, Dorset, UK  
Boeco, Hamburg, Germany 
Braintree Scientific Inc., Massachusetts, USA 
Cayman Chemical Company, Michigan, USA 
Charles River, Kent, UK  
Crystal Chem Inc., Illinois, USA  
Dako UK Ltd., Cambridgeshire, UK  
DiaSorin, Dublin, Ireland 
Eppendorf, Hamburg, Germany 
Generon, Berkshire, UK 
GraphPad Software Inc., California, USA 
Hettich Lab Technology, Tuttlingen, Germany  
Invitrogen, Paisley, UK 
Merck Chemicals Ltd., Nottinghamshire, UK 
MJ Research Inc., Quebec, Canada 
NIDDK, Bethesda, USA 
Qiagen, Venlo, Netherlands 
R&D Systems, Abingdon, UK 
Shandon Southern Products Ltd., Cheshire, UK 
Sigma-Aldrich, Dorset, UK 
Special Diet Services Ltd., Witham, Essex 
Tate & Lyle, London, UK 
Thermo Scientific, Massachusetts, USA 
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Vector Laboratories, Peterborough, UK 
VWR International Ltd., Dorset, UK 
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